{
    "headline": "Unlocking market access for gene therapies in the United States",
    "link": "https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states",
    "content": "<!DOCTYPE html><html dir=\"ltr\" lang=\"en\"><head><meta charset=\"utf-8\"><meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\"><meta http-equiv=\"X-UA-Compatible\" content=\"IE=edge\"><iframe src=\"javascript:void(0)\" title=\"\" role=\"presentation\" style=\"width: 0px; height: 0px; border: 0px; display: none;\"></iframe><script>var McKinsey = {\"ArticleTemplate\":\"Legacy\",\"DaysSinceCMSPublication\":\"600\",\"DisplayDate\":\"8/22/2019\",\"OriginalPublicationDate\":\"8/22/2019\",\"SitecoreId\":\"{81394B9F-5451-4AA5-BAD7-E4DCCFC807B3}\",\"Title\":\"Unlocking market access for gene therapies in the United States\",\"ArticleType\":\"Article\",\"ContentType\":\"Article\",\"ServerNumber\":\"\",\"IsPageRestricted\":\"true\",\"UserID\":\"\",\"RegistrationDate\":\"\",\"LoginStatus\":\"logged_out\",\"JobTitle\":\"\",\"CompanyName\":\"\",\"blogTags\":null}; var pageMetaInformation = {\"CurrentLanguage\":\"en\",\"AlternateLanguages\":[{\"DisplayName\":\"English\",\"LanguageCode\":\"en\",\"Url\":\"/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\"}],\"NavigationLink\":\"industries\",\"ActiveItemId\":\"{BB8498AC-8CC4-4BFB-8832-53C76F3E61CF}\",\"OfficeCode\":\"\",\"MiniSiteId\":\"{CDBF3A89-AE60-459E-ACF8-786E31307534}\"};</script><link rel=\"icon\" href=\"/favicon.ico\"><link href=\"https://www.mckinsey.com/redesign/resources/css/styles-rc.css\" rel=\"stylesheet\"><link rel=\"manifest\" href=\"/manifest.json\"><link rel=\"dns-prefetch\" href=\"//cdn.dynamicyield.com\"><link rel=\"dns-prefetch\" href=\"//st.dynamicyield.com\"><link rel=\"dns-prefetch\" href=\"//rcom.dynamicyield.com\"><link rel=\"dns-prefetch\" href=\"//cdn.cookielaw.org\"><link rel=\"preconnect\" href=\"//assets.adobedtm.com\"><link rel=\"preconnect\" href=\"//connect.facebook.net\"><link rel=\"preconnect\" href=\"//static.hotjar.com\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/bower/Bower-Bold.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/regular/McKinseySans-Regular.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/medium/McKinseySans-Medium.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/light/McKinseySans-Light.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/italic/McKinseySans-Italic.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/light-italic/McKinseySans-LightItalic.woff2\" type=\"font/woff2\" crossorigin=\"\"><link rel=\"preload\" as=\"font\" href=\"/next-static/fonts/mckinsey-sans/medium-italic/McKinseySans-MediumItalic.woff2\" type=\"font/woff2\" crossorigin=\"\"><meta name=\"apple-itunes-app\" content=\"app-id=674902075\"><link rel=\"apple-touch-icon\" sizes=\"57x57\" href=\"/next-static/images/mck-touch-icon-57x57.png\"><link rel=\"apple-touch-icon\" sizes=\"72x72\" href=\"/next-static/images/mck-touch-icon-72x72.png\"><link rel=\"apple-touch-icon\" sizes=\"114x114\" href=\"/next-static/images/mck-touch-icon-114x114.png\"><link rel=\"apple-touch-icon\" sizes=\"144x144\" href=\"/next-static/images/mck-touch-icon-144x144.png\"><link rel=\"apple-touch-icon\" sizes=\"152x152\" href=\"/next-static/images/mck-touch-icon-152x152.png\"><link rel=\"apple-touch-icon\" sizes=\"167x167\" href=\"/next-static/images/mck-touch-icon-167x167.png\"><link rel=\"apple-touch-icon\" sizes=\"180x180\" href=\"/next-static/images/mck-touch-icon-180x180.png\"><meta content=\"no-referrer-when-downgrade\" name=\"referrer\"><meta content=\"McKinsey &amp; Company\" property=\"og:site_name\" name=\"site_name\"><meta content=\"Unlocking market access for gene therapies in the United States\" property=\"og:title\" name=\"title\"><meta content=\"Widening access to the gene therapy market through a better payment system holds great promise for treating a variety of diseases.\" property=\"og:description\" name=\"description\"><meta content=\"https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\" name=\"url\" property=\"og:url\"><meta content=\"index,follow,all\" name=\"robots\"><meta content=\"https://www.mckinsey.com/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/unlocking-market-access-5050-1536x1536.jpg\" property=\"og:image\" name=\"image\"><meta content=\"{81394B9F-5451-4AA5-BAD7-E4DCCFC807B3}\" name=\"sid\"><link href=\"https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\" rel=\"canonical\"><meta content=\"Life Sciences\" name=\"practice-name\"><meta content=\"N20\" name=\"practice-code\"><meta content=\"summary_large_image\" name=\"twitter:card\"><meta content=\"@mckinsey\" name=\"twitter:site\"><title>Unlocking access to the gene therapy market in the United States | McKinsey</title><meta content=\"Insights &amp; Publications\" name=\"sections\"><meta content=\"Unlocking market access for gene therapies in the United States\" name=\"twitter:title\"><meta content=\"Widening access to the gene therapy market through a better payment system holds great promise for treating a variety of diseases.\" name=\"twitter:description\"><meta content=\"Article\" property=\"contenttype\" name=\"contenttype\"><meta content=\"https://www.mckinsey.com/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/unlocking-market-access-5050-1536x1536.jpg?mw=677&amp;car=42:25\" name=\"twitter:image\"><meta content=\"Unlocking market access for gene therapies in the United States\" name=\"twitter:image:alt\"><meta content=\"true\" name=\"mobileready\"><meta content=\"public\" name=\"accesslevel\"><meta content=\"false\" name=\"excludefromclientlink\"><meta content=\"article\" name=\"articletype\"><meta content=\"Toby AuWerter | Jeff Smith | Josh Sternberg | Lydia The\" name=\"authors-name\"><meta content=\"2019-08-22T00:00:00Z\" name=\"itemdate\"><meta content=\"Life Sciences | Article | August 22, 2019\" name=\"searchresults-tags\"><script type=\"application/ld+json\">{\"@context\":\"https://schema.org\",\"@type\":\"Article\",\"url\":\"https://www.mckinsey.com\",\"publisher\":{\"@type\":\"Organization\",\"name\":\"McKinsey & Company\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://www.mckinsey.com/~/media/Thumbnails/Mck_Logo\"}},\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\"},\"datePublished\":\"2019-08-22T00:00:00Z\",\"dateCreated\":\"2019-08-20T07:22:45Z\",\"dateModified\":\"2019-08-22T00:00:00Z\",\"heading\":\"Unlocking market access for gene therapies in the United States\",\"image\":\"https://www.mckinsey.com/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/unlocking-market-access-5050-1536x1536.jpg\",\"description\":\"Widening access to the gene therapy market through a better payment system holds great promise for treating a variety of diseases.\",\"author\":[{\"@type\":\"Person\",\"name\":\"Toby AuWerter\"},{\"@type\":\"Person\",\"name\":\"Jeff Smith\"},{\"@type\":\"Person\",\"name\":\"Josh Sternberg\"},{\"@type\":\"Person\",\"name\":\"Lydia The\"}]}</script><meta charset=\"utf-8\"><meta name=\"next-head-count\" content=\"58\"><meta name=\"next-font-preconnect\"><script src=\"\" id=\"onetrust-wrapperchecker\" data-nscript=\"beforeInteractive\">function OptanonWrapperChecker() {}</script><link rel=\"preload\" href=\"/_next/static/css/2fad2c5744177bb8.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/2fad2c5744177bb8.css\" data-n-g=\"\"><link rel=\"preload\" href=\"/_next/static/css/dc5a0fd9c531d8ae.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/dc5a0fd9c531d8ae.css\" data-n-p=\"\"><link rel=\"preload\" href=\"/_next/static/css/529ed6e2fac958b2.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/529ed6e2fac958b2.css\"><link rel=\"preload\" href=\"/_next/static/css/72fc56b1fbe032aa.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/72fc56b1fbe032aa.css\"><link rel=\"preload\" href=\"/_next/static/css/06ae37db5ebc260c.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/06ae37db5ebc260c.css\"><link rel=\"preload\" href=\"/_next/static/css/5e45d445fc213154.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/5e45d445fc213154.css\"><link rel=\"preload\" href=\"/_next/static/css/0935b32e9890fd0a.css\" as=\"style\"><link rel=\"stylesheet\" href=\"/_next/static/css/0935b32e9890fd0a.css\"><noscript data-n-css=\"\"></noscript><script defer=\"\" nomodule=\"\" src=\"/_next/static/chunks/polyfills-5cd94c89d3acac5f.js\"></script><script src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\" data-document-language=\"true\" type=\"text/javascript\" data-domain-script=\"915b5091-0d7e-44d2-a8c4-cf08267e52fe\" defer=\"\" data-nscript=\"beforeInteractive\"></script><script defer=\"\" src=\"/_next/static/chunks/281.674cd4210cb46873.js\"></script><script defer=\"\" src=\"/_next/static/chunks/6731.9bccca8a7edb0704.js\"></script><script defer=\"\" src=\"/_next/static/chunks/8578.3a4bfe7b76c8d5b2.js\"></script><script defer=\"\" src=\"/_next/static/chunks/2991.4cb0aa2f9f53e653.js\"></script><script defer=\"\" src=\"/_next/static/chunks/8391.a64dec5b7b976b97.js\"></script><script defer=\"\" src=\"/_next/static/chunks/67.8479772cf0b0738e.js\"></script><script src=\"/_next/static/chunks/webpack.47afe4b83145c95f.js\" defer=\"\"></script><script src=\"/_next/static/chunks/framework.62bbe2ca94854a85.js\" defer=\"\"></script><script src=\"/_next/static/chunks/main.51e10588adc949ca.js\" defer=\"\"></script><script src=\"/_next/static/chunks/pages/_app.e3dd57df2dc16789.js\" defer=\"\"></script><script src=\"/_next/static/chunks/3b1baa31.cd6cdac6158774d8.js\" defer=\"\"></script><script src=\"/_next/static/chunks/7d0bf13e.8f3383787afb45af.js\" defer=\"\"></script><script src=\"/_next/static/chunks/1354.c34ddc4bd7c986c8.js\" defer=\"\"></script><script src=\"/_next/static/chunks/408.9bf4e4647a127fd0.js\" defer=\"\"></script><script src=\"/_next/static/chunks/pages/%5B%5B...path%5D%5D.99501948ed14e00a.js\" defer=\"\"></script><script src=\"/_next/static/AymXir4ImcRSnB3UIpSL6/_buildManifest.js\" defer=\"\"></script><script src=\"/_next/static/AymXir4ImcRSnB3UIpSL6/_ssgManifest.js\" defer=\"\"></script><script src=\"/_next/static/AymXir4ImcRSnB3UIpSL6/_middlewareManifest.js\" defer=\"\"></script>\n<script>(window.BOOMR_mq=window.BOOMR_mq||[]).push([\"addVar\",{\"rua.upush\":\"false\",\"rua.cpush\":\"false\",\"rua.upre\":\"false\",\"rua.cpre\":\"false\",\"rua.uprl\":\"false\",\"rua.cprl\":\"false\",\"rua.cprf\":\"false\",\"rua.trans\":\"SJ-b7ca1abb-ecba-4149-9919-3f315fab5f35\",\"rua.cook\":\"true\",\"rua.ims\":\"false\",\"rua.ufprl\":\"false\",\"rua.cfprl\":\"false\",\"rua.isuxp\":\"false\",\"rua.texp\":\"norulematch\",\"rua.ceh\":\"false\",\"rua.ueh\":\"false\",\"rua.ieh.st\":\"0\"}]);</script>\n                              <script>!function(a){var e=\"https://s.go-mpulse.net/boomerang/\",t=\"addEventListener\";if(\"False\"==\"True\")a.BOOMR_config=a.BOOMR_config||{},a.BOOMR_config.PageParams=a.BOOMR_config.PageParams||{},a.BOOMR_config.PageParams.pci=!0,e=\"https://s2.go-mpulse.net/boomerang/\";if(window.BOOMR_API_key=\"TURRK-8ADJT-WDUC5-TC32E-KV9ND\",function(){function n(e){a.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!a.BOOMR||!a.BOOMR.version&&!a.BOOMR.snippetExecuted){a.BOOMR=a.BOOMR||{},a.BOOMR.snippetExecuted=!0;var i,_,o,r=document.createElement(\"iframe\");if(a[t])a[t](\"load\",n,!1);else if(a.attachEvent)a.attachEvent(\"onload\",n);r.src=\"javascript:void(0)\",r.title=\"\",r.role=\"presentation\",(r.frameElement||r).style.cssText=\"width:0;height:0;border:0;display:none;\",o=document.getElementsByTagName(\"script\")[0],o.parentNode.insertBefore(r,o);try{_=r.contentWindow.document}catch(O){i=document.domain,r.src=\"javascript:var d=document.open();d.domain='\"+i+\"';void(0);\",_=r.contentWindow.document}_.open()._l=function(){var a=this.createElement(\"script\");if(i)this.domain=i;a.id=\"boomr-if-as\",a.src=e+\"TURRK-8ADJT-WDUC5-TC32E-KV9ND\",BOOMR_lstart=(new Date).getTime(),this.body.appendChild(a)},_.write(\"<bo\"+'dy onload=\"document._l();\">'),_.close()}}(),\"\".length>0)if(a&&\"performance\"in a&&a.performance&&\"function\"==typeof a.performance.setResourceTimingBufferSize)a.performance.setResourceTimingBufferSize();!function(){if(BOOMR=a.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var e=\"false\"==\"true\"?1:0,t=\"cookiepresent\",n=\"ajsxrwycc6kamzy2osga-f-b91e55685-clientnsv4-s.akamaihd.net\",i=\"false\"==\"true\"?2:1,_={\"ak.v\":\"39\",\"ak.cp\":\"19387\",\"ak.ai\":parseInt(\"285213\",10),\"ak.ol\":\"0\",\"ak.cr\":15,\"ak.ipv\":4,\"ak.proto\":\"h2\",\"ak.rid\":\"4aed5f\",\"ak.r\":49473,\"ak.a2\":e,\"ak.m\":\"a\",\"ak.n\":\"essl\",\"ak.bpcip\":\"2.101.120.0\",\"ak.cport\":63914,\"ak.gh\":\"2.21.6.28\",\"ak.quicv\":\"\",\"ak.tlsv\":\"tls1.3\",\"ak.0rtt\":\"\",\"ak.0rtt.ed\":\"\",\"ak.csrc\":\"-\",\"ak.acc\":\"\",\"ak.t\":\"1729787020\",\"ak.ak\":\"hOBiQwZUYzCg5VSAfCLimQ==lj9AM+V1R5hOl+kt5pLG5UUrs5YrXLGgnM9q13aLIz+nWfb3HwIqDtLYvHyxDFnTI4AyhQzc+J+45SP6SQgavvW6yyLSZ1OWQ26I9QAyYHE3mQgXlL/F3SiE1ZOA3J6ZLnOLJVkefeJZS24SsUJ8xvcD7XTQxfINolffw8762PNpzzfGS2jNSoJz53+EElgzEN62rxneymuRIDx51bGRPhzp4OCjGahl1NXD8dN1pTJupezh2j9RrIi8hTWwMAUak1bBSOAsRPv/8AUEs9NjpkLTe3F0o3un32Y3D+ot7l8RMgCoGlMA4olURrxIxF9Ay37Lg2jcdvbE6sPCOvVhjALf8rH+XctpmXhRcT13UKJPb4RS+acYNz7/BDdVYtH6/UiU34HZPyQKJ+H+ikLdB1Dh8kElHeVRh1FH6reAcpw=\",\"ak.pv\":\"570\",\"ak.dpoabenc\":\"\",\"ak.tf\":i};if(\"\"!==t)_[\"ak.ruds\"]=t;var o={i:!1,av:function(e){var t=\"http.initiator\";if(e&&(!e[t]||\"spa_hard\"===e[t]))_[\"ak.feo\"]=void 0!==a.aFeoApplied?1:0,BOOMR.addVar(_)},rv:function(){var a=[\"ak.bpcip\",\"ak.cport\",\"ak.cr\",\"ak.csrc\",\"ak.gh\",\"ak.ipv\",\"ak.m\",\"ak.n\",\"ak.ol\",\"ak.proto\",\"ak.quicv\",\"ak.tlsv\",\"ak.0rtt\",\"ak.0rtt.ed\",\"ak.r\",\"ak.acc\",\"ak.t\",\"ak.tf\"];BOOMR.removeVar(a)}};BOOMR.plugins.AK={akVars:_,akDNSPreFetchDomain:n,init:function(){if(!o.i){var a=BOOMR.subscribe;a(\"before_beacon\",o.av,null,null),a(\"onbeacon\",o.rv,null,null),o.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script><style type=\"text/css\">.mdc-c-button___U4iY2_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;border:var(--mdc-size-border-width-1) solid #0000;border-radius:0;color:var(--text-color-default);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);padding:0;text-align:center}.mdc-c-button___U4iY2_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--primary___Ed-lT_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;background-color:var(--button-primary-background);border:var(--mdc-size-border-width-1) solid #0000;border-radius:0;color:var(--button-primary-text);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);min-height:var(--mdc-size-spacing-32);min-width:200px;padding:0;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16);text-align:center;transition:all .12s linear}@media (hover:hover){.mdc-c-button--primary___Ed-lT_990311c:hover{background-color:var(--button-primary-background-hover);border:var(--mdc-size-border-width-1) solid var(--button-primary-border-hover);box-shadow:0 7px 14px 0 #0003;color:var(--button-primary-text-hover);outline:none;transform:translateY(-2px)}}.mdc-c-button--primary___Ed-lT_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--primary___Ed-lT_990311c .mdc-c-icon___1vWkz_990311c:before{color:var(--button-primary-text)}.mdc-c-button--primary___Ed-lT_990311c .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-primary-text);color:var(--button-primary-background)}@media (hover:hover){.mdc-c-button--primary___Ed-lT_990311c:hover .mdc-c-icon___1vWkz_990311c:before{color:var(--button-primary-text-hover)}.mdc-c-button--primary___Ed-lT_990311c:hover .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-primary-text-hover);color:var(--button-primary-background-hover)}}.mdc-c-button--primary___Ed-lT_990311c:focus .mdc-c-icon___1vWkz_990311c:before{color:var(--button-primary-text)}.mdc-c-button--primary___Ed-lT_990311c:focus .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-primary-text);color:var(--button-primary-background)}.mdc-c-button--secondary___Boipq_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;background-color:var(--button-primary-background);background-color:var(--button-secondary-background);border:var(--mdc-size-border-width-1) solid var(--button-secondary-border);border-radius:0;color:var(--button-primary-text);color:var(--button-secondary-text);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);min-height:var(--mdc-size-spacing-32);min-width:200px;padding:0;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16);text-align:center;transition:all .12s linear}@media (hover:hover){.mdc-c-button--secondary___Boipq_990311c:hover{background-color:var(--button-primary-background-hover);background-color:var(--button-secondary-background-hover);border:var(--mdc-size-border-width-1) solid var(--button-primary-border-hover);border:var(--mdc-size-border-width-1) solid var(--button-secondary-border-hover);box-shadow:0 7px 14px 0 #0003;color:var(--button-primary-text-hover);color:var(--button-secondary-text-hover);outline:none;transform:translateY(-2px)}}.mdc-c-button--secondary___Boipq_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--secondary___Boipq_990311c .mdc-c-icon___1vWkz_990311c:before{color:var(--button-secondary-text);line-height:1}.mdc-c-button--secondary___Boipq_990311c .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-secondary-text);color:var(--mdc-color-neutral-white)}@media (hover:hover){.mdc-c-button--secondary___Boipq_990311c:hover .mdc-c-icon___1vWkz_990311c:before{color:var(--button-secondary-text-hover)}.mdc-c-button--secondary___Boipq_990311c:hover .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-secondary-text-hover);color:var(--button-secondary-background-hover)}}.mdc-c-button--secondary___Boipq_990311c:focus .mdc-c-icon___1vWkz_990311c:before{color:var(--button-secondary-text)}.mdc-c-button--secondary___Boipq_990311c:focus .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-secondary-text);color:var(--button-secondary-icon-focus)}.mdc-c-button--tertiary___zPM6q_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:var(--button-primary-background);background-color:initial;border:var(--mdc-size-border-width-1) solid var(--button-tertiary-border);border-radius:0;color:var(--button-primary-text);color:var(--button-tertiary-text);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);min-height:var(--mdc-size-spacing-32);min-width:200px;padding:0;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16);text-align:center;transition:all .12s linear}@media (hover:hover){.mdc-c-button--tertiary___zPM6q_990311c:hover{background-color:var(--button-primary-background-hover);background-color:var(--button-tertiary-background-hover);border:var(--mdc-size-border-width-1) solid var(--button-primary-border-hover);border:var(--mdc-size-border-width-1) solid var(--button-tertiary-border-hover);box-shadow:0 7px 14px 0 #0003;color:var(--button-primary-text-hover);color:var(--button-tertiary-text-hover);outline:none;transform:translateY(-2px)}}.mdc-c-button--tertiary___zPM6q_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--tertiary___zPM6q_990311c .mdc-c-icon___1vWkz_990311c:before{color:var(--button-tertiary-text)}.mdc-c-button--tertiary___zPM6q_990311c .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-tertiary-text);color:var(--button-tertiary-text-hover)}@media (hover:hover){.mdc-c-button--tertiary___zPM6q_990311c:hover .mdc-c-icon___1vWkz_990311c:before{color:var(--button-tertiary-text-hover)}.mdc-c-button--tertiary___zPM6q_990311c:hover .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-tertiary-text-hover);color:var(--button-tertiary-text)}}.mdc-c-button--tertiary___zPM6q_990311c:focus .mdc-c-icon___1vWkz_990311c:before{color:var(--button-tertiary-text)}.mdc-c-button--tertiary___zPM6q_990311c:focus .mdc-c-icon--radial___uCcK5_990311c:before{background-color:var(--button-tertiary-text);color:var(--button-tertiary-text-hover)}.mdc-c-button--minimal___Uzgaz_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;border-bottom:var(--mdc-size-border-width-1) solid #0000;border:var(--mdc-size-border-width-1) solid #0000;border-bottom-width:var(--mdc-size-border-width-2);border-radius:0;color:var(--button-minimal-primary);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);padding:0;text-align:center}@media (hover:hover){.mdc-c-button--minimal___Uzgaz_990311c:hover{border-bottom-color:var(--button-minimal-primary)}}.mdc-c-button--minimal___Uzgaz_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--minimal___Uzgaz_990311c.mdc-c-button--size-large___jwpUy_990311c,.mdc-c-button--minimal___Uzgaz_990311c.mdc-c-button--size-small___uvMIB_990311c{padding-left:0;padding-right:0}.mdc-c-button--minimal-secondary___W0Qrc_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;border-bottom:var(--mdc-size-border-width-1) solid #0000;border:var(--mdc-size-border-width-1) solid #0000;border-bottom-width:var(--mdc-size-border-width-2);border-radius:0;color:var(--button-minimal-secondary);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);padding:0;text-align:center}@media (hover:hover){.mdc-c-button--minimal-secondary___W0Qrc_990311c:hover{border-bottom-color:var(--button-minimal-secondary)}}.mdc-c-button--minimal-secondary___W0Qrc_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--minimal-secondary___W0Qrc_990311c.mdc-c-button--size-large___jwpUy_990311c,.mdc-c-button--minimal-secondary___W0Qrc_990311c.mdc-c-button--size-small___uvMIB_990311c{padding-left:0;padding-right:0}.mdc-c-button--minimal-tertiary___YwyAF_990311c{grid-gap:var(--mdc-size-spacing-8);align-items:center;background-color:initial;border-bottom:var(--mdc-size-border-width-1) solid #0000;border:var(--mdc-size-border-width-1) solid #0000;border-bottom-width:var(--mdc-size-border-width-2);border-radius:0;color:var(--button-minimal-tertiary);cursor:pointer;display:inline-grid;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);grid-auto-flow:column;justify-content:center;line-height:var(--mdc-size-line-height-24);padding:0;text-align:center}@media (hover:hover){.mdc-c-button--minimal-tertiary___YwyAF_990311c:hover{border-bottom-color:var(--button-minimal-tertiary-hover);color:var(--button-minimal-tertiary-hover)}}.mdc-c-button--minimal-tertiary___YwyAF_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default)}.mdc-c-button--minimal-tertiary___YwyAF_990311c.mdc-c-button--size-large___jwpUy_990311c,.mdc-c-button--minimal-tertiary___YwyAF_990311c.mdc-c-button--size-small___uvMIB_990311c{padding-left:0;padding-right:0}.mdc-c-button--size-large___jwpUy_990311c{font-size:var(--mdc-size-font-18);line-height:var(--mdc-size-line-height-28);min-height:var(--mdc-size-spacing-48);padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-24)}.mdc-c-button--size-small___uvMIB_990311c{font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20);min-height:var(--mdc-size-spacing-32);min-width:var(--mdc-size-spacing-72);padding:var(--mdc-size-spacing-4) var(--mdc-size-spacing-16)}.mdc-c-button--btn-compact___P-iHa_990311c{min-width:auto}.mdc-c-button--disabled___Xbyp5_990311c{border:none!important;cursor:not-allowed}.mdc-c-button--disabled___Xbyp5_990311c:active,.mdc-c-button--disabled___Xbyp5_990311c:focus,.mdc-c-button--disabled___Xbyp5_990311c:hover{border:none!important;box-shadow:none!important;outline:none!important;transform:none!important}.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--primary___Ed-lT_990311c{background-color:var(--button-primary-disabled-background);color:var(--button-disabled-text)}.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--secondary___Boipq_990311c,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--tertiary___zPM6q_990311c{background-color:var(--button-secondary-disabled-background);border:var(--mdc-size-border-width-1) solid var(--button-secondary-disabled-border)!important;color:var(--button-disabled-text)}.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--secondary___Boipq_990311c:active,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--secondary___Boipq_990311c:focus,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--secondary___Boipq_990311c:hover,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--tertiary___zPM6q_990311c:active,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--tertiary___zPM6q_990311c:focus,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--tertiary___zPM6q_990311c:hover{border:var(--mdc-size-border-width-1) solid var(--button-secondary-disabled-border)!important}.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--minimal-secondary___W0Qrc_990311c,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--minimal-tertiary___YwyAF_990311c,.mdc-c-button--disabled___Xbyp5_990311c.mdc-c-button--minimal___Uzgaz_990311c{color:var(--button-minimal-disabled)}</style><style type=\"text/css\">.mdc-c-link-cta___NBQVi_990311c,.mdc-c-link-icon___SEKyg_990311c,.mdc-c-link-inline___7DRrt_990311c,.mdc-c-link___lBbY1_990311c{align-items:center;color:currentcolor;display:inline-flex;gap:var(--mdc-size-spacing-8)}.mdc-c-link-cta___NBQVi_990311c:focus-visible,.mdc-c-link-icon___SEKyg_990311c:focus-visible,.mdc-c-link-inline___7DRrt_990311c:focus-visible,.mdc-c-link___lBbY1_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--link-color-selected);outline-offset:var(--mdc-size-border-width-4)}.mdc-c-link___lBbY1_990311c{color:var(--link-color-default);text-decoration:none}.mdc-c-link___lBbY1_990311c:focus .mdc-c-link__label___Pfqtd_990311c,.mdc-c-link___lBbY1_990311c:hover .mdc-c-link__label___Pfqtd_990311c{text-decoration-line:underline;text-decoration-thickness:calc(var(--mdc-size-spacing-4)/2);text-underline-offset:calc(var(--mdc-size-spacing-4)/2)}.mdc-c-link--secondary___TSFam_990311c{color:var(--link-color-secondary-default)}.mdc-c-link-inline___7DRrt_990311c{border-bottom:2px solid var(--link-inline-default-border-color);color:currentcolor;line-height:1;padding-left:calc(var(--mdc-size-spacing-4)/2);padding-right:calc(var(--mdc-size-spacing-4)/2);text-decoration:none;transition:.12s linear;transition-property:background-color,color}.mdc-c-link-inline___7DRrt_990311c:hover{background-color:var(--link-inline-default-background-hover-color);border-color:var(--link-inline-default-border-hover-color);color:var(--link-inline-default-hover-color);text-decoration:none}.mdc-c-link-inline--secondary___YKoOK_990311c{border-bottom-color:initial}.mdc-c-link-inline--secondary___YKoOK_990311c:hover{background-color:var(--link-inline-secondary-background-hover-color);border-bottom-color:var(--link-inline-secondary-background-hover-color);color:var(--link-inline-secondary-hover-color)}.mdc-c-link-cta___NBQVi_990311c{color:var(--link-color-text-default);display:inline-block;font-weight:var(--mdc-font-weight-medium)}.mdc-c-link-cta___NBQVi_990311c span[class$=icon]{padding-left:var(--mdc-size-spacing-8);padding-right:var(--mdc-size-spacing-16);transition:padding .4s ease-in-out;vertical-align:initial}.mdc-c-link-cta___NBQVi_990311c span[class$=icon]:before{color:var(--link-cta-icon-color)}.mdc-c-link-cta___NBQVi_990311c:active,.mdc-c-link-cta___NBQVi_990311c:focus,.mdc-c-link-cta___NBQVi_990311c:hover{color:var(--link-color-text-default-hover)}.mdc-c-link-cta___NBQVi_990311c:active span[class$=icon],.mdc-c-link-cta___NBQVi_990311c:focus span[class$=icon],.mdc-c-link-cta___NBQVi_990311c:hover span[class$=icon]{padding-left:var(--mdc-size-spacing-24);padding-right:0}.mdc-c-link-cta--size-large___udJoH_990311c{font-size:var(--mdc-size-font-20);font-weight:var(--mdc-font-weight-regular);line-height:var(--mdc-size-line-height-32)}@media (min-width:1180px){.mdc-c-link-cta--size-large___udJoH_990311c{font-size:var(--mdc-size-font-28);line-height:var(--mdc-size-line-height-40)}.mdc-c-link-cta--size-large___udJoH_990311c span[class$=icon]{padding-left:var(--mdc-size-spacing-16);padding-right:var(--mdc-size-spacing-32);transition:padding .4s ease-in-out;vertical-align:initial}.mdc-c-link-cta--size-large___udJoH_990311c span[class$=icon]:before{color:var(--link-cta-icon-color)}.mdc-c-link-cta--size-large___udJoH_990311c:active,.mdc-c-link-cta--size-large___udJoH_990311c:focus,.mdc-c-link-cta--size-large___udJoH_990311c:hover{color:var(--link-color-text-default-hover)}.mdc-c-link-cta--size-large___udJoH_990311c:active span[class$=icon],.mdc-c-link-cta--size-large___udJoH_990311c:focus span[class$=icon],.mdc-c-link-cta--size-large___udJoH_990311c:hover span[class$=icon]{padding-left:var(--mdc-size-spacing-48);padding-right:0}}.mdc-c-link-icon___SEKyg_990311c{color:var(--link-icon-color)}.mdc-c-link-icon___SEKyg_990311c:focus,.mdc-c-link-icon___SEKyg_990311c:hover{color:var(--link-icon-hover-color)}.mdc-c-link-icon___SEKyg_990311c:focus [class^=\"mdc-c-icon--radial::before\"],.mdc-c-link-icon___SEKyg_990311c:hover [class^=\"mdc-c-icon--radial::before\"]{background-color:var(--link-icon-hover-color);color:var(--link-icon-radial-hover-color)}.mdc-c-link-icon___SEKyg_990311c:focus .mdc-c-link__label___Pfqtd_990311c,.mdc-c-link-icon___SEKyg_990311c:hover .mdc-c-link__label___Pfqtd_990311c{text-decoration-line:underline}.mdc-c-link-heading___Zggl8_990311c{color:var(--link-heading-color);font-weight:var(--mdc-font-weight-medium)}.mdc-c-link-heading___Zggl8_990311c:focus,.mdc-c-link-heading___Zggl8_990311c:hover{color:var(--link-heading-hover-color);text-decoration-line:underline;text-decoration-thickness:.07em;text-underline-offset:var(--mdc-size-spacing-4)}.mdc-c-link-heading___Zggl8_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--link-color-selected);outline-offset:var(--mdc-size-border-width-4)}.mdc-c-link-heading--with-icon___ssPll_990311c{display:inline;padding-right:var(--mdc-size-spacing-8)}</style><style type=\"text/css\">.mdc-c-toast__wrapper--active___FhXwN_990311c{z-index:9999}.mdc-c-toast__wrapper--active___FhXwN_990311c>*{pointer-events:auto}.mdc-c-toast__content___aJ0xH_990311c{background:var(--mdc-color-neutral-white);box-shadow:0 7px 14px 0 #0003;max-width:min(100%,var(--mdc-breakpoint-md));padding:var(--mdc-size-spacing-16);pointer-events:auto;will-change:transform}.mdc-c-toast__alert-container___bP-MJ_990311c{padding:0!important}.mdc-c-toast__alert___xdRqn_990311c{background-color:var(--mdc-color-neutral-white)!important;border-color:var(--mdc-color-neutral-gray-06)!important;max-width:min(100%,var(--mdc-breakpoint-lg))}.mdc-c-toast__alert___xdRqn_990311c [data-component=mdc-c-icon]:focus:before,.mdc-c-toast__alert___xdRqn_990311c [data-component=mdc-c-icon]:hover:before{background-color:var(--mdc-color-neutral-gray-06)}.mdc-c-toast__message___r6An3_990311c{color:inherit;display:flex;flex:1 1 auto;justify-content:center;white-space:pre-line}</style><style type=\"text/css\">.mdc-c-module-wrapper--full-page___3XZ1n_990311c{align-items:center;display:flex;height:100dvh;justify-content:center;left:0;margin:0!important;padding:0!important;top:0;width:100vw}.mdc-c-module-wrapper--full-page___3XZ1n_990311c img:first-of-type,.mdc-c-module-wrapper--full-page___3XZ1n_990311c video:first-of-type,.mdc-c-module-wrapper--full-page___3XZ1n_990311c>.image___T6Mcc_990311c,.mdc-c-module-wrapper--full-page___3XZ1n_990311c>.mdc-c-bg-image___z77CN_990311c{height:100%;object-fit:cover;width:100%}.story-wrapper{padding:0!important}</style><style type=\"text/css\">:root .mdc-c-icon-svg___68K-O_990311c,[data-module-theme=light] .mdc-c-icon-svg___68K-O_990311c{--icon-svg-stroke-color:currentcolor;--icon-svg-fill-color:none}[data-module-theme=dark] .mdc-c-icon-svg___68K-O_990311c{--icon-svg-stroke-color:var(--mdc-color-neutral-white);--icon-svg-fill-color:none}.mdc-c-icon-svg___68K-O_990311c{display:inline-flex}.mdc-c-icon-svg___68K-O_990311c svg{fill:var(--icon-svg-fill-color)}</style><style type=\"text/css\">:root .mdc-c-icon___oi7ef_990311c,[data-module-theme=light] .mdc-c-icon___oi7ef_990311c{--icon-radial-color:var(--mdc-color-neutral-white);--icon-radial-background-color:var(--mdc-color-neutral-black);--icon-radial-background-color-hover:var(--mdc-color-palette-electric-blue)}[data-module-theme=dark] .mdc-c-icon___oi7ef_990311c{--icon-radial-color:var(--mdc-color-neutral-black);--icon-radial-background-color:var(--mdc-color-neutral-white);--icon-radial-background-color-hover:var(--mdc-color-palette-cyan)}:root .mdc-c-icon--secondary___dSlsG_990311c,[data-module-theme=light] .mdc-c-icon--secondary___dSlsG_990311c{--icon-radial-color:var(--mdc-color-neutral-black);--icon-radial-background-color:unset;--icon-radial-background-color-hover:var(--mdc-color-neutral-gray-06)}[data-module-theme=dark] .mdc-c-icon--secondary___dSlsG_990311c{--icon-radial-color:var(--mdc-color-neutral-white);--icon-radial-background-color:unset;--icon-radial-background-color-hover:var(--mdc-color-palette-cyan)}.mdc-c-icon___oi7ef_990311c{display:inline;line-height:inherit;vertical-align:middle}.mdc-c-icon___oi7ef_990311c:before{color:currentcolor;vertical-align:middle}.mdc-c-icon--outline___MU0j1_990311c:before,.mdc-c-icon--radial___y3csX_990311c:before,.mdc-c-icon-default___0TDAM_990311c:before{font-size:inherit;position:relative}.mdc-c-icon--outline___MU0j1_990311c:hover span,.mdc-c-icon--radial___y3csX_990311c:hover span,.mdc-c-icon-default___0TDAM_990311c:hover span{border-color:inherit;color:inherit}.mdc-c-icon--default___f-hQM_990311c:before{display:block}.mdc-c-icon--outline___MU0j1_990311c:before,.mdc-c-icon--radial___y3csX_990311c:before{align-items:center;border-radius:50%;display:inline-flex;flex-shrink:0;font-size:.5em;height:var(--mdc-size-icon-16);justify-content:center;width:var(--mdc-size-icon-16)}a .mdc-c-icon--outline___MU0j1_990311c:only-child:before,a .mdc-c-icon--radial___y3csX_990311c:only-child:before{transition:.12s linear;transition-property:all}a .mdc-c-icon--outline___MU0j1_990311c:hover:only-child:before,a .mdc-c-icon--radial___y3csX_990311c:hover:only-child:before{box-shadow:0 7px 14px 0 #0003;transform:translateY(-2px)}.mdc-c-icon--radial___y3csX_990311c:before{background-color:var(--icon-radial-background-color);color:var(--icon-radial-color)}a .mdc-c-icon--radial___y3csX_990311c:hover:before,button .mdc-c-icon--radial___y3csX_990311c:hover:before{background-color:var(--icon-radial-background-color-hover)}a:focus .mdc-c-icon--radial___y3csX_990311c:before,a:hover .mdc-c-icon--radial___y3csX_990311c:before{background-color:var(--link-icon-hover-color);color:var(--link-icon-radial-hover-color)}.mdc-c-icon--success___2CfF7_990311c.mdc-c-icon--radial___y3csX_990311c:before{background-color:var(--mdc-color-status-dark-green);color:var(--mdc-color-neutral-white)}.mdc-c-icon--error___3PoQX_990311c:before{color:var(--mdc-color-status-dark-red)}.mdc-c-icon--error___3PoQX_990311c.mdc-c-icon--radial___y3csX_990311c:before{background-color:var(--mdc-color-status-dark-red);color:var(--mdc-color-neutral-white)}.mdc-c-icon--info___fsGGT_990311c:before{color:var(--mdc-color-palette-electric-blue)}.mdc-c-icon--warning___iP6zl_990311c:before{color:var(--mdc-color-status-dark-yellow)}.mdc-c-icon--active___4KblW_990311c.mdc-c-icon--radial___y3csX_990311c:before{background-color:var(--icon-radial-background-color-hover)}.mdc-c-icon--active___4KblW_990311c.mdc-c-icon--outline___MU0j1_990311c:before{background-color:unset;border:var(--mdc-size-border-width-1) solid var(--icon-radial-background-color-hover);color:var(--icon-radial-background-color-hover)}a .mdc-c-icon--secondary___dSlsG_990311c.mdc-c-icon--radial___y3csX_990311c:only-child:before{transition:none}a .mdc-c-icon--secondary___dSlsG_990311c.mdc-c-icon--radial___y3csX_990311c:hover:only-child:before{box-shadow:none;transform:none}.mdc-c-icon--outline___MU0j1_990311c:before{border:var(--mdc-size-border-width-1) solid;border-radius:50%;font-size:.5em}.mdc-c-icon--size-xs___g8-q5_990311c{font-size:var(--mdc-size-icon-10)}.mdc-c-icon--size-xs___g8-q5_990311c:before{height:var(--mdc-size-icon-10);width:var(--mdc-size-icon-10)}.mdc-c-icon--size-sm___2FLYH_990311c{font-size:var(--mdc-size-icon-12)}.mdc-c-icon--size-sm___2FLYH_990311c:before{height:var(--mdc-size-icon-12);width:var(--mdc-size-icon-12)}.mdc-c-icon--size-md___yi5fA_990311c{font-size:var(--mdc-size-icon-16)}.mdc-c-icon--size-md___yi5fA_990311c:before{height:var(--mdc-size-icon-16);width:var(--mdc-size-icon-16)}.mdc-c-icon--size-lg___5rPck_990311c{font-size:var(--mdc-size-icon-24)}.mdc-c-icon--size-lg___5rPck_990311c:before{height:var(--mdc-size-icon-24);width:var(--mdc-size-icon-24)}.mdc-c-icon--size-xl___3BEee_990311c{font-size:var(--mdc-size-icon-32)}.mdc-c-icon--size-xl___3BEee_990311c:before{height:var(--mdc-size-icon-32);width:var(--mdc-size-icon-32)}.mdc-c-icon--size-xxl___cL3ZT_990311c{font-size:var(--mdc-size-icon-40)}.mdc-c-icon--size-xxl___cL3ZT_990311c:before{height:var(--mdc-size-icon-40);width:var(--mdc-size-icon-40)}.mdc-c-icon--align-right___94-AR_990311c{order:2}.mdc-c-content-icon--size-sm___2acYB_990311c,.mdc-c-content-icon--size-xs___hPSY1_990311c{font-size:var(--mdc-size-font-16)}.mdc-c-content-icon--size-md___U5-qz_990311c{font-size:var(--mdc-size-font-24)}.mdc-c-content-icon--size-lg___ALqld_990311c{font-size:var(--mdc-size-font-28)}.mdc-c-content-icon--size-xl___4LKWE_990311c{font-size:var(--mdc-size-font-36)}.mdc-c-content-icon--size-xxl___PB38p_990311c{font-size:var(--mdc-size-font-44)}</style><style type=\"text/css\">.mdc-c-heading___0fM1W_990311c{text-shadow:var(--text-shadow)}.mdc-c-heading--title___5qyOB_990311c{font-family:var(--mdc-font-family-default-primary);font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-medium);letter-spacing:.075rem;line-height:var(--mdc-size-line-height-24);text-transform:uppercase}.mdc-c-heading--title___5qyOB_990311c:lang(ar){font-family:var(--mdc-font-family-arabic-primary,var(--mdc-font-family-default-primary))}.mdc-c-heading--title___5qyOB_990311c:lang(ru){font-family:var(--mdc-font-family-russian-primary,var(--mdc-font-family-default-primary))}.mdc-c-heading--title___5qyOB_990311c:lang(vi){font-family:var(--mdc-font-family-vietnamese-primary,var(--mdc-font-family-default-primary))}.mdc-c-heading--title___5qyOB_990311c:lang(ja){font-family:var(--mdc-font-family-japanese-primary,var(--mdc-font-family-default-primary))}.mdc-c-heading--border___K8dj3_990311c{border-top:var(--mdc-size-border-width-1) solid;padding-top:var(--mdc-size-spacing-24)}.mdc-c-heading__icon___TbFKK_990311c{color:var(--link-cta-icon-color);position:absolute}</style><style type=\"text/css\">.mdc-c-description___SrnQP_990311c{text-shadow:var(--text-shadow)}.mdc-c-description___SrnQP_990311c>p:last-child{margin-bottom:0}</style><style type=\"text/css\">.mdc-c-accordion__items___yF0jA_990311c{border-bottom:var(--mdc-size-border-width-1) solid;border-top:var(--mdc-size-border-width-1) solid}.mdc-c-accordion__items--border-0___elAT7_990311c{border:none}.mdc-c-accordion__item___TaDQ0_990311c{word-break:break-word}.mdc-c-accordion__item___TaDQ0_990311c:not(:last-child){border-bottom:var(--mdc-size-border-width-1) solid}.mdc-c-accordion__title-wrapper___ujaRh_990311c{display:block!important;position:relative;text-align:inherit!important;width:100%}.mdc-c-accordion__title-wrapper___ujaRh_990311c:hover div{color:var(--button-minimal-primary)}.mdc-c-accordion__title___S2Csf_990311c{border-bottom:0;display:block;padding:var(--mdc-size-spacing-16) var(--mdc-size-spacing-48) var(--mdc-size-spacing-16) 0}.mdc-c-accordion__icon___MnUrM_990311c{position:absolute;right:var(--mdc-size-spacing-16);top:50%;transform:translateY(-50%);width:-webkit-max-content;width:max-content}.mdc-c-accordion__content-wrapper___WBkbu_990311c{padding-bottom:var(--mdc-size-spacing-16)}</style><style type=\"text/css\">.mdc-c-content-block___7p6Lu_990311c{grid-gap:var(--mdc-size-spacing-16);display:grid}.mdc-c-content-block--size-xxl___N8MW3_990311c{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-content-block--size-xxl___N8MW3_990311c [class^=mdc-c-heading]{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-76);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-92)}.mdc-c-content-block--size-xxl___N8MW3_990311c [class^=mdc-c-heading]:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xxl___N8MW3_990311c [class^=mdc-c-heading]:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xxl___N8MW3_990311c [class^=mdc-c-heading]:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xxl___N8MW3_990311c [class^=mdc-c-heading]:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xl___USpo5_990311c{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-content-block--size-xl___USpo5_990311c [class^=mdc-c-heading]{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-44);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-52)}.mdc-c-content-block--size-xl___USpo5_990311c [class^=mdc-c-heading]:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xl___USpo5_990311c [class^=mdc-c-heading]:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xl___USpo5_990311c [class^=mdc-c-heading]:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-xl___USpo5_990311c [class^=mdc-c-heading]:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-lg___183sK_990311c{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-content-block--size-lg___183sK_990311c [class^=mdc-c-heading]{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-36);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-44)}.mdc-c-content-block--size-lg___183sK_990311c [class^=mdc-c-heading]:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-lg___183sK_990311c [class^=mdc-c-heading]:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-lg___183sK_990311c [class^=mdc-c-heading]:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-lg___183sK_990311c [class^=mdc-c-heading]:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}.mdc-c-content-block--size-md___ZNL6I_990311c{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-content-block--size-md___ZNL6I_990311c [class^=mdc-c-heading]{font-size:var(--mdc-size-font-24);line-height:var(--mdc-size-line-height-36)}.mdc-c-content-block--size-sm___8ZwhU_990311c{font-size:var(--mdc-size-font-16);line-height:var(--mdc-size-line-height-24)}.mdc-c-content-block--size-sm___8ZwhU_990311c [class^=mdc-c-heading]{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-content-block--align-center___KRLtu_990311c{text-align:center}.mdc-c-content-block--align-center___KRLtu_990311c [class^=mdc-c-link-container]{justify-content:center;justify-items:center}.mdc-c-content-block--align-right___yCJP2_990311c{text-align:right}.mdc-c-content-block--align-right___yCJP2_990311c [class^=mdc-c-link-container]{justify-content:right;justify-items:right}</style><style type=\"text/css\">.mdc-c-link-container___xefGu_990311c{grid-gap:var(--mdc-size-spacing-16);align-items:flex-start;display:flex;flex-flow:column wrap}.mdc-c-link-container--display-column___X0HDD_990311c{align-items:center!important;flex-flow:row wrap;justify-content:flex-start}.mdc-c-link-container--align-center___ar3mu_990311c{align-items:center;justify-content:center}.mdc-c-link-container--align-right___6XjJx_990311c{align-items:flex-end;justify-content:flex-end}.mdc-c-link-container--display-row___LYWqK_990311c [class^=mdc-c-button]{align-self:stretch;max-width:100%}</style><style type=\"text/css\">.mdc-c-avatar___kVSTP_990311c{align-items:center;display:inline-flex;height:var(--mdc-avatar-size);justify-content:center;width:var(--mdc-avatar-size)}.mdc-c-avatar___kVSTP_990311c a{align-items:center;border-radius:inherit;color:var(--mdc-color-neutral-white);display:flex;height:100%;justify-content:center;overflow:hidden;width:100%}.mdc-c-avatar__hide___rnSnd_990311c{display:none}.mdc-c-avatar___kVSTP_990311c img{border-radius:inherit;height:inherit;width:inherit}.mdc-c-avatar--image___levct_990311c{background-color:var(--mdc-color-neutral-gray-04);border-radius:50%;display:inline-block}.mdc-c-avatar--image-placeholder___BX3C4_990311c{background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg width='62' height='62' xmlns='http://www.w3.org/2000/svg'%3E%3Cdefs%3E%3Cfilter id='a'%3E%3CfeColorMatrix in='SourceGraphic' values='0 0 0 0 0.701961 0 0 0 0 0.701961 0 0 0 0 0.701961 0 0 0 1.000000 0'/%3E%3C/filter%3E%3C/defs%3E%3Cg filter='url(%23a)' transform='translate(-1 -1)' fill='%23B3B3B3' fill-rule='evenodd'%3E%3Cpath d='M32 1C14.906 1 1 14.907 1 32s13.906 31 31 31 31-13.907 31-31S49.094 1 32 1ZM20 28c0-6.617 5.383-12 12-12s12 5.383 12 12v3c0 6.617-5.383 12-12 12s-12-5.383-12-12v-3Zm12 33a28.847 28.847 0 0 1-17.789-6.122C17.082 49.99 22.26 47 28 47h8c5.733 0 10.911 2.99 13.788 7.879A28.845 28.845 0 0 1 32 61Z' fill='%23000'/%3E%3C/g%3E%3C/svg%3E\");background-repeat:no-repeat;background-size:contain}.mdc-c-avatar--text___Z2T5E_990311c{align-items:center;background-color:var(--mdc-color-palette-deep-blue);border-radius:50%;color:var(--mdc-color-neutral-white);display:inline-flex;font-weight:var(--mdc-font-weight-regular);justify-content:center}</style><style type=\"text/css\">.mdc-c-header__eyebrow___PZMpI_990311c{display:inline-block;font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20);margin-bottom:var(--mdc-size-spacing-8)}.mdc-c-header__block___i1Lg-_990311c{grid-gap:var(--mdc-size-spacing-16);display:grid}</style><style type=\"text/css\">.mdc-c-bg-image___GJdv1_990311c{background-size:cover;min-height:100%}.mdc-c-bg-image--opaque-bg___CauU1_990311c{background-color:var(--mdc-color-neutral-black);bottom:0;left:0;position:absolute;right:0;top:0}</style><style type=\"text/css\">.mdc-c-tooltip___iYQYf_990311c{max-width:90%;min-width:160px;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16);position:absolute;text-align:center}@media (min-width:768px){.mdc-c-tooltip___iYQYf_990311c{max-width:500px}}.mdc-c-tooltip--min-width-auto___Na7Bp_990311c{min-width:auto}.mdc-c-tooltip__arrow___BvUKx_990311c{position:absolute;width:15px}.mdc-c-tooltip__arrow--static___tBroH_990311c{bottom:-14px;left:50%;transform:translateX(-50%)}.mdc-c-tooltip--light___3HIZT_990311c{background-color:var(--mdc-color-neutral-white)}.mdc-c-tooltip--light___3HIZT_990311c .mdc-c-tooltip__arrow___BvUKx_990311c span:before{color:var(--mdc-color-neutral-white)}.mdc-c-tooltip--semi-light___nUvVM_990311c{background-color:var(--mdc-color-neutral-gray-06)}.mdc-c-tooltip--semi-light___nUvVM_990311c .mdc-c-tooltip__arrow___BvUKx_990311c span:before{color:var(--mdc-color-neutral-gray-06)}.mdc-c-tooltip--dark___EVQsg_990311c{background-color:var(--mdc-color-palette-deep-blue)}.mdc-c-tooltip--dark___EVQsg_990311c .mdc-c-tooltip__arrow___BvUKx_990311c span:before{color:var(--mdc-color-palette-deep-blue)}.mdc-c-tooltip--elevated___KfVi2_990311c{box-shadow:0 7px 14px 0 #0003}</style><style type=\"text/css\">.mdc-c-brand-lines___HsR8E_990311c{height:0;width:0}.mdc-c-brand-lines__line___tr8-f_990311c{background-color:var(--mdc-color-palette-electric-blue);position:absolute}.mdc-c-brand-lines__line--left___tRtEV_990311c{left:0}.mdc-c-brand-lines__line--right___GLoBF_990311c{right:0}.mdc-c-brand-lines__line--top___4jrrn_990311c{top:0}.mdc-c-brand-lines__line--bottom___P7RVL_990311c{bottom:0}.mdc-c-brand-lines__line--horizontal___6Cq7-_990311c{height:20px;width:100%}@media (min-width:768px){.mdc-c-brand-lines__line--horizontal___6Cq7-_990311c{height:25px}}@media (min-width:1180px){.mdc-c-brand-lines__line--horizontal___6Cq7-_990311c{height:30px}}.mdc-c-brand-lines__line--vertical___ZPEOH_990311c{height:100%;width:20px}@media (min-width:768px){.mdc-c-brand-lines__line--vertical___ZPEOH_990311c{width:25px}}@media (min-width:1180px){.mdc-c-brand-lines__line--vertical___ZPEOH_990311c{width:30px}}.mdc-c-brand-lines__offset-line--left___e2-2s_990311c{left:-20px}.mdc-c-brand-lines__offset-line--right___rcjIK_990311c{right:-20px}.mdc-c-brand-lines__offset-line--top___-dgSE_990311c{top:-20px}.mdc-c-brand-lines__offset-line--bottom___R01BP_990311c{bottom:-20px}@media (min-width:768px){.mdc-c-brand-lines__offset-line--left___e2-2s_990311c{left:-25px}.mdc-c-brand-lines__offset-line--right___rcjIK_990311c{right:-25px}.mdc-c-brand-lines__offset-line--top___-dgSE_990311c{top:-25px}.mdc-c-brand-lines__offset-line--bottom___R01BP_990311c{bottom:-25px}}@media (min-width:1180px){.mdc-c-brand-lines__offset-line--left___e2-2s_990311c{left:-30px}.mdc-c-brand-lines__offset-line--right___rcjIK_990311c{right:-30px}.mdc-c-brand-lines__offset-line--top___-dgSE_990311c{top:-30px}.mdc-c-brand-lines__offset-line--bottom___R01BP_990311c{bottom:-30px}}.mdc-c-brand-lines__offset-filler___xRGlR_990311c{background-color:var(--mdc-color-palette-electric-blue);height:20px;position:absolute;width:20px}@media (min-width:768px){.mdc-c-brand-lines__offset-filler___xRGlR_990311c{height:25px}}@media (min-width:1180px){.mdc-c-brand-lines__offset-filler___xRGlR_990311c{height:30px}}@media (min-width:768px){.mdc-c-brand-lines__offset-filler___xRGlR_990311c{width:25px}}@media (min-width:1180px){.mdc-c-brand-lines__offset-filler___xRGlR_990311c{width:30px}}.mdc-c-brand-lines__offset-filler--left___Y71dP_990311c{left:-20px}.mdc-c-brand-lines__offset-filler--right___UeKiB_990311c{right:-20px}.mdc-c-brand-lines__offset-filler--top___yJSYc_990311c{top:-20px}.mdc-c-brand-lines__offset-filler--bottom___YyTtZ_990311c{bottom:-20px}@media (min-width:768px){.mdc-c-brand-lines__offset-filler--left___Y71dP_990311c{left:-25px}.mdc-c-brand-lines__offset-filler--right___UeKiB_990311c{right:-25px}.mdc-c-brand-lines__offset-filler--top___yJSYc_990311c{top:-25px}.mdc-c-brand-lines__offset-filler--bottom___YyTtZ_990311c{bottom:-25px}}@media (min-width:1180px){.mdc-c-brand-lines__offset-filler--left___Y71dP_990311c{left:-30px}.mdc-c-brand-lines__offset-filler--right___UeKiB_990311c{right:-30px}.mdc-c-brand-lines__offset-filler--top___yJSYc_990311c{top:-30px}.mdc-c-brand-lines__offset-filler--bottom___YyTtZ_990311c{bottom:-30px}}</style><style type=\"text/css\">@charset \"UTF-8\";blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c{border-left:none;padding-left:0}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c p{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-28);font-weight:var(--mdc-font-weight-regular);line-height:var(--mdc-size-line-height-40)}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c p:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c p:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c p:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c p:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c>p:first-of-type:before{content:\"“\";margin-left:-.4em}blockquote.mdc-c-blockquote--is-quotes___TozKo_990311c>p:last-of-type:after{content:\"”\"}blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p{font-size:var(--mdc-size-font-28);line-height:var(--mdc-size-line-height-40)}@media (min-width:768px){blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-36);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-44)}blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-medium___Q6-Js_990311c p:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p{font-size:var(--mdc-size-font-28);line-height:var(--mdc-size-line-height-40)}@media (min-width:768px){blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-36);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-44)}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}}@media (min-width:1180px){blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p{font-family:var(--mdc-font-family-default-secondary);font-size:var(--mdc-size-font-44);font-weight:var(--mdc-font-weight-light);line-height:var(--mdc-size-line-height-52)}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ar){font-family:var(--mdc-font-family-arabic-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ru){font-family:var(--mdc-font-family-russian-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(vi){font-family:var(--mdc-font-family-vietnamese-secondary,var(--mdc-font-family-default-secondary))}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c p:lang(ja){font-family:var(--mdc-font-family-japanese-secondary,var(--mdc-font-family-default-secondary))}}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c cite{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}@media (min-width:768px){blockquote.mdc-c-blockquote--size-large___n9Z06_990311c cite{font-size:var(--mdc-size-font-24);line-height:var(--mdc-size-line-height-36)}}blockquote.mdc-c-blockquote--size-large___n9Z06_990311c cite span{font-size:var(--mdc-size-font-18);line-height:var(--mdc-size-line-height-28)}@media (min-width:768px){blockquote.mdc-c-blockquote--size-large___n9Z06_990311c cite span{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}}blockquote.mdc-c-blockquote--is-align-center___l-q5n_990311c{text-align:center}blockquote.mdc-c-blockquote--is-align-right___yD7vc_990311c{text-align:right}@media (min-width:1180px){blockquote.mdc-c-blockquote--is-not-full-width___Dyvim_990311c{margin:0 auto;width:490px}}blockquote .mdc-c-blockquote__author-name___u4L7-_990311c{display:inline-block;text-decoration:inherit}</style><style type=\"text/css\">.mdc-c-progress-bar___PW5Xi_990311c{height:calc(var(--mdc-size-spacing-40)/2);overflow:hidden;position:relative}.mdc-c-progress-bar__progress___wQRDN_990311c{-webkit-appearance:none;appearance:none;height:inherit;overflow:hidden;position:absolute;width:100%}.mdc-c-progress-bar__progress___wQRDN_990311c::-webkit-progress-bar{background-color:var(--mdc-color-neutral-gray-06)}.mdc-c-progress-bar__progress___wQRDN_990311c::-moz-progress-bar{background-color:var(--mdc-color-neutral-gray-06)}.mdc-c-progress-bar__progress___wQRDN_990311c::-moz-progress-value{background-color:var(--mdc-color-neutral-gray-54);-moz-transition:width .6s ease-in-out;transition:width .6s ease-in-out}.mdc-c-progress-bar__progress___wQRDN_990311c::-webkit-progress-value{background-color:var(--mdc-color-neutral-gray-54);-webkit-transition:width .6s ease-in-out;transition:width .6s ease-in-out}.mdc-c-progress-bar__label___JDW5s_990311c{color:var(--mdc-color-neutral-white);font-size:var(--mdc-size-font-16);line-height:var(--mdc-size-line-height-24);line-height:var(--mdc-size-line-height-20);position:absolute;top:0;transform:translate(calc(-100% - var(--mdc-size-spacing-8)));transition:left .6s ease-in-out}.mdc-c-progress-bar__label--align-outside___-YOop_990311c{color:var(--mdc-color-neutral-gray-54);padding-left:var(--mdc-size-spacing-8)}</style><style type=\"text/css\">.mdc-c-drop-down__rootmenu___yJzvz_990311c{color:var(--root-share-icon-color)!important;cursor:pointer;display:inline-grid!important;font-size:.75rem!important;font-weight:var(--mdc-font-weight-light)!important;gap:0!important;grid-auto-flow:row!important;line-height:1rem!important}.mdc-c-drop-down__rootmenu___yJzvz_990311c span:before{margin:auto}.mdc-c-drop-down__rootmenu--active___VHnk6_990311c,.mdc-c-drop-down__rootmenu___yJzvz_990311c:hover{color:var(--root-share-icon-color-hover)}.mdc-c-drop-down__menu___z9UVl_990311c{background:var(--mdc-color-neutral-white);box-shadow:var(--mdc-elevation-2);display:grid;gap:var(--mdc-size-spacing-16);padding:var(--mdc-size-spacing-24)}.mdc-c-drop-down__menu___z9UVl_990311c ul{margin:0;padding:0}.mdc-c-drop-down__menu___z9UVl_990311c ul li{list-style-type:none}.mdc-c-drop-down__menu___z9UVl_990311c ul li:not(:last-of-type){margin-bottom:var(--mdc-size-spacing-8)}.mdc-c-drop-down__menuitem___xIPFf_990311c{gap:var(--mdc-size-spacing-8)!important;line-height:1}.mdc-c-drop-down__arrow___O0eKP_990311c{position:absolute;transform:rotate(180deg)}.mdc-c-drop-down__arrow___O0eKP_990311c span{filter:drop-shadow(0 1px .5px rgba(5,28,44,.2));line-height:var(--mdc-size-line-height-24)}.mdc-c-drop-down__arrow___O0eKP_990311c span:before{color:var(--mdc-color-neutral-white)}</style><style type=\"text/css\">.mdc-c-bg-video___KqGb1_990311c{height:100%;object-fit:cover;width:100%}.mdc-c-play-pause-button___dscFo_990311c{bottom:var(--mdc-size-spacing-16);position:absolute;right:var(--mdc-size-spacing-24);z-index:var(--mdc-zindex-1)}.mdc-c-play-pause-button___dscFo_990311c span:before{background-color:var(--mdc-color-neutral-black)!important;color:var(--mdc-color-neutral-white)!important}.mdc-c-play-pause-button___dscFo_990311c span:hover:before{background-color:var(--mdc-color-palette-electric-blue)!important;box-shadow:0 7px 14px 0 #0003;transform:translateY(-2px)}</style><style type=\"text/css\">.mdc-c-alert___HJ1s1_990311c{align-items:center;display:flex;gap:var(--mdc-size-spacing-8);justify-content:space-between;opacity:var(--mdc-opacity-100);padding:var(--mdc-size-spacing-16);transition-timing-function:ease-out}.mdc-c-alert--close-alert___BZpm3_990311c{opacity:0;transition:.2s}.mdc-c-alert--success___moj-j_990311c{background-color:var(--mdc-color-status-light-green);border:var(--mdc-size-border-width-1) solid var(--mdc-color-status-light-green)}.mdc-c-alert--error___iR23S_990311c{background-color:var(--mdc-color-status-light-red);border:var(--mdc-size-border-width-1) solid var(--mdc-color-status-light-red)}.mdc-c-alert--info___2ifXt_990311c{background-color:var(--mdc-color-status-light-blue);border:var(--mdc-size-border-width-1) solid var(--mdc-color-status-light-blue)}.mdc-c-alert--warning___2vdhU_990311c{background-color:var(--mdc-color-status-light-yellow);border:var(--mdc-size-border-width-1) solid var(--mdc-color-status-light-yellow)}.mdc-c-alert__message___CA3pW_990311c{display:flex;flex:1 1 0%;flex-wrap:wrap;justify-content:space-between}.mdc-c-alert__container___OY1LN_990311c{display:flex;gap:var(--mdc-size-spacing-16)}.mdc-c-alert__alert-icon___UDJog_990311c{flex:1 0 var(--mdc-size-spacing-24)}.mdc-c-alert__close-alert___UNT03_990311c{align-self:baseline;cursor:pointer;flex:0 0 var(--mdc-size-spacing-24)}.mdc-c-alert__close-alert___UNT03_990311c span:before{background-color:initial;color:var(--mdc-color-neutral-black)}.mdc-c-alert__close-alert___UNT03_990311c:focus span:before,.mdc-c-alert__close-alert___UNT03_990311c:hover span:before{background-color:#ffffff4d}</style><style type=\"text/css\">.mdc-c-loader___W8w3-_990311c{animation:spin___HfHqf_990311c 1.4s linear infinite;border:var(--mdc-size-spacing-4) solid var(--loader-border);border-radius:50%;border-top:var(--mdc-size-spacing-4) solid var(--loader-border-top);margin:0 auto}.mdc-c-loader--size-sm___K1ZMm_990311c{height:var(--mdc-size-spacing-32);width:var(--mdc-size-spacing-32)}.mdc-c-loader--size-md___EAQRY_990311c{height:var(--mdc-size-spacing-48);width:var(--mdc-size-spacing-48)}.mdc-c-loader--size-lg___0hH02_990311c{height:var(--mdc-size-spacing-72);width:var(--mdc-size-spacing-72)}.mdc-c-loader--border-1___w1cAp_990311c{border-width:1px}.mdc-c-loader--border-2___b8kJb_990311c{border-width:2px}.mdc-c-loader--border-3___AeSHf_990311c{border-width:3px}.mdc-c-loader--border-4___AsS32_990311c{border-width:4px}.mdc-c-loader--border-5___JRHFb_990311c{border-width:5px}.mdc-c-loader--inline___laBg6_990311c{margin:0}@keyframes spin___HfHqf_990311c{0%{transform:rotate(0deg)}to{transform:rotate(1turn)}}</style><style type=\"text/css\">.mdc-c-char-counter___vIMEm_990311c{color:var(--mdc-color-neutral-gray-70);font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20);margin-left:auto}.mdc-c-char-counter--error___09qgB_990311c{color:var(--mdc-color-status-red)}</style><style type=\"text/css\">.mdc-c-form-control___ib-Ut_990311c{display:flex;flex-direction:column;gap:var(--mdc-size-spacing-8)}.mdc-c-form-control__label___ICXbu_990311c{color:var(--mdc-color-neutral-black);font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-regular);line-height:var(--mdc-size-line-height-24);margin:0}.mdc-c-form-control--error___9sMf7_990311c{color:var(--mdc-color-status-red)}.mdc-c-form-control--state-error___yU8iu_990311c .mdc-c-form-control__field___PTF2Y_990311c,.mdc-c-form-control--state-error___yU8iu_990311c .mdc-c-form-control__textarea___3V76M_990311c{border-color:var(--mdc-color-status-red);color:var(--mdc-color-status-red)}.mdc-c-form-control--state-error___yU8iu_990311c label{color:var(--mdc-color-status-red)}.mdc-c-form-control--state-error___yU8iu_990311c .mdc-c-form-control__editor___TSbUw_990311c{border:var(--mdc-size-border-width-1) solid var(--mdc-color-status-red);color:var(--mdc-color-status-red)}.mdc-c-form-control--size-sm___OAC6g_990311c .mdc-c-form-control__field___PTF2Y_990311c{font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20);min-height:var(--mdc-size-spacing-32)}.mdc-c-form-control--size-md___nT0HS_990311c .mdc-c-form-control__field___PTF2Y_990311c{font-size:var(--mdc-size-font-16);line-height:var(--mdc-size-line-height-24);min-height:var(--mdc-size-spacing-42)}.mdc-c-form-control--size-lg___UeotQ_990311c .mdc-c-form-control__field___PTF2Y_990311c{font-size:var(--mdc-size-font-16);line-height:var(--mdc-size-line-height-24);min-height:var(--mdc-size-spacing-48)}.mdc-c-form-control--size-xl___8xbCi_990311c .mdc-c-form-control__field___PTF2Y_990311c{font-size:var(--mdc-size-font-24);line-height:var(--mdc-size-line-height-36);min-height:var(--mdc-size-spacing-56);padding:var(--mdc-size-spacing-24)}.mdc-c-form-control--size-xxl___LoPhp_990311c .mdc-c-form-control__field___PTF2Y_990311c{font-size:var(--mdc-size-font-24);line-height:var(--mdc-size-line-height-36);min-height:var(--mdc-size-spacing-64);padding:var(--mdc-size-spacing-32) var(--mdc-size-spacing-24)}.mdc-c-form-control__text-helper___gGlvN_990311c,.mdc-c-form-control__text-hint___rHwCJ_990311c{color:var(--mdc-color-neutral-gray-54)}.mdc-c-form-control__text-hint___rHwCJ_990311c{font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20)}.mdc-c-form-control__text-icon___ZRGsL_990311c{line-height:var(--mdc-size-spacing-4);margin-right:var(--mdc-size-spacing-4)}.mdc-c-form-control__text-error___grncf_990311c{color:var(--mdc-color-status-red);font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20)}.mdc-c-form-control__control___oPCjw_990311c{position:relative}.mdc-c-form-control__show-icon___DcQyC_990311c{display:inline-flex;position:absolute;right:var(--mdc-size-spacing-16);top:50%;transform:translateY(-50%)}.mdc-c-form-control__show-icon--icon-left___bTByt_990311c{left:var(--mdc-size-spacing-16);right:inherit}.mdc-c-form-control__info-tooltip-wrapper___WvQ1m_990311c{align-items:center;display:flex;gap:var(--mdc-size-spacing-8)}.mdc-c-form-control___ib-Ut_990311c [class^=mdc-c-tooltip]{color:var(--mdc-color-neutral-gray-54);z-index:var(--mdc-zindex-1)}.mdc-c-form-control__textarea___3V76M_990311c{font-weight:var(--mdc-font-weight-regular);height:96px;max-height:600px}.mdc-c-form-control__textarea___3V76M_990311c.error___gKx3A_990311c{border-color:var(--mdc-color-status-red)}.mdc-c-form-control___ib-Ut_990311c .mdc-c-form-control__field--icon-right___W4s-t_990311c{padding-right:var(--mdc-size-spacing-56)}.mdc-c-form-control___ib-Ut_990311c .mdc-c-form-control__field--icon-left___YoJju_990311c{padding-left:var(--mdc-size-spacing-56)}.mdc-c-form-control__input-bottom___q3J5i_990311c{display:flex;gap:var(--mdc-size-spacing-32);justify-content:space-between}.mdc-c-form-control__input-bottom___q3J5i_990311c .mdc-c-form-control__container___1bzSs_990311c{display:flex;flex-direction:column}</style><style type=\"text/css\">.mdc-c-checkbox-control___UWECp_990311c{align-self:flex-start;cursor:pointer;display:flex;flex-direction:row;padding:var(--mdc-size-spacing-4) 0}.mdc-c-checkbox-control__wrapper___QhZEn_990311c{display:flex;flex-direction:row}.mdc-c-checkbox-control__label-container___xQnnT_990311c{display:flex;flex-direction:column;flex-grow:1;margin-left:var(--mdc-size-spacing-8)}.mdc-c-checkbox-control__hint___A79E-_990311c{overflow:hidden}.mdc-c-checkbox-control__display-name___DpsHy_990311c{font-weight:var(--mdc-font-weight-light);overflow:hidden}.mdc-c-checkbox-control__display-name___DpsHy_990311c span{border-bottom:var(--mdc-size-border-width-2) solid #0000;color:var(--mdc-color-neutral-black);font-size:var(--mdc-size-font-16);line-height:var(--mdc-size-line-height-24)}.mdc-c-checkbox-control__tooltip-content___a0MS3_990311c{margin-left:var(--mdc-size-spacing-8)}.mdc-c-checkbox-control___UWECp_990311c label.mdc-c-checkbox-control__display-name___DpsHy_990311c{text-transform:none}.mdc-c-checkbox-control___UWECp_990311c:focus-within .mdc-c-checkbox-control__checkbox___pjkv3_990311c,.mdc-c-checkbox-control___UWECp_990311c:hover .mdc-c-checkbox-control__checkbox___pjkv3_990311c{border-color:var(--mdc-color-palette-electric-blue)}.mdc-c-checkbox-control___UWECp_990311c:focus-within .mdc-c-checkbox-control__display-name___DpsHy_990311c span,.mdc-c-checkbox-control___UWECp_990311c:hover .mdc-c-checkbox-control__display-name___DpsHy_990311c span{border-color:var(--mdc-color-palette-electric-blue);color:var(--mdc-color-palette-electric-blue);cursor:pointer}.mdc-c-checkbox-control__checkbox___pjkv3_990311c{align-items:center;-webkit-appearance:none;appearance:none;background:var(--mdc-color-neutral-white);border:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-black);cursor:pointer;display:flex;flex:0 0 auto;flex-shrink:0;font-family:mck-icons;justify-content:center}.mdc-c-checkbox-control__checkbox___pjkv3_990311c:checked{background:var(--mdc-color-palette-electric-blue);border-color:var(--mdc-color-palette-electric-blue)}.mdc-c-checkbox-control__checkbox___pjkv3_990311c:checked:after{color:var(--mdc-color-neutral-white);content:\"\\e612\"}.mdc-c-checkbox-control--size-md___-06Hq_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c,.mdc-c-checkbox-control--size-sm___z-REr_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c{height:var(--mdc-size-spacing-16);width:var(--mdc-size-spacing-16)}.mdc-c-checkbox-control--size-md___-06Hq_990311c .mdc-c-checkbox-control__display-name___DpsHy_990311c,.mdc-c-checkbox-control--size-sm___z-REr_990311c .mdc-c-checkbox-control__display-name___DpsHy_990311c{font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20)}.mdc-c-checkbox-control--size-lg___1E9cE_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c{height:var(--mdc-size-spacing-24);width:var(--mdc-size-spacing-24)}.mdc-c-checkbox-control--size-xl___FfdJO_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c{height:var(--mdc-size-spacing-32);width:var(--mdc-size-spacing-32)}.mdc-c-checkbox-control--size-xl___FfdJO_990311c .mdc-c-checkbox-control__display-name___DpsHy_990311c{font-size:var(--mdc-size-font-20);line-height:var(--mdc-size-line-height-32)}.mdc-c-checkbox-control--size-xxl___YZHt-_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c{font-size:var(--mdc-size-font-24);font-weight:bolder;height:var(--mdc-size-spacing-40);line-height:var(--mdc-size-line-height-36);width:var(--mdc-size-spacing-40)}.mdc-c-checkbox-control--size-xxl___YZHt-_990311c .mdc-c-checkbox-control__display-name___DpsHy_990311c{font-size:var(--mdc-size-font-24);line-height:var(--mdc-size-line-height-36)}.mdc-c-checkbox-control--disabled___h4gzX_990311c:focus-within .mdc-c-checkbox-control__checkbox___pjkv3_990311c,.mdc-c-checkbox-control--disabled___h4gzX_990311c:hover .mdc-c-checkbox-control__checkbox___pjkv3_990311c{border-color:var(--mdc-color-neutral-gray-30)}.mdc-c-checkbox-control--disabled___h4gzX_990311c:focus-within .mdc-c-checkbox-control__checkbox___pjkv3_990311c:checked,.mdc-c-checkbox-control--disabled___h4gzX_990311c:hover .mdc-c-checkbox-control__checkbox___pjkv3_990311c:checked{border-color:var(--mdc-color-status-light-blue)}.mdc-c-checkbox-control--disabled___h4gzX_990311c:focus-within .mdc-c-checkbox-control__display-name___DpsHy_990311c span,.mdc-c-checkbox-control--disabled___h4gzX_990311c:hover .mdc-c-checkbox-control__display-name___DpsHy_990311c span{border:none;color:var(--mdc-color-neutral-gray-30);cursor:not-allowed}.mdc-c-checkbox-control--disabled___h4gzX_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c{background:var(--mdc-color-neutral-gray-18);border-color:var(--mdc-color-neutral-gray-30);cursor:not-allowed}.mdc-c-checkbox-control--disabled___h4gzX_990311c .mdc-c-checkbox-control__display-name___DpsHy_990311c span{color:var(--mdc-color-neutral-gray-30)}.mdc-c-checkbox-control--disabled___h4gzX_990311c .mdc-c-checkbox-control__checkbox___pjkv3_990311c:checked{background:var(--mdc-color-status-light-blue);border-color:var(--mdc-color-status-light-blue)}.mdc-c-checkbox-group___K-viM_990311c{display:flex}.mdc-c-checkbox-group--direction-row___vFCK9_990311c{flex-direction:row;gap:var(--mdc-size-spacing-8);justify-content:flex-start}.mdc-c-checkbox-group--direction-column___VeWCA_990311c{align-items:flex-start;flex-direction:column;gap:var(--mdc-size-spacing-4)}</style><style type=\"text/css\">.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c{border:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-black);cursor:pointer;font-family:mck-icons;opacity:0;position:absolute}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:checked+label .mdc-c-radial-checkbox-control__plus-icon___F697M_990311c,.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:not(:checked)+label .mdc-c-radial-checkbox-control__checkmark-icon___dv6ix_990311c{display:none}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:checked+label .mdc-c-radial-checkbox-control__checkmark-icon___dv6ix_990311c{display:block}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:checked+label .mdc-c-radial-checkbox-control__checkmark-icon___dv6ix_990311c:before{background-color:var(--mdc-color-palette-electric-blue)}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:focus+label,.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:hover+label{cursor:pointer}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:focus+label span:before,.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:hover+label span:before{box-shadow:0 7px 14px 0 #0003;transform:translateY(-2px)}.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:focus+label .mdc-c-radial-checkbox-control__plus-icon___F697M_990311c,.mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c:hover+label .mdc-c-radial-checkbox-control__plus-icon___F697M_990311c{border-color:var(--mdc-color-palette-electric-blue);color:var(--mdc-color-palette-electric-blue)}.mdc-c-radial-checkbox-control--size-md___sYwDS_990311c .mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c,.mdc-c-radial-checkbox-control--size-sm___FGVel_990311c .mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c{height:var(--mdc-size-spacing-16);width:var(--mdc-size-spacing-16)}.mdc-c-radial-checkbox-control--size-lg___o6P1-_990311c .mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c{height:var(--mdc-size-spacing-24);width:var(--mdc-size-spacing-24)}.mdc-c-radial-checkbox-control--size-xl___xTUNR_990311c .mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c{height:var(--mdc-size-spacing-32);width:var(--mdc-size-spacing-32)}.mdc-c-radial-checkbox-control--size-xxl___uDI7N_990311c .mdc-c-radial-checkbox-control__radial-checkbox___29DwO_990311c{font-size:var(--mdc-size-font-24);font-weight:bolder;height:var(--mdc-size-spacing-40);line-height:var(--mdc-size-line-height-36);width:var(--mdc-size-spacing-40)}</style><style type=\"text/css\">.mdc-c-tag___bvVWv_990311c{align-items:center;background-color:var(--mdc-color-neutral-gray-18);border-radius:var(--mdc-size-border-radius-4);color:var(--mdc-color-neutral-black);display:flex;font-family:var(--mdc-font-family-default-primary);font-size:var(--mdc-size-font-12);font-weight:var(--mdc-font-weight-light);gap:var(--mdc-size-spacing-8);line-height:var(--mdc-size-line-height-16);padding:var(--mdc-size-spacing-8);width:-webkit-fit-content;width:-moz-fit-content;width:fit-content}.mdc-c-tag___bvVWv_990311c:lang(ar){font-family:var(--mdc-font-family-arabic-primary,var(--mdc-font-family-default-primary))}.mdc-c-tag___bvVWv_990311c:lang(ru){font-family:var(--mdc-font-family-russian-primary,var(--mdc-font-family-default-primary))}.mdc-c-tag___bvVWv_990311c:lang(vi){font-family:var(--mdc-font-family-vietnamese-primary,var(--mdc-font-family-default-primary))}.mdc-c-tag___bvVWv_990311c:lang(ja){font-family:var(--mdc-font-family-japanese-primary,var(--mdc-font-family-default-primary))}.mdc-c-tag--with-hover___OE7lc_990311c:hover{background-color:var(--mdc-color-palette-electric-blue);box-shadow:var(--mdc-elevation-8);color:var(--mdc-color-neutral-white);cursor:pointer}.mdc-c-tag--with-hover___OE7lc_990311c:focus-visible{border:var(--mdc-size-border-width-1) solid var(--mdc-color-palette-electric-blue);outline:var(--mdc-size-border-width-4) solid #2155ff66}.mdc-c-tag--checked___BnJWp_990311c{background-color:var(--mdc-color-neutral-gray-70);color:var(--mdc-color-neutral-white)}</style><style type=\"text/css\">.mdc-c-select-custom___TOhaq_990311c{max-width:100%;position:relative}.mdc-c-select-custom--fit-content-width___epwhR_990311c{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content}.mdc-c-select-custom__select-button___5fnAN_990311c{background-color:var(--mdc-color-neutral-white);border:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-black);color:var(--mdc-color-neutral-black);cursor:pointer;grid-auto-flow:column;justify-content:space-between;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-8) var(--mdc-size-spacing-8) var(--mdc-size-spacing-16);transition:all .12s linear}.mdc-c-select-custom__select-button--expanded___eNvKm_990311c{background-color:var(--mdc-color-palette-electric-blue);border:0;color:var(--mdc-color-neutral-white)}.mdc-c-select-custom__label___8vCRC_990311c{text-wrap:nowrap;overflow:hidden;text-overflow:ellipsis}.mdc-c-select-custom__list___xXyVs_990311c{background-color:var(--mdc-color-neutral-white);box-shadow:var(--mdc-elevation-8);margin:0;max-width:90vw;min-width:100%;padding:0;position:absolute;width:-webkit-max-content;width:max-content;z-index:1}.mdc-c-select-custom__list--collapsed___jyYdT_990311c{display:none}.mdc-c-select-custom__list--right___SwAN0_990311c{right:0}@media (min-width:768px){.mdc-c-select-custom__list___xXyVs_990311c{max-width:max(50vw,100%)}}.mdc-c-select-custom__list-item___7DeLO_990311c{cursor:pointer;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16)}.mdc-c-select-custom__list-item___7DeLO_990311c:focus,.mdc-c-select-custom__list-item___7DeLO_990311c:hover{background-color:var(--mdc-color-neutral-gray-06)}.mdc-c-select-custom__list-item--select-all___7U9Az_990311c{border-bottom:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-gray-10)}.mdc-c-select-custom__footer___dMcSY_990311c{box-shadow:var(--mdc-elevation-8);padding:var(--mdc-size-spacing-16)}.mdc-c-select-custom___TOhaq_990311c [class^=mdc-c-button]{min-width:-webkit-fit-content;min-width:-moz-fit-content;min-width:fit-content}</style><style type=\"text/css\">.mdc-c-datepicker___706mw_990311c{color:var(--mdc-color-neutral-gray-80);position:relative}.mdc-c-datepicker__input___-ZW4z_990311c{padding-right:var(--mdc-size-spacing-32)!important}.mdc-c-datepicker__popper___AOPhF_990311c{background-color:var(--mdc-color-neutral-white);box-shadow:var(--mdc-elevation-4);font-family:var(--mdc-font-family-default-primary);padding:var(--mdc-size-spacing-16) var(--mdc-size-spacing-24);z-index:var(--mdc-zindex-10)}.mdc-c-datepicker__popper___AOPhF_990311c:lang(ar){font-family:var(--mdc-font-family-arabic-primary,var(--mdc-font-family-default-primary))}.mdc-c-datepicker__popper___AOPhF_990311c:lang(ru){font-family:var(--mdc-font-family-russian-primary,var(--mdc-font-family-default-primary))}.mdc-c-datepicker__popper___AOPhF_990311c:lang(vi){font-family:var(--mdc-font-family-vietnamese-primary,var(--mdc-font-family-default-primary))}.mdc-c-datepicker__popper___AOPhF_990311c:lang(ja){font-family:var(--mdc-font-family-japanese-primary,var(--mdc-font-family-default-primary))}.mdc-c-datepicker__popper-header___9HTov_990311c{align-items:center;display:flex;justify-content:space-between}.mdc-c-datepicker__popper-header___9HTov_990311c button{background:none;border:0;cursor:pointer;height:var(--mdc-size-spacing-40);outline:none;width:var(--mdc-size-spacing-40)}.mdc-c-datepicker__popper-header___9HTov_990311c button:hover{background-color:var(--mdc-color-neutral-gray-06);border-radius:50%}.mdc-c-datepicker__popper-year-nav___sRMUD_990311c{align-items:center;display:flex;flex:1;font-size:var(--mdc-size-font-16);font-weight:var(--mdc-font-weight-medium);gap:var(--mdc-size-spacing-8);justify-content:center;line-height:var(--mdc-size-line-height-24)}.mdc-c-datepicker__popper-year-nav___sRMUD_990311c select{border:none;cursor:pointer;outline:none;padding:0 var(--mdc-size-spacing-32) 0 0;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content}.mdc-c-datepicker__year-select___YPSz2_990311c{align-self:normal}.mdc-c-datepicker__reset-btn___tdJ-r_990311c{margin-right:var(--mdc-size-spacing-32)}.mdc-c-datepicker___706mw_990311c .react-datepicker__calendar-icon{color:var(--mdc-color-neutral-gray-80);cursor:pointer;position:absolute;right:var(--mdc-size-spacing-16);top:var(--mdc-size-spacing-8)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day-names{display:flex;font-size:var(--mdc-size-font-14);font-weight:var(--mdc-font-weight-medium);line-height:var(--mdc-size-line-height-20)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day,.mdc-c-datepicker___706mw_990311c .react-datepicker__day-name{height:var(--mdc-size-spacing-40);line-height:var(--mdc-size-spacing-40);outline:none;text-align:center;width:var(--mdc-size-spacing-40)}.mdc-c-datepicker___706mw_990311c .react-datepicker__month{font-size:var(--mdc-size-font-14);line-height:var(--mdc-size-line-height-20)}.mdc-c-datepicker___706mw_990311c .react-datepicker__week{display:flex}.mdc-c-datepicker___706mw_990311c .react-datepicker__day{cursor:pointer}.mdc-c-datepicker___706mw_990311c .react-datepicker__day:hover{background-color:var(--mdc-color-neutral-gray-10)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day--outside-month{color:var(--mdc-color-neutral-gray-30)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day--today{border:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-gray-80);font-weight:var(--mdc-font-weight-bold)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day--in-range,.mdc-c-datepicker___706mw_990311c .react-datepicker__day--in-selecting-range{background-color:var(--mdc-color-status-light-blue)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day--range-end,.mdc-c-datepicker___706mw_990311c .react-datepicker__day--selected{background-color:var(--mdc-color-palette-electric-blue);color:var(--mdc-color-neutral-white);font-weight:var(--mdc-font-weight-bold)}.mdc-c-datepicker___706mw_990311c .react-datepicker__day--range-end:hover,.mdc-c-datepicker___706mw_990311c .react-datepicker__day--selected:hover{background-color:var(--mdc-color-status-dark-blue)}.mdc-c-datepicker___706mw_990311c .react-datepicker__today-button{display:flex;justify-content:space-between;padding-top:var(--mdc-size-spacing-8);width:100%}.mdc-c-datepicker___706mw_990311c .react-datepicker__aria-live{border:0;-webkit-clip-path:circle(0);clip-path:circle(0);height:0;overflow:hidden;padding:0;position:absolute;white-space:nowrap;width:0}</style><style type=\"text/css\">.mdc-c-modal__backdrop___-KX-s_990311c{align-items:center;animation-duration:.4s;animation-name:animatetop___aWqMX_990311c;background-color:#000c;inset:0;justify-content:center;overflow:auto;position:fixed;z-index:var(--mdc-zindex-20)}.mdc-c-modal__backdrop--bottom___le1-H_990311c{animation-name:animatebottom___4ILUZ_990311c}.mdc-c-modal__backdrop--hide___LW7W8_990311c{opacity:0}@keyframes animatetop___aWqMX_990311c{0%{opacity:0;top:-300px}to{opacity:1;top:0}}@keyframes animatebottom___4ILUZ_990311c{0%{bottom:-300px;opacity:0}to{bottom:0;opacity:1}}.mdc-c-modal__content___os-1D_990311c{box-sizing:border-box;margin:96px auto auto;max-width:624px;padding:var(--mdc-size-spacing-64);position:relative;width:100%}@media (max-width:1179px){.mdc-c-modal__content___os-1D_990311c{margin-top:var(--mdc-size-spacing-80)}}@media (max-width:767px){.mdc-c-modal__content___os-1D_990311c{margin:0;max-width:100%;min-height:100%;padding:var(--mdc-size-spacing-40)}}.mdc-c-modal__content--align-top___BfmM5_990311c{margin-top:0}.mdc-c-modal__content--align-bottom___-T7nI_990311c{animation-name:animatebottom___4ILUZ_990311c;bottom:0;position:absolute}.mdc-c-modal__content--full-width___hDjtB_990311c{max-width:100%}.mdc-c-modal__content--spacing-compact___5fP7H_990311c{padding:var(--mdc-size-spacing-40)}.mdc-c-modal__content___os-1D_990311c .mdc-c-modal__close-button___ZYOFu_990311c{position:absolute;right:var(--mdc-size-spacing-8);top:var(--mdc-size-spacing-8)}@media (min-width:768px){.mdc-c-modal__content___os-1D_990311c .mdc-c-modal__close-button___ZYOFu_990311c{right:var(--mdc-size-spacing-16);top:var(--mdc-size-spacing-16)}}.mdc-c-modal__content___os-1D_990311c .mdc-c-modal__header___Fts7-_990311c{margin-bottom:var(--mdc-size-spacing-32)}.mdc-c-modal__content___os-1D_990311c .mdc-c-modal__header___Fts7-_990311c p{font-size:var(--mdc-size-font-18);line-height:var(--mdc-size-line-height-28)}</style><style type=\"text/css\">:root .mdc-c-tabs___7eVdv_990311c,[data-module-theme=light] .mdc-c-tabs___7eVdv_990311c{--paddle-bg-right:linear-gradient(to right,#0000,var(--mdc-color-neutral-white) 50%);--paddle-bg-left:linear-gradient(to left,#0000,var(--mdc-color-neutral-white) 50%)}[data-module-theme=dark] .mdc-c-tabs___7eVdv_990311c{--paddle-bg-right:linear-gradient(to right,#0000,var(--mdc-color-palette-deep-blue) 50%);--paddle-bg-left:linear-gradient(to left,#0000,var(--mdc-color-palette-deep-blue) 50%)}.mdc-c-tabs___7eVdv_990311c{position:relative}.mdc-c-tabs__tablist-wrapper___dBa0k_990311c{overflow-x:scroll}.mdc-c-tabs__tablist-wrapper___dBa0k_990311c::-webkit-scrollbar{height:0;width:0}.mdc-c-tabs__tablist___I130n_990311c{grid-gap:var(--mdc-size-spacing-24);display:grid;grid-auto-flow:column;justify-content:start;margin:0;margin-bottom:calc(var(--mdc-size-border-width-1)*-1);padding:0;width:-webkit-max-content;width:max-content}.mdc-c-tabs__tablist--centered___UQ0o8_990311c{justify-content:center}.mdc-c-tabs__tab___IXSdl_990311c{border:0;border-bottom:var(--mdc-size-border-width-4) solid #0000;display:block;font-family:var(--mdc-font-family-default-primary);font-weight:var(--mdc-font-weight-light);padding:var(--mdc-size-spacing-16) var(--mdc-size-spacing-4);width:-webkit-max-content;width:max-content}.mdc-c-tabs__tab___IXSdl_990311c:lang(ar){font-family:var(--mdc-font-family-arabic-primary,var(--mdc-font-family-default-primary))}.mdc-c-tabs__tab___IXSdl_990311c:lang(ru){font-family:var(--mdc-font-family-russian-primary,var(--mdc-font-family-default-primary))}.mdc-c-tabs__tab___IXSdl_990311c:lang(vi){font-family:var(--mdc-font-family-vietnamese-primary,var(--mdc-font-family-default-primary))}.mdc-c-tabs__tab___IXSdl_990311c:lang(ja){font-family:var(--mdc-font-family-japanese-primary,var(--mdc-font-family-default-primary))}.mdc-c-tabs__tab--is-active___G72D-_990311c{border-bottom-color:var(--button-minimal-tertiary-hover)}.mdc-c-tabs__tabpanel___chsU7_990311c{border-top:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-gray-18);padding:var(--mdc-size-spacing-16) 0}.mdc-c-tabs__paddles___msvdU_990311c .mdc-c-tabs__paddle___Y09Ta_990311c{background-image:var(--paddle-bg-left);border:0;min-width:var(--mdc-size-spacing-16);padding:var(--mdc-size-spacing-16) var(--mdc-size-spacing-24) var(--mdc-size-spacing-16) var(--mdc-size-spacing-8);position:absolute;top:0}.mdc-c-tabs__paddles___msvdU_990311c .mdc-c-tabs__paddle--right___KtnNh_990311c{background-image:var(--paddle-bg-right);padding-left:var(--mdc-size-spacing-24);padding-right:var(--mdc-size-spacing-8);right:0}.mdc-c-tabs__paddle___Y09Ta_990311c:focus,.mdc-c-tabs__tab___IXSdl_990311c:focus{outline:none}.mdc-c-tabs__paddle___Y09Ta_990311c:focus-visible,.mdc-c-tabs__tab___IXSdl_990311c:focus-visible{outline:var(--mdc-size-border-width-4) solid var(--button-focus-default);outline-offset:calc(var(--mdc-size-border-width-4)*-1)}</style><style type=\"text/css\">.mdc-c-typeahead___31M3S_990311c{position:relative}.mdc-c-typeahead__menu___kINRW_990311c{background-color:var(--mdc-color-neutral-white);border:var(--mdc-size-border-width-1) solid var(--mdc-color-neutral-gray-30);box-shadow:var(--mdc-elevation-2);margin-top:var(--mdc-size-spacing-4);padding:0;width:100%;z-index:1}.mdc-c-typeahead__menu___kINRW_990311c ul{list-style:none;margin:0;padding:0}.mdc-c-typeahead__menu___kINRW_990311c ul li{cursor:pointer;padding:var(--mdc-size-spacing-8) var(--mdc-size-spacing-16)}.mdc-c-typeahead__menu-item--active___q5GP9_990311c{background-color:var(--mdc-color-neutral-gray-03);outline:none}</style><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/08dfc05290ce60e1.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-3464\" src=\"/_next/static/chunks/3464.caabbe0cce2df796.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-2453\" src=\"/_next/static/chunks/2453.5bbec710ffd42462.js\"></script><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/7f0894b6dca7827f.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-2169\" src=\"/_next/static/chunks/2169.db1ed0d7c6e757b7.js\"></script><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/46b1c7e4e497c465.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-5317\" src=\"/_next/static/chunks/5317.7ad5e77119c7b9d7.js\"></script><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/8cd0628f2230b764.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-6957\" src=\"/_next/static/chunks/6957.260f832111970a25.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-895\" src=\"/_next/static/chunks/895.63b261a2b180ec79.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-7044\" src=\"/_next/static/chunks/7044.d5c57fbc84841f29.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-906\" src=\"/_next/static/chunks/906.033c0adf90096a05.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-9829\" src=\"/_next/static/chunks/9829.1c1a2c713fe60a17.js\"></script><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/d4aec97cc669860d.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-3305\" src=\"/_next/static/chunks/3305.922e1efcae077965.js\"></script><link rel=\"stylesheet\" type=\"text/css\" href=\"/_next/static/css/5c2a9bc874cbce83.css\"><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-1649\" src=\"/_next/static/chunks/1649.100f3837f09cbcf8.js\"></script><script charset=\"utf-8\" data-webpack=\"_N_E:chunk-1230\" src=\"/_next/static/chunks/1230.de91f4807c3ee7d1.js\"></script></head><body style=\"\"><div id=\"__next\" data-reactroot=\"\"><div class=\"Layout_mck-c-skipbar__K684J\"><a data-component=\"mdc-c-link\" href=\"#skipToMain\" class=\"mdc-c-button___U4iY2_990311c mdc-c-button--primary___Ed-lT_990311c mdc-c-button--size-medium\"><span class=\"mdc-c-link__label___Pfqtd_990311c\">Skip to main content</span></a></div><main class=\"mck-o-container--outer\" data-layer-region=\"body\" role=\"main\" id=\"skipToMain\"><div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"dark\" data-module-background=\"deep-blue\" data-module-category=\"\" data-module-gradient-position=\"bottom-right\" class=\"mck-o-edge-to-edge FiftyFiftyHero_mck-c-fifty-fifty-hero__wrapper__74aGq\"><div><div class=\"mck-o-container\"><div class=\"mck-o-container--wrapped mdc-u-grid\"><div class=\"FiftyFiftyHero_mck-c-fifty-fifty-hero__dI9Yx\"><style>\n    .background-image-fifty-fifty-hero-undefined {\n      background-image: url('/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/unlocking-market-access-5050-1536x1536.jpg?cq=50&mw=767&car=4:3&cpy=Center');\n      background-position: center center;\n      width: auto;\n    }\n  \n          @media screen and (min-width: 768px){\n            \n    .background-image-fifty-fifty-hero-undefined {\n      background-image: url('/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/unlocking-market-access-5050-1536x1536.jpg?cq=50&mw=1536&car=16:9&cpy=Center');\n      background-position: center center;\n      width: auto;\n    }\n  \n          }\n        </style><div data-component=\"mdc-c-background-image\" class=\"mdc-c-bg-image___GJdv1_990311c background-image-fifty-fifty-hero-undefined FiftyFiftyHero_mck-c-fifty-fifty-hero__media__TroHX FiftyFiftyHero_mck-c-fifty-fifty-hero__media--absolute__YlXtV\"></div><div class=\"FiftyFiftyHero_mck-c-fifty-fifty-hero__wrapper-text__13v1d FiftyFiftyHero_mck-c-fifty-fifty-hero__wrapper-text--default-style__TJLUl mdc-u-spaced-mobile\"><div class=\"mdc-u-grid\"><div class=\"mdc-u-grid mdc-u-grid-gutter-lg mdc-u-grid-col-sm-1 mdc-u-grid--align-start GenericItem_mck-c-generic-item__sGwKL\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c mdc-u-grid-gutter-xs GenericItem_mck-c-generic-item__content__gq1m0\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c\"><h1 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-u-ts-2\"><div>Unlocking market access for gene therapies in the United States</div></h1><div data-component=\"mdc-c-description\" class=\"mdc-c-description___SrnQP_990311c mdc-u-ts-10\"><div class=\"mck-u-links-inline mck-c-generic-item__description\"><time datetime=\"2019-08-22T00:00:00Z\">August 22, 2019</time> | Article</div></div></div></div></div></div></div></div></div></div></div></div><div class=\"mck-o-container\"><div class=\"mck-o-container--wrapped mck-o-container--mobile-spacing mdc-u-grid mdc-u-grid-gutter-xxl\"><section data-layer-region=\"article-body-header\" class=\"mdc-u-grid mdc-u-grid-col-md-12 mck-u-animation-blur-in-400 byline-share-container\"><div class=\"mdc-u-grid-col-md-start-2 mdc-u-grid-col-md-end-8 mdc-u-grid-col-lg-start-3 mdc-u-grid-col-lg-end-8 mdc-u-ts-9\"><span>By </span><span>Toby AuWerter</span>,  <span>Jeff Smith</span>,  <span>Josh Sternberg</span><span>,  and </span><span>Lydia The</span></div><div class=\"mdc-u-grid-col-md-start-8 mdc-u-grid-col-md-end-12 mdc-u-grid-col-lg-start-8 mdc-u-grid-col-lg-end-11 ArticleContent_mck-c-article-content__share-tools__kWRRw\"></div></section><section class=\"mdc-u-grid mdc-u-grid-col-md-12 mck-u-animation-blur-in-400\"><div class=\"mdc-u-grid-col-md-start-2 mdc-u-grid-col-md-end-12 mdc-u-grid-col-lg-start-3 mdc-u-grid-col-lg-end-11\"><div data-component=\"mdc-c-description\" class=\"mdc-c-description___SrnQP_990311c mdc-u-ts-5\"><div class=\"mck-u-links-inline\">Gene therapy holds great promise for treating a variety of diseases, but without changes, today’s payment system could limit the number of patients who benefit.</div></div></div></section><main data-layer-region=\"article-body\" class=\"mdc-u-grid mdc-u-grid-gutter-xxl\"><div class=\"mdc-u-grid mdc-u-grid-col-1 mdc-u-grid-col-md-12\"><div class=\"mdc-u-grid-col-md-start-2 mdc-u-grid-col-md-end-12 mdc-u-grid-col-lg-start-3 mdc-u-grid-col-lg-end-11\"><div class=\"mdc-o-content-body mck-u-dropcap\"><div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"DownloadsSidebar_mck-c-downloads-sidebar__iFmyt mck-o-xs-right-span\"><div data-layer-region=\"downloads-right-rail\"><h3 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-c-heading--title___5qyOB_990311c mdc-c-heading--border___K8dj3_990311c\">DOWNLOADS</h3><div><div data-component=\"mdc-c-link-container\" class=\"mdc-c-link-container___xefGu_990311c\"><a data-component=\"mdc-c-link\" href=\"#/download/%2F~%2Fmedia%2Fmckinsey%2Findustries%2Flife%20sciences%2Four%20insights%2Funlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states%2Funlocking-market-access-for-gene-therapies-in-the-united-states.pdf%3FshouldIndex%3Dfalse\" class=\"DownloadsSidebar_mck-c-downloads-sidebar__download-link__fPqFQ mdc-c-link___lBbY1_990311c\" target=\"_self\" data-layer-event-prefix=\"Download Link\" data-layer-action=\"click\" data-layer-report-type=\"Article\" data-layer-file-name=\"unlocking-market-access-for-gene-therapies-in-the-united-states\" data-layer-report-name=\"unlocking-market-access-for-gene-therapies-in-the-united-states>Article\"><span data-component=\"mdc-c-icon\" class=\"mdc-c-icon___oi7ef_990311c mdc-c-icon--size-md___yi5fA_990311c mck-download-icon\"></span><span class=\"mdc-c-link__label___Pfqtd_990311c\">Article (PDF-408 KB)</span></a></div></div></div></div>\n<p><strong>Gene therapy has the potential</strong> to eradicate the increasing number of diseases we know are associated with faulty or missing genes—or at least provide a functional cure for a period of time.<span class=\"FootNote_footnote-holder__tjRqy\"><a aria-label=\"footnote\" href=\"javascript:void(0);\" class=\"FootNote_footnote-wrapper__AIRwL undefined FootNote_inactive__VZfCp\" aria-describedby=\"371b8d7e-5c8b-4a1e-90ee-edb7dade88d8\"><sup class=\"FootNote_footnotesup__e73z_\">1</sup><span class=\"FootNote_notch-wrapper__b_5NS\"><span class=\"FootNote_notch__omKtY\"></span></span><span class=\"FootNote_tooltip__QtrbA mdc-u-mt-2\"><span class=\"FootNote_footnote-content__r2OVl\"><span id=\"371b8d7e-5c8b-4a1e-90ee-edb7dade88d8\" aria-hidden=\"true\" data-module-theme=\"light\" class=\"FootNote_footnote-text__VjKgO mck-u-links-inline\">In this article, “gene therapies” refer to direct, in vivo administration of DNA-based therapies. Their most common delivery method is via a viral vector, such as a lentivirus or adeno-associated virus.</span></span></span></a></span> Take hemophilia A, for example. Patients with this debilitating disease lack a gene that produces an essential blood-clotting protein, factor VIII. Gene therapy replaces that gene. Moreover, in contrast with other forms of therapy for hemophilia, in which weekly or monthly infusions of clotting-factor drugs are often necessary, gene therapy has the potential to be “once and done.” For years after administration, the patient may only require periodic follow-ups with a physician to monitor the continued safety and efficacy of the therapy.</p>\n<p>Other gene therapies could have similar benefits, and many of those in development tackle rare diseases for which there are limited—or no—good treatments. Yet for all the promise of gene therapy, the therapy-payment system in the United States will need to change fundamentally to enable widespread access to it. This article explains why and suggests the steps manufacturers, with the cooperation of other stakeholders in the healthcare value chain, can take to help overcome the current challenges and give more patients access to these innovative therapies.</p>\n<h2>Current headwinds in reimbursement</h2>\n<p>Reimbursement of pharmaceutical products today occurs on a per-unit basis, which spreads out the costs of drugs and other services for chronic conditions over years. The cost of a gene therapy, however, would be much more concentrated—potentially in a single payment. In addition, given that the treatment is new, its full benefits and risks remain unclear. This combination of concentrated cost and uncertain outcome presents payment risks for two entities: payers and healthcare providers.</p>\n<!-- -->\n<p>High one-time costs would make it hard for payers to underwrite the risk of full payment for the entire range of gene therapies coming to market simultaneously. In addition, a fixed, up-front pricing structure leaves the payer with all the risk of the therapy not working, given that the long-term efficacy of gene therapy as well as the risk of toxicity and other harmful effects to patients are not known with certainty at the time of first regulatory approval, though many risks will be addressed during pivotal studies and US Food and Drug Administration (FDA) review and approval. Payers and pharmacy benefit managers (PBMs) may require real-world data before covering the cost of gene therapy for all potential patients. And even with restricting coverage to a few therapies for which real-world evidence was available—or to a subset of eligible patients—cost spikes in annual budgets would be significant concerns.</p>\n<p>Prior experience often shapes payer thinking on coverage for gene therapy. In particular, the concern over budget impact is a direct result of recent payer experience with innovative therapies for conditions like hepatitis C. The high level of unmet need when the first of these products launched in 2013, particularly for populations covered by Medicare and state Medicaid plans, created significant pressure on payer budgets. As more products came to market, increasing competition brought prices down, but the lesson for gene therapy is clear: carefully planning for and managing utilization is critical.</p>\n<p>Patient portability also poses a challenge. Patients in the United States frequently switch their health insurers, with the average tenure estimated to be three to six years. The benefits of gene therapy could last years or even a lifetime, however, posing a unique challenge for the treatment when it comes to portability. Who pays for the benefits? A payer could find itself shouldering all the costs but enjoying few of the subsequent benefits when the patient switched to a different insurer. Those benefits would accrue to the new payer, which would now have a healthier patient in its insurance plan.</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-disruptor1up mck-o-md-center mck-u-inline-module-border-top mck-u-inline-module-border-bottom mck-u-screen-only\" data-layer-region=\"disruptor-1up\"><div class=\"mdc-u-grid mdc-u-grid-gutter-md mdc-u-grid-col-lg-12 mdc-u-grid-col-md-12 \"><div class=\"mdc-u-grid-col-md-span-12\"><header data-component=\"mdc-c-header\" class=\"mdc-c-header\"><div class=\"mdc-c-header__block___i1Lg-_990311c\"><h3 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c\"><div>Would you like to learn more about our <a href=\"/industries/life-sciences/how-we-help-clients\">Life Sciences Practice</a>?</div></h3></div></header></div></div></div>\n<p>For healthcare providers, the path to adoption of gene therapy is similarly murky. Reimbursement of many biologic therapies in the United States today occurs under a buy-and-bill model. A treatment facility purchases the therapy for a fixed price, a physician administers it, and the facility then receives reimbursement. The physician receives a separate administration fee. This process can take 30 days or longer, potentially limiting the pool of healthcare providers with enough working capital to assume the reimbursement risk for high-cost gene therapy. In addition, some health plans only cover products in treatment facilities that have negotiated lower reimbursement rates. Given the lower margins, these facilities may be less likely to want to take on reimbursement risks unless they are confident they can attract enough new patients to reduce their costs below reimbursement rates. A smaller provider pool may limit the adoption of gene therapy to nearby patients or those willing to travel but may result in higher-quality, specialized care.</p>\n<p>A range of industry stakeholders, including manufacturers, patient-advocacy groups, and payers, have recognized the need to adapt or replace the standard payment system if gene therapy is to become widely available. Several alternative payment mechanisms, including the following, have been proposed:</p>\n<ul>\n    <li><em>Annuity-based payment.</em> The payer agrees to pay a fixed price for the therapy but pays in regular installments, like with an annuity, spreading the cost over time.</li>\n    <li><em>Outcomes-based payment.</em> The payer pays only a portion of the full price up front. If the therapy achieves prespecified outcomes, the payer pays the remainder in full. This model spreads the risk, therefore, between the payer and manufacturer.</li>\n    <li><em>Outcomes-based rebate.</em> The payer pays the full price of the drug up front but receives a rebate if the drug does not achieve prespecified outcomes. This model, again, spreads the risk between the payer and manufacturer.</li>\n    <li><em>Outcomes-based annuity.</em> The payer pays a fixed price, with payments spread over many installments, but only if the drug continues to meet certain prespecified outcomes. This model, too, spreads the risk between the payer and manufacturer.</li>\n</ul>\n<p>These proposals are promising in theory and are in use for other drug categories. For example, with cell therapies—which have also demonstrated long-term durable responses for certain patients and faced many of the same reimbursement challenges as gene therapies face—manufacturers are experimenting with outcomes-based payment models. While reimbursement remains a challenge for cell therapies, limiting their uptake among eligible patients, the lessons learned in that space will likely be relevant to gene therapies.</p>\n<p>We are also seeing manufacturers of the next wave of gene therapies attempt to use alternative payment models. For example, Novartis received FDA approval for Zolgensma, a gene therapy for pediatric patients with spinal muscular atrophy with SMN1 mutations, in May 2019, and it is engaging with payers to create installment- and outcomes-based-payment options. Another example is bluebird bio, which has discussed offering an installment plan for its gene-replacement therapy Zynteglo, a therapy for beta-thalassemia approved in May 2019 in the European Union.</p>\n<p>The challenges of alternative payment models, including price-reporting requirements, administration, and patient portability, however, are significant (Exhibit 1). They will need to be addressed to allow any alternative payment scheme to be workable.</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-inline-module-container mck-o-md-center\"><div class=\"mdc-u-grid mdc-u-grid-gutter-lg mdc-u-grid-col-sm-1 mdc-u-grid--align-start mdc-u-mb-3 GenericItem_mck-c-generic-item__sGwKL\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c mdc-u-grid-gutter-xs GenericItem_mck-c-generic-item__content__gq1m0\"><div class=\"mck-c-eyebrow mdc-u-ts-10\"><span>Exhibit 1</span></div></div></div><div class=\"mck-u-inline-module-border-top mck-u-inline-module-border-bottom\"><picture data-component=\"mdc-c-picture\" class=\"Exhibit_mck-c-exhibit__image__pyIDm\"><source media=\"(min-width: 768px)\" srcset=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex1.svgz?cq=50&amp;cpy=Center\"><img alt=\"The challenges with alternative-payment models are significant.\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex1.svgz?cq=50&amp;cpy=Center\" loading=\"lazy\"></picture></div><div class=\"mck-u-sr-only\">We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: <a href=\"mailto:McKinsey_Website_Accessibility@mckinsey.com\">McKinsey_Website_Accessibility@mckinsey.com</a></div></div>\n<h3>Price-reporting requirements</h3>\n<p>Current price-reporting requirements in the United States limit the ability of manufacturers to offer outcomes-based payments and payments over time. Under best-price regulations, they must report all prices paid for therapy, with the lowest price—or the average price minus a specified percentage, likely to be 23 percent for gene therapy—becoming the benchmark paid within US Medicaid programs and the government’s 340B drug-discount program.</p>\n<p>With an outcomes-based system, just one patient who failed to respond to gene therapy could set the price paid at a low level for all patients—including those who respond well—unless the rebate or discount was within 23 percent of the average price. Similarly, payment over time would be limited unless every potential payer was using the same scheme. Otherwise, different payments from different organizations would make the average price reported by manufacturers inconsistent as installment payments came in.</p>\n<h3>Administration</h3>\n<p>Alternative payment models are more complex to administer than traditional, one-time payments are. Some payers may not have systems in place to carry them out. For example, payers that do not have readily available data on patient outcomes would be reliant on providers or other third parties to share whether patients have experienced durable benefits. Additionally, successful administration of the alternative payment models would require manufacturers and payers to agree on definitions of “positive” outcomes in complex diseases that vary widely in how they present in patients.</p>\n<h3>Patient portability and the buy-and-bill model</h3>\n<p>Alternative reimbursement models are designed to address payer concerns about high one-time costs and to reduce the risk payers shoulder. However, initial proposals do not address patient portability, as mentioned earlier, and provider challenges with the buy-and-bill model. Conceivably, broadening the contracts could spread the costs over multiple payers if a patient moves. Additionally, similar alternative contracts could reduce up-front payments and risk to providers.</p>\n<h2>The way forward in payment options</h2>\n<p>There are two high-level approaches manufacturers can take to facilitate payment for gene therapy and hence widen availability: work within the system, or change it. The latter would entail changing market structures or changing regulations and legislation. And the options are not mutually exclusive (Exhibit 2).</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-inline-module-container mck-o-md-center\"><div class=\"mdc-u-grid mdc-u-grid-gutter-lg mdc-u-grid-col-sm-1 mdc-u-grid--align-start mdc-u-mb-3 GenericItem_mck-c-generic-item__sGwKL\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c mdc-u-grid-gutter-xs GenericItem_mck-c-generic-item__content__gq1m0\"><div class=\"mck-c-eyebrow mdc-u-ts-10\"><span>Exhibit 2</span></div></div></div><div class=\"mck-u-inline-module-border-top mck-u-inline-module-border-bottom\"><picture data-component=\"mdc-c-picture\" class=\"Exhibit_mck-c-exhibit__image__pyIDm\"><source media=\"(min-width: 768px)\" srcset=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex2.svgz?cq=50&amp;cpy=Center\"><img alt=\"Manufacturers have options when considering how to change payment for gene therapy.\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex2.svgz?cq=50&amp;cpy=Center\" loading=\"lazy\"></picture></div><div class=\"mck-u-sr-only\">We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: <a href=\"mailto:McKinsey_Website_Accessibility@mckinsey.com\">McKinsey_Website_Accessibility@mckinsey.com</a></div></div>\n<h3>Option 1: Work within the current system</h3>\n<p>Working within the current legal and regulatory framework and market structures is the default approach—and the least resource intensive. The aim would be to set a single price for a one-time, up-front payment to a manufacturer based on a robust assessment of the clinical and economic benefits, including cost effectiveness, of a product.</p>\n<p>Achieving this would require the engagement of a broad set of stakeholders, including United States–based third-party value-assessment groups, such as the Institute for Clinical and Economic Review and the Patient-Centered Outcomes Research Institute. Manufacturers would also need to seek collective agreement on the merits of different cost-effectiveness methodologies and to share relevant data, such as clinical-trial results. While manufacturers already share data, they may need to collect more data or modify the design of their studies to meet the requirements of cost-effectiveness studies. Additionally, they may need to share more data ahead of launch to enable these assessments to occur in a timely manner.</p>\n<p>This solution could provide alignment on the appropriate value of gene therapies across manufacturers and payers but may not address the other payer concerns with one-time costs and the risk they are taking on. Also, it would not address provider challenges with the buy-and-bill model.</p>\n<h3>Option 2: Change the market structure</h3>\n<p>Developing different market structures that support different payment models is another way forward that could address payer concerns with risk by distributing it across multiple players.</p>\n<p>One such example would be manufacturers experimenting with a new launch strategy that also changes the distribution of payment risk in the market. Rather than a company selling its product directly to payers and other stakeholders, it could enter a partnership with a PBM—and potentially, its associated specialty pharmacy—whereby the PBM would agree to buy a gene therapy and act as its distributor. The intention would be for the PBM to be able to agree on new payment structures with other payers, such as in the annuity or outcomes-based models described earlier or a model that allows payment to “follow the patient” if he or she switches insurers. In other words, the PBM and specialty pharmacy would assume part of the risk rather than the payer.</p>\n<p>The arrangement would initially generate fees for the specialty pharmacy for dispensing the product. Over time, however, the PBM would gather patient-outcome data, which would help value the product and set a precedent for similar models for other gene therapies. In addition, this arrangement has the benefit of simplifying contracting for the manufacturer: it receives fixed terms from a single entity. Spark Therapeutics and Express Scripts Holding have pursued such an arrangement for Luxturna, Spark Therapeutics’s adeno-associated virus gene therapy that treats certain inherited retinal diseases associated with loss of sight and, in 2017, became the first FDA-approved gene therapy (Exhibit 3).</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-inline-module-container mck-o-md-center\"><div class=\"mdc-u-grid mdc-u-grid-gutter-lg mdc-u-grid-col-sm-1 mdc-u-grid--align-start mdc-u-mb-3 GenericItem_mck-c-generic-item__sGwKL\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c mdc-u-grid-gutter-xs GenericItem_mck-c-generic-item__content__gq1m0\"><div class=\"mck-c-eyebrow mdc-u-ts-10\"><span>Exhibit 3</span></div></div></div><div class=\"mck-u-inline-module-border-top mck-u-inline-module-border-bottom\"><picture data-component=\"mdc-c-picture\" class=\"Exhibit_mck-c-exhibit__image__pyIDm\"><source media=\"(min-width: 768px)\" srcset=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex3.svgz?cq=50&amp;cpy=Center\"><img alt=\"Spark Therapeutics has innovative payment programs for its Luxturna retinal-disease gene therapy.\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/unlocking%20market%20access%20for%20gene%20therapies%20in%20the%20united%20states/svgz-unlocking-market-access-ex3.svgz?cq=50&amp;cpy=Center\" loading=\"lazy\"></picture></div><div class=\"mck-u-sr-only\">We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: <a href=\"mailto:McKinsey_Website_Accessibility@mckinsey.com\">McKinsey_Website_Accessibility@mckinsey.com</a></div></div>\n<p>The downside of this type of arrangement could be that manufacturers relinquish the ability to control, directly, the payment structures offered by distributors. Under normal contracts with payers, manufacturers can stipulate certain parameters (for example, that therapies are covered consistent with their labels, that benefits are processed rapidly, and that out-of-pocket costs are capped at in-network limits). By no longer selling directly to payers, manufacturers lose some of this contracting control.</p>\n<p>Another model that shifts market structurers might be one that distributes the payment risk among a greater number of entities, not just between manufacturers and payers (as in the outcomes-based models described). As companies not traditionally in healthcare, such as technology companies and banks, look to gain exposure to the healthcare space, they could be interested in assuming some of the risk.</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-disruptor1up mck-o-md-center mck-u-inline-module-border-top mck-u-inline-module-border-bottom mck-u-screen-only\" data-layer-region=\"disruptor-1up\"><div class=\"mdc-u-grid mdc-u-grid-gutter-md mdc-u-grid-col-lg-12 mdc-u-grid-col-md-12 \"><div class=\"mdc-u-grid-col-lg-span-4 mdc-u-grid-col-md-span-5 Disruptor1Up_mck-c-disruptor1up__image___2Gc4\"><picture data-component=\"mdc-c-picture\"><img alt=\"Developing tomorrow’s leaders in life sciences\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/developing%20tomorrows%20leaders%20in%20life%20sciences/developing-tomorrows-leaders-1536x1536-0.jpg?cq=50&amp;mh=145&amp;car=16:9&amp;cpy=Center\" loading=\"lazy\"></picture></div><div class=\"mdc-u-grid-col-lg-span-8 mdc-u-grid-col-md-span-7\"><header data-component=\"mdc-c-header\" class=\"mdc-c-header\"><div class=\"mdc-c-header__block___i1Lg-_990311c\"><h3 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c\"><div>Developing tomorrow’s leaders in life sciences</div></h3></div></header><div data-component=\"mdc-c-link-container\" class=\"mdc-c-link-container___xefGu_990311c mdc-c-link-container--display-column___X0HDD_990311c mck-c-disruptor1up__content Disruptor1Up_mck-c-disruptor1up__content--links__VV4lE mdc-u-grid-gutter-md\"><a data-component=\"mdc-c-link\" href=\"/industries/life-sciences/our-insights/developing-tomorrows-leaders-in-life-sciences\" class=\"mdc-c-link-cta___NBQVi_990311c\"><span class=\"mdc-c-link__label___Pfqtd_990311c\">Read the article</span><span data-component=\"mdc-c-icon\" class=\"mdc-c-icon___oi7ef_990311c mck-link-arrow-right-icon\"></span></a></div></div></div></div>\n<p>New forms of insurance aimed at spreading risk might also emerge. For example, in contracts between health-plan sponsors (employers and governments) and PBMs, there could be carve-outs for gene therapy that exclude gene-therapy products from net-cost guarantees. Instead, separate reinsurance funds could be set up to cover these products. Other stakeholders, including manufacturers, that were keen to support the adoption of gene therapy could contribute to the funds along with health-plan sponsors. The US federal government and several states have set up reinsurance programs to protect payers against the risk of covering high-cost Patient Protection and Affordable Care Act enrollees. A reinsurance fund for gene therapy could work similarly—the reinsurance program would pool risk across different payers and be responsible for all or part of the gene-therapy claims that surpass an “attachment point” that triggers reinsurance.</p>\n<h3>Option 3: Change the legal and regulatory environments</h3>\n<p>There may be a need for stakeholders to consider jointly some potential changes to the policy framework and the legal and regulatory environments for gene-therapy reimbursement. A number of forums (such as MIT CBI’s New Drug Development Paradigms and Duke University’s Robert J. Margolis, MD, Center for Health Policy<span class=\"FootNote_footnote-holder__tjRqy\"><a aria-label=\"footnote\" href=\"javascript:void(0);\" class=\"FootNote_footnote-wrapper__AIRwL undefined FootNote_inactive__VZfCp\" aria-describedby=\"9693123b-a231-4e07-b7b9-2bc2becf8f6d\"><sup class=\"FootNote_footnotesup__e73z_\">2</sup><span class=\"FootNote_notch-wrapper__b_5NS\"><span class=\"FootNote_notch__omKtY\"></span></span><span class=\"FootNote_tooltip__QtrbA mdc-u-mt-2\"><span class=\"FootNote_footnote-content__r2OVl\"><span id=\"9693123b-a231-4e07-b7b9-2bc2becf8f6d\" aria-hidden=\"true\" data-module-theme=\"light\" class=\"FootNote_footnote-text__VjKgO mck-u-links-inline\">Gregory W. Daniel et al., <em>Overcoming the legal and regulatory hurdles to value-based payment arrangements for medical products</em>, Robert J. Margolis, MD, Center for Health Policy, December 15, 2017, healthpolicy.duke.edu.</span></span></span></a></span>) have brought together multiple stakeholder groups over the past several years to consider changes to the policy framework for gene therapy.</p>\n<p>In addition, manufacturers could use Centers for Medicare &amp; Medicaid Services (CMS) demonstration projects to test alternative payment models in an environment that allows for waiving of some requirements (for example, best price) for the purpose of the pilots. Spark Therapeutics has already engaged CMS to examine the economic impact of installment payments and higher rebates tied to clinical outcomes.<span class=\"FootNote_footnote-holder__tjRqy\"><a aria-label=\"footnote\" href=\"javascript:void(0);\" class=\"FootNote_footnote-wrapper__AIRwL undefined FootNote_inactive__VZfCp\" aria-describedby=\"85c75f8f-07af-4e75-829c-2dd521cad68e\"><sup class=\"FootNote_footnotesup__e73z_\">3</sup><span class=\"FootNote_notch-wrapper__b_5NS\"><span class=\"FootNote_notch__omKtY\"></span></span><span class=\"FootNote_tooltip__QtrbA mdc-u-mt-2\"><span class=\"FootNote_footnote-content__r2OVl\"><span id=\"85c75f8f-07af-4e75-829c-2dd521cad68e\" aria-hidden=\"true\" data-module-theme=\"light\" class=\"FootNote_footnote-text__VjKgO mck-u-links-inline\">Cathy Kelly, “Installment payments for gene therapy; from Luxturna to hemophilia,” Informa, January 4, 2018, pink.pharmaintelligence.informa.com.</span></span></span></a></span> Other demonstration projects could test reinsurance models to generate evidence for a range of different payment models.</p>\n<hr>\n<p>Gene therapy holds incredible potential to transform the treatment of debilitating diseases. There are several exciting proposals that could address payer concerns with one-time costs, risk, and patient portability. But manufacturers will have to work creatively with other stakeholders to make these proposals reality. They will also have to develop new solutions to overcome challenges providers face with the buy-and-bill model. Unlocking market access for gene therapy will be critical to its adoption and to meeting patients’ needs.</p>\n<div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"default\" data-module-background=\"transparent\" data-module-category=\"\" class=\"mck-c-disruptor-signup mck-o-lg-right-span mck-u-inline-module-border-top mck-u-inline-module-border-bottom mck-u-screen-only\" data-layer-region=\"disruptor-signup\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c\"><h2 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-u-ts-4 DisruptorSignUp_mck-c-disruptor-signup__heading__JR4i0\"><div>Stay current on your favorite topics</div></h2></div><div data-component=\"mdc-c-link-container\" class=\"mdc-c-link-container___xefGu_990311c mdc-c-link-container--align-left\"><a data-component=\"mdc-c-link\" href=\"/user-registration/register-mvc\" class=\"mdc-c-button___U4iY2_990311c mdc-c-button--primary___Ed-lT_990311c mdc-c-button--size-large___jwpUy_990311c\"><span class=\"mdc-c-link__label___Pfqtd_990311c\">Subscribe</span></a></div></div></div><div class=\"container-placeholder\"></div></div></div><div class=\"mdc-u-grid mdc-u-grid-gutter-xl\"><section role=\"contentinfo\" data-layer-region=\"article-about-authors\" class=\"mdc-u-grid mdc-u-grid-col-md-12 AboutAuthor_mck-c-about-author__nRJzu\"><div class=\"mdc-u-grid-col-md-start-2 mdc-u-grid-col-md-end-12 mdc-u-grid-col-lg-start-3 mdc-u-grid-col-lg-end-11\"><h5 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-c-heading--title___5qyOB_990311c mdc-c-heading--border___K8dj3_990311c mdc-u-align-center\">About the author(s)</h5><div data-component=\"mdc-c-description\" class=\"mdc-c-description___SrnQP_990311c mdc-u-ts-8 mck-u-links-inline mck-u-links-inline--secondary mdc-u-mt-5\"><div><p><strong>Toby AuWerter</strong> is a consultant in McKinsey’s Minneapolis office, <strong>Jeff Smith</strong> is a partner in the Boston office, <strong>Josh Sternberg</strong> is an associate partner at the Waltham Client Capability Hub, and <strong>Lydia The</strong> is an associate partner in the Silicon Valley office.</p></div></div></div></section><section class=\"mdc-u-grid mdc-u-grid-col-md-12 mck-u-screen-only\"><div class=\"mdc-u-grid-col-md-start-2 mdc-u-grid-col-md-end-12 mdc-u-grid-col-lg-start-5 mdc-u-grid-col-lg-end-9\"><h5 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-c-heading--title___5qyOB_990311c mdc-c-heading--border___K8dj3_990311c mdc-u-align-center\">Explore a career with us</h5><div data-component=\"mdc-c-link-container\" class=\"mdc-c-link-container___xefGu_990311c mdc-c-link-container--align-center___ar3mu_990311c\"><a data-component=\"mdc-c-link\" href=\"/careers/search-jobs\" class=\"mdc-c-button___U4iY2_990311c mdc-c-button--secondary___Boipq_990311c mdc-c-button--size-large___jwpUy_990311c\" aria-label=\"Search Openings\" data-layer-event-prefix=\"CTA Link\" data-layer-action=\"click\" data-layer-category=\"careers\" data-layer-subcategory=\"search\" data-layer-text=\"Search Openings\"><span class=\"mdc-c-link__label___Pfqtd_990311c\">Search Openings</span></a></div></div></section></div></main></div><div data-component=\"mdc-c-module-wrapper\" data-module-theme=\"light\" data-module-background=\"lightest-grey\" data-module-category=\"StandalonePromo\" class=\"RelatedArticle_mck-c-article-related__GGA76 mck-u-screen-only\" data-layer-region=\"related-articles\"><div class=\"mdc-o-container__wrapper is-wrapped mdc-u-spaced-mobile\"><h5 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-c-heading--title___5qyOB_990311c mdc-u-align-center\">Related Articles</h5><div class=\"mdc-u-grid mdc-u-grid-col-md-3 RelatedArticle_items-container__s2uD0\"><div class=\"mdc-u-grid mdc-u-grid-gutter-lg Card_card__diA2r Card_hover-effect__RGb9b\"><div class=\"Card_wrapper-image__8b4P6\"><a data-component=\"mdc-c-link\" href=\"/capabilities/people-and-organizational-performance/our-insights/agile-the-new-active-ingredient-in-pharma-development\" class=\"mdc-c-link___lBbY1_990311c\"><picture data-component=\"mdc-c-picture\" class=\"Card_wrapper-image__8b4P6\"><style>.picture-uniqueKey-agile-0 { aspect-ratio: 16/9 }</style><img alt=\"Agile: The new active ingredient in pharma development\" class=\"picture-uniqueKey-agile-0\" src=\"/~/media/mckinsey/business%20functions/people%20and%20organizational%20performance/our%20insights/agile%20the%20new%20active%20ingredient%20in%20pharma%20development/agile-the-new-active-ingredient-1536x1536_400.jpg?cq=50&amp;mw=767&amp;car=16:9&amp;cpy=Center\" loading=\"lazy\"></picture></a></div><div class=\"Card_wrapper-text__U6Y3k\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c Card_content-block__pF6Z1\"><span>Interview</span><h6 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-u-ts-6\"><a data-component=\"mdc-c-link\" href=\"/capabilities/people-and-organizational-performance/our-insights/agile-the-new-active-ingredient-in-pharma-development\" class=\"mdc-c-link-heading___Zggl8_990311c mdc-c-link___lBbY1_990311c\"><div>Agile: The new active ingredient in pharma development</div></a></h6></div></div></div><div class=\"mdc-u-grid mdc-u-grid-gutter-lg Card_card__diA2r Card_hover-effect__RGb9b\"><div class=\"Card_wrapper-image__8b4P6\"><a data-component=\"mdc-c-link\" href=\"/industries/life-sciences/our-insights/whats-next-for-biosimilars-in-emerging-markets\" class=\"mdc-c-link___lBbY1_990311c\"><picture data-component=\"mdc-c-picture\" class=\"Card_wrapper-image__8b4P6\"><style>.picture-uniqueKey-what&-0 { aspect-ratio: 16/9 }</style><img alt=\"What’s next for biosimilars in emerging markets?\" class=\"picture-uniqueKey-what&amp;-0\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/whats%20next%20for%20biosimilars%20in%20emerging%20market/whats%20next%20biosimilars_1536x1536_220.jpg?cq=50&amp;mw=767&amp;car=16:9&amp;cpy=Center\" loading=\"lazy\"></picture></a></div><div class=\"Card_wrapper-text__U6Y3k\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c Card_content-block__pF6Z1\"><span>Article</span><h6 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-u-ts-6\"><a data-component=\"mdc-c-link\" href=\"/industries/life-sciences/our-insights/whats-next-for-biosimilars-in-emerging-markets\" class=\"mdc-c-link-heading___Zggl8_990311c mdc-c-link___lBbY1_990311c\"><div>What’s next for biosimilars in emerging markets?</div></a></h6></div></div></div><div class=\"mdc-u-grid mdc-u-grid-gutter-lg Card_card__diA2r Card_hover-effect__RGb9b\"><div class=\"Card_wrapper-image__8b4P6\"><a data-component=\"mdc-c-link\" href=\"/industries/life-sciences/our-insights/helping-to-accelerate-cures-regulating-the-rapidly-evolving-field-of-cell-and-gene-therapies\" class=\"mdc-c-link___lBbY1_990311c\"><picture data-component=\"mdc-c-picture\" class=\"Card_wrapper-image__8b4P6\"><style>.picture-uniqueKey-helpi-0 { aspect-ratio: 16/9 }</style><img alt=\"Helping to accelerate cures: Regulating the rapidly evolving field of cell and gene therapies\" class=\"picture-uniqueKey-helpi-0\" src=\"/~/media/mckinsey/industries/life%20sciences/our%20insights/helping%20to%20accelerate%20cures%20regulating%20the%20rapidly%20evolving%20field%20of%20cell%20and%20gene%20therapies/helping-to-accelerate-cures-1536x1536-600.jpg?cq=50&amp;mw=767&amp;car=16:9&amp;cpy=Center\" loading=\"lazy\"></picture></a></div><div class=\"Card_wrapper-text__U6Y3k\"><div data-component=\"mdc-c-content-block\" class=\"mdc-c-content-block___7p6Lu_990311c Card_content-block__pF6Z1\"><span>Interview</span><h6 data-component=\"mdc-c-heading\" class=\"mdc-c-heading___0fM1W_990311c mdc-u-ts-6\"><a data-component=\"mdc-c-link\" href=\"/industries/life-sciences/our-insights/helping-to-accelerate-cures-regulating-the-rapidly-evolving-field-of-cell-and-gene-therapies\" class=\"mdc-c-link-heading___Zggl8_990311c mdc-c-link___lBbY1_990311c\"><div>Helping to accelerate cures: Regulating the rapidly evolving field of cell and gene therapies</div></a></h6></div></div></div></div></div></div></div></main><div class=\"mck-u-sr-only\" role=\"log\" aria-live=\"polite\" aria-relevant=\"additions\" aria-atomic=\"true\"></div></div><script id=\"__NEXT_DATA__\" type=\"application/json\">{\"props\":{\"pageProps\":{\"locale\":\"en\",\"dictionary\":{},\"sitecoreContext\":{\"route\":{\"name\":\"Unlocking market access for gene therapies in the United States\",\"displayName\":\"Unlocking market access for gene therapies in the United States\",\"fields\":null,\"databaseName\":\"web\",\"deviceId\":\"fe5d7fdf-89c0-4d99-9aa3-b5fbd009c9f3\",\"itemId\":\"81394b9f-5451-4aa5-bad7-e4dccfc807b3\",\"itemLanguage\":\"en\",\"itemVersion\":1,\"layoutId\":\"ae753eb4-a035-40b4-83bf-4b4438df6742\",\"templateId\":\"683910db-02ba-40ba-92e7-726c880160a9\",\"templateName\":\"ArticleJSS\",\"placeholders\":{\"jss-main\":[{\"uid\":\"232bb7e9-289f-492d-a916-2b6185e44a84\",\"componentName\":\"ArticleTemplate\",\"dataSource\":\"\",\"fields\":{\"data\":{\"articleTemplate\":{\"title\":{\"jsonValue\":{\"value\":\"Unlocking market access for gene therapies in the United States\"}},\"sEOTitle\":{\"value\":\"Unlocking access to the gene therapy market in the United States\"},\"description\":{\"jsonValue\":{\"value\":\"Gene therapy holds great promise for treating a variety of diseases, but without changes, today\\u0026rsquo;s payment system could limit the number of patients who benefit.\"}},\"sEODescription\":{\"value\":\"Widening access to the gene therapy market through a better payment system holds great promise for treating a variety of diseases.\"},\"displayDate\":{\"jsonValue\":{\"value\":\"2019-08-22T00:00:00Z\"}},\"body\":{\"value\":\"[[DownloadsSidebar]]\\n\\u003cp\\u003e\\u003cstrong\\u003eGene therapy has the potential\\u003c/strong\\u003e to eradicate the increasing number of diseases we know are associated with faulty or missing genes\\u0026mdash;or at least provide a functional cure for a period of time.[[footnote 1]] Take hemophilia A, for example. Patients with this debilitating disease lack a gene that produces an essential blood-clotting protein, factor VIII. Gene therapy replaces that gene. Moreover, in contrast with other forms of therapy for hemophilia, in which weekly or monthly infusions of clotting-factor drugs are often necessary, gene therapy has the potential to be \\u0026ldquo;once and done.\\u0026rdquo; For years after administration, the patient may only require periodic follow-ups with a physician to monitor the continued safety and efficacy of the therapy.\\u003c/p\\u003e\\n\\u003cp\\u003eOther gene therapies could have similar benefits, and many of those in development tackle rare diseases for which there are limited\\u0026mdash;or no\\u0026mdash;good treatments. Yet for all the promise of gene therapy, the therapy-payment system in the United States will need to change fundamentally to enable widespread access to it. This article explains why and suggests the steps manufacturers, with the cooperation of other stakeholders in the healthcare value chain, can take to help overcome the current challenges and give more patients access to these innovative therapies.\\u003c/p\\u003e\\n\\u003ch2\\u003eCurrent headwinds in reimbursement\\u003c/h2\\u003e\\n\\u003cp\\u003eReimbursement of pharmaceutical products today occurs on a per-unit basis, which spreads out the costs of drugs and other services for chronic conditions over years. The cost of a gene therapy, however, would be much more concentrated\\u0026mdash;potentially in a single payment. In addition, given that the treatment is new, its full benefits and risks remain unclear. This combination of concentrated cost and uncertain outcome presents payment risks for two entities: payers and healthcare providers.\\u003c/p\\u003e\\n[[MostPopularArticles 5]]\\n\\u003cp\\u003eHigh one-time costs would make it hard for payers to underwrite the risk of full payment for the entire range of gene therapies coming to market simultaneously. In addition, a fixed, up-front pricing structure leaves the payer with all the risk of the therapy not working, given that the long-term efficacy of gene therapy as well as the risk of toxicity and other harmful effects to patients are not known with certainty at the time of first regulatory approval, though many risks will be addressed during pivotal studies and US Food and Drug Administration (FDA) review and approval. Payers and pharmacy benefit managers (PBMs) may require real-world data before covering the cost of gene therapy for all potential patients. And even with restricting coverage to a few therapies for which real-world evidence was available\\u0026mdash;or to a subset of eligible patients\\u0026mdash;cost spikes in annual budgets would be significant concerns.\\u003c/p\\u003e\\n\\u003cp\\u003ePrior experience often shapes payer thinking on coverage for gene therapy. In particular, the concern over budget impact is a direct result of recent payer experience with innovative therapies for conditions like hepatitis C. The high level of unmet need when the first of these products launched in 2013, particularly for populations covered by Medicare and state Medicaid plans, created significant pressure on payer budgets. As more products came to market, increasing competition brought prices down, but the lesson for gene therapy is clear: carefully planning for and managing utilization is critical.\\u003c/p\\u003e\\n\\u003cp\\u003ePatient portability also poses a challenge. Patients in the United States frequently switch their health insurers, with the average tenure estimated to be three to six years. The benefits of gene therapy could last years or even a lifetime, however, posing a unique challenge for the treatment when it comes to portability. Who pays for the benefits? A payer could find itself shouldering all the costs but enjoying few of the subsequent benefits when the patient switched to a different insurer. Those benefits would accrue to the new payer, which would now have a healthier patient in its insurance plan.\\u003c/p\\u003e\\n[[disruptor1Up dis1]]\\n\\u003cp\\u003eFor healthcare providers, the path to adoption of gene therapy is similarly murky. Reimbursement of many biologic therapies in the United States today occurs under a buy-and-bill model. A treatment facility purchases the therapy for a fixed price, a physician administers it, and the facility then receives reimbursement. The physician receives a separate administration fee. This process can take 30 days or longer, potentially limiting the pool of healthcare providers with enough working capital to assume the reimbursement risk for high-cost gene therapy. In addition, some health plans only cover products in treatment facilities that have negotiated lower reimbursement rates. Given the lower margins, these facilities may be less likely to want to take on reimbursement risks unless they are confident they can attract enough new patients to reduce their costs below reimbursement rates. A smaller provider pool may limit the adoption of gene therapy to nearby patients or those willing to travel but may result in higher-quality, specialized care.\\u003c/p\\u003e\\n\\u003cp\\u003eA range of industry stakeholders, including manufacturers, patient-advocacy groups, and payers, have recognized the need to adapt or replace the standard payment system if gene therapy is to become widely available. Several alternative payment mechanisms, including the following, have been proposed:\\u003c/p\\u003e\\n\\u003cul\\u003e\\n    \\u003cli\\u003e\\u003cem\\u003eAnnuity-based payment.\\u003c/em\\u003e The payer agrees to pay a fixed price for the therapy but pays in regular installments, like with an annuity, spreading the cost over time.\\u003c/li\\u003e\\n    \\u003cli\\u003e\\u003cem\\u003eOutcomes-based payment.\\u003c/em\\u003e The payer pays only a portion of the full price up front. If the therapy achieves prespecified outcomes, the payer pays the remainder in full. This model spreads the risk, therefore, between the payer and manufacturer.\\u003c/li\\u003e\\n    \\u003cli\\u003e\\u003cem\\u003eOutcomes-based rebate.\\u003c/em\\u003e The payer pays the full price of the drug up front but receives a rebate if the drug does not achieve prespecified outcomes. This model, again, spreads the risk between the payer and manufacturer.\\u003c/li\\u003e\\n    \\u003cli\\u003e\\u003cem\\u003eOutcomes-based annuity.\\u003c/em\\u003e The payer pays a fixed price, with payments spread over many installments, but only if the drug continues to meet certain prespecified outcomes. This model, too, spreads the risk between the payer and manufacturer.\\u003c/li\\u003e\\n\\u003c/ul\\u003e\\n\\u003cp\\u003eThese proposals are promising in theory and are in use for other drug categories. For example, with cell therapies\\u0026mdash;which have also demonstrated long-term durable responses for certain patients and faced many of the same reimbursement challenges as gene therapies face\\u0026mdash;manufacturers are experimenting with outcomes-based payment models. While reimbursement remains a challenge for cell therapies, limiting their uptake among eligible patients, the lessons learned in that space will likely be relevant to gene therapies.\\u003c/p\\u003e\\n\\u003cp\\u003eWe are also seeing manufacturers of the next wave of gene therapies attempt to use alternative payment models. For example, Novartis received FDA approval for Zolgensma, a gene therapy for pediatric patients with spinal muscular atrophy with SMN1 mutations, in May 2019, and it is engaging with payers to create installment- and outcomes-based-payment options. Another example is bluebird bio, which has discussed offering an installment plan for its gene-replacement therapy Zynteglo, a therapy for beta-thalassemia approved in May 2019 in the European Union.\\u003c/p\\u003e\\n\\u003cp\\u003eThe challenges of alternative payment models, including price-reporting requirements, administration, and patient portability, however, are significant (Exhibit 1). They will need to be addressed to allow any alternative payment scheme to be workable.\\u003c/p\\u003e\\n[[Exhibit 1]]\\n\\u003ch3\\u003ePrice-reporting requirements\\u003c/h3\\u003e\\n\\u003cp\\u003eCurrent price-reporting requirements in the United States limit the ability of manufacturers to offer outcomes-based payments and payments over time. Under best-price regulations, they must report all prices paid for therapy, with the lowest price\\u0026mdash;or the average price minus a specified percentage, likely to be 23 percent for gene therapy\\u0026mdash;becoming the benchmark paid within US Medicaid programs and the government\\u0026rsquo;s 340B drug-discount program.\\u003c/p\\u003e\\n\\u003cp\\u003eWith an outcomes-based system, just one patient who failed to respond to gene therapy could set the price paid at a low level for all patients\\u0026mdash;including those who respond well\\u0026mdash;unless the rebate or discount was within 23 percent of the average price. Similarly, payment over time would be limited unless every potential payer was using the same scheme. Otherwise, different payments from different organizations would make the average price reported by manufacturers inconsistent as installment payments came in.\\u003c/p\\u003e\\n\\u003ch3\\u003eAdministration\\u003c/h3\\u003e\\n\\u003cp\\u003eAlternative payment models are more complex to administer than traditional, one-time payments are. Some payers may not have systems in place to carry them out. For example, payers that do not have readily available data on patient outcomes would be reliant on providers or other third parties to share whether patients have experienced durable benefits. Additionally, successful administration of the alternative payment models would require manufacturers and payers to agree on definitions of \\u0026ldquo;positive\\u0026rdquo; outcomes in complex diseases that vary widely in how they present in patients.\\u003c/p\\u003e\\n\\u003ch3\\u003ePatient portability and the buy-and-bill model\\u003c/h3\\u003e\\n\\u003cp\\u003eAlternative reimbursement models are designed to address payer concerns about high one-time costs and to reduce the risk payers shoulder. However, initial proposals do not address patient portability, as mentioned earlier, and provider challenges with the buy-and-bill model. Conceivably, broadening the contracts could spread the costs over multiple payers if a patient moves. Additionally, similar alternative contracts could reduce up-front payments and risk to providers.\\u003c/p\\u003e\\n\\u003ch2\\u003eThe way forward in payment options\\u003c/h2\\u003e\\n\\u003cp\\u003eThere are two high-level approaches manufacturers can take to facilitate payment for gene therapy and hence widen availability: work within the system, or change it. The latter would entail changing market structures or changing regulations and legislation. And the options are not mutually exclusive (Exhibit 2).\\u003c/p\\u003e\\n[[Exhibit 2]]\\n\\u003ch3\\u003eOption 1: Work within the current system\\u003c/h3\\u003e\\n\\u003cp\\u003eWorking within the current legal and regulatory framework and market structures is the default approach\\u0026mdash;and the least resource intensive. The aim would be to set a single price for a one-time, up-front payment to a manufacturer based on a robust assessment of the clinical and economic benefits, including cost effectiveness, of a product.\\u003c/p\\u003e\\n\\u003cp\\u003eAchieving this would require the engagement of a broad set of stakeholders, including United States\\u0026ndash;based third-party value-assessment groups, such as the Institute for Clinical and Economic Review and the Patient-Centered Outcomes Research Institute. Manufacturers would also need to seek collective agreement on the merits of different cost-effectiveness methodologies and to share relevant data, such as clinical-trial results. While manufacturers already share data, they may need to collect more data or modify the design of their studies to meet the requirements of cost-effectiveness studies. Additionally, they may need to share more data ahead of launch to enable these assessments to occur in a timely manner.\\u003c/p\\u003e\\n\\u003cp\\u003eThis solution could provide alignment on the appropriate value of gene therapies across manufacturers and payers but may not address the other payer concerns with one-time costs and the risk they are taking on. Also, it would not address provider challenges with the buy-and-bill model.\\u003c/p\\u003e\\n\\u003ch3\\u003eOption 2: Change the market structure\\u003c/h3\\u003e\\n\\u003cp\\u003eDeveloping different market structures that support different payment models is another way forward that could address payer concerns with risk by distributing it across multiple players.\\u003c/p\\u003e\\n\\u003cp\\u003eOne such example would be manufacturers experimenting with a new launch strategy that also changes the distribution of payment risk in the market. Rather than a company selling its product directly to payers and other stakeholders, it could enter a partnership with a PBM\\u0026mdash;and potentially, its associated specialty pharmacy\\u0026mdash;whereby the PBM would agree to buy a gene therapy and act as its distributor. The intention would be for the PBM to be able to agree on new payment structures with other payers, such as in the annuity or outcomes-based models described earlier or a model that allows payment to \\u0026ldquo;follow the patient\\u0026rdquo; if he or she switches insurers. In other words, the PBM and specialty pharmacy would assume part of the risk rather than the payer.\\u003c/p\\u003e\\n\\u003cp\\u003eThe arrangement would initially generate fees for the specialty pharmacy for dispensing the product. Over time, however, the PBM would gather patient-outcome data, which would help value the product and set a precedent for similar models for other gene therapies. In addition, this arrangement has the benefit of simplifying contracting for the manufacturer: it receives fixed terms from a single entity. Spark Therapeutics and Express Scripts Holding have pursued such an arrangement for Luxturna, Spark Therapeutics\\u0026rsquo;s adeno-associated virus gene therapy that treats certain inherited retinal diseases associated with loss of sight and, in 2017, became the first FDA-approved gene therapy (Exhibit 3).\\u003c/p\\u003e\\n[[Exhibit 3]]\\n\\u003cp\\u003eThe downside of this type of arrangement could be that manufacturers relinquish the ability to control, directly, the payment structures offered by distributors. Under normal contracts with payers, manufacturers can stipulate certain parameters (for example, that therapies are covered consistent with their labels, that benefits are processed rapidly, and that out-of-pocket costs are capped at in-network limits). By no longer selling directly to payers, manufacturers lose some of this contracting control.\\u003c/p\\u003e\\n\\u003cp\\u003eAnother model that shifts market structurers might be one that distributes the payment risk among a greater number of entities, not just between manufacturers and payers (as in the outcomes-based models described). As companies not traditionally in healthcare, such as technology companies and banks, look to gain exposure to the healthcare space, they could be interested in assuming some of the risk.\\u003c/p\\u003e\\n[[disruptor1Up dis2]]\\n\\u003cp\\u003eNew forms of insurance aimed at spreading risk might also emerge. For example, in contracts between health-plan sponsors (employers and governments) and PBMs, there could be carve-outs for gene therapy that exclude gene-therapy products from net-cost guarantees. Instead, separate reinsurance funds could be set up to cover these products. Other stakeholders, including manufacturers, that were keen to support the adoption of gene therapy could contribute to the funds along with health-plan sponsors. The US federal government and several states have set up reinsurance programs to protect payers against the risk of covering high-cost Patient Protection and Affordable Care Act enrollees. A reinsurance fund for gene therapy could work similarly\\u0026mdash;the reinsurance program would pool risk across different payers and be responsible for all or part of the gene-therapy claims that surpass an \\u0026ldquo;attachment point\\u0026rdquo; that triggers reinsurance.\\u003c/p\\u003e\\n\\u003ch3\\u003eOption 3: Change the legal and regulatory environments\\u003c/h3\\u003e\\n\\u003cp\\u003eThere may be a need for stakeholders to consider jointly some potential changes to the policy framework and the legal and regulatory environments for gene-therapy reimbursement. A number of forums (such as MIT CBI\\u0026rsquo;s New Drug Development Paradigms and Duke University\\u0026rsquo;s Robert J. Margolis, MD, Center for Health Policy[[footnote 2]]) have brought together multiple stakeholder groups over the past several years to consider changes to the policy framework for gene therapy.\\u003c/p\\u003e\\n\\u003cp\\u003eIn addition, manufacturers could use Centers for Medicare \\u0026amp; Medicaid Services (CMS) demonstration projects to test alternative payment models in an environment that allows for waiving of some requirements (for example, best price) for the purpose of the pilots. Spark Therapeutics has already engaged CMS to examine the economic impact of installment payments and higher rebates tied to clinical outcomes.[[footnote 3]] Other demonstration projects could test reinsurance models to generate evidence for a range of different payment models.\\u003c/p\\u003e\\n\\u003chr /\\u003e\\n\\u003cp\\u003eGene therapy holds incredible potential to transform the treatment of debilitating diseases. There are several exciting proposals that could address payer concerns with one-time costs, risk, and patient portability. But manufacturers will have to work creatively with other stakeholders to make these proposals reality. They will also have to develop new solutions to overcome challenges providers face with the buy-and-bill model. Unlocking market access for gene therapy will be critical to its adoption and to meeting patients\\u0026rsquo; needs.\\u003c/p\\u003e\\n[[DisruptorSignUp full-width]]\"},\"isFullScreenInteractive\":{\"boolValue\":false},\"hideStickySocialShareBar\":{\"boolValue\":false},\"desktopID\":{\"value\":\"\"},\"mobileID\":{\"value\":\"\"},\"desktopURL\":{\"value\":\"\"},\"mobileURL\":{\"value\":\"\"},\"desktopPaddingPercentage\":{\"value\":\"\"},\"mobilePaddingPercentage\":{\"value\":\"\"},\"desktopOverrideHeight\":{\"value\":\"\"},\"mobileOverrideHeight\":{\"value\":\"\"},\"cerosOembedURL\":{\"value\":\"\"},\"cerosRenderMode\":{\"targetItem\":null},\"cerosBackgroundColor\":{\"targetItem\":null},\"hideByLine\":{\"boolValue\":false},\"tableOfContentsTitle\":{\"value\":\"TABLE OF CONTENTS\"},\"accessStatus\":{\"targetItem\":{\"key\":{\"value\":\"RegisteredUsers\"},\"value\":{\"value\":\"Registered Users\"}}},\"articleType\":{\"targetItem\":{\"displayName\":\"Article\"}},\"hasSpecialReport\":{\"boolValue\":false},\"contentType\":{\"targetItem\":{\"displayName\":\"Article\"}},\"sourcePublication\":{\"targetItem\":null},\"externalPublication\":{\"value\":\"\"},\"mobileReady\":{\"boolValue\":true},\"forClientsOnly\":{\"boolValue\":false},\"excludeFromClientLink\":{\"boolValue\":false},\"originalPublishDate\":{\"jsonValue\":{\"value\":\"2019-08-22T00:00:00Z\"}},\"footnotes\":{\"value\":\"\\u003col\\u003e\\n    \\u003cli\\u003eIn this article, \\u0026ldquo;gene therapies\\u0026rdquo; refer to direct, in vivo administration of DNA-based therapies. Their most common delivery method is via a viral vector, such as a lentivirus or adeno-associated virus.\\u003c/li\\u003e\\n    \\u003cli\\u003eGregory W. Daniel et al., \\u003cem\\u003eOvercoming the legal and regulatory hurdles to value-based payment arrangements for medical products\\u003c/em\\u003e, Robert J. Margolis, MD, Center for Health Policy, December 15, 2017, healthpolicy.duke.edu.\\u003c/li\\u003e\\n    \\u003cli\\u003eCathy Kelly, \\u0026ldquo;Installment payments for gene therapy; from Luxturna to hemophilia,\\u0026rdquo; Informa, January 4, 2018, pink.pharmaintelligence.informa.com.\\u003c/li\\u003e\\n\\u003c/ol\\u003e\"},\"contributoryPractice\":{\"targetItems\":[{\"displayName\":\"Life Sciences\"}]},\"aboutTheAuthors\":{\"value\":\"\\u003cp\\u003e\\u003cstrong\\u003eToby AuWerter\\u003c/strong\\u003e is a consultant in McKinsey\\u0026rsquo;s Minneapolis office, \\u003cstrong\\u003eJeff Smith\\u003c/strong\\u003e is a partner in the Boston office, \\u003cstrong\\u003eJosh Sternberg\\u003c/strong\\u003e is an associate partner at the Waltham Client Capability Hub, and \\u003cstrong\\u003eLydia The\\u003c/strong\\u003e is an associate partner in the Silicon Valley office.\\u003c/p\\u003e\"},\"authors\":{\"targetItems\":[{\"template\":{\"id\":\"3FBABDB63A094F68B1F8E1BBE1BA124E\",\"name\":\"Author\"},\"id\":\"C71B050D8E8F4565A6FCA06AD4916FD0\",\"name\":\"Toby AuWerter\",\"authorTitle\":{\"value\":\"Toby AuWerter\"},\"description\":{\"value\":\"\"},\"thumbnailImage\":{\"alt\":\"\",\"src\":null},\"profile\":{\"targetItems\":[]}},{\"template\":{\"id\":\"3FBABDB63A094F68B1F8E1BBE1BA124E\",\"name\":\"Author\"},\"id\":\"BA87ED5A996D4B829FF2723835B4AC1A\",\"name\":\"Jeff Smith\",\"authorTitle\":{\"value\":\"Jeff Smith\"},\"description\":{\"value\":\"\"},\"thumbnailImage\":{\"alt\":\"\",\"src\":null},\"profile\":{\"targetItems\":[]}},{\"template\":{\"id\":\"3FBABDB63A094F68B1F8E1BBE1BA124E\",\"name\":\"Author\"},\"id\":\"CA4E06BA8AE843BAA24EE9787E7EE032\",\"name\":\"Josh Sternberg\",\"authorTitle\":{\"value\":\"Josh Sternberg\"},\"description\":{\"value\":\"\"},\"thumbnailImage\":{\"alt\":\"\",\"src\":null},\"profile\":{\"targetItems\":[]}},{\"template\":{\"id\":\"3FBABDB63A094F68B1F8E1BBE1BA124E\",\"name\":\"Author\"},\"id\":\"0CCF83846AA64EC58FE0C918C003830F\",\"name\":\"Lydia The\",\"authorTitle\":{\"value\":\"Lydia The\"},\"description\":{\"value\":\"\"},\"thumbnailImage\":{\"alt\":\"\",\"src\":null},\"profile\":{\"targetItems\":[]}}]},\"nonPartnerAuthors\":{\"targetItems\":[]},\"interactiveToUse\":{\"targetItem\":null},\"enableArticleComponents\":{\"boolValue\":false},\"relatedArticles\":{\"targetItems\":[{\"sourcePublication\":{\"targetItem\":null},\"publicationSource\":null,\"externalPublication\":{\"value\":\"\"},\"title\":{\"value\":\"Agile: The new active ingredient in pharma development\"},\"url\":{\"path\":\"/capabilities/people-and-organizational-performance/our-insights/agile-the-new-active-ingredient-in-pharma-development\"},\"eyebrow\":{\"targetItem\":{\"name\":\"Interview\"}},\"articleType\":{\"targetItem\":{\"name\":\"Interview\"}},\"contentType\":{\"targetItem\":{\"name\":\"Article\"}},\"description\":{\"value\":\"Roche\\u0026rsquo;s Frank Duff and Malte Schutz explain how trust, a faster pace, and evolutionary design have transformed their highly technical (and highly regulated) work.\"},\"standardImage\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/our insights/agile the new active ingredient in pharma development/agile-the-new-active-ingredient-1536x1536_400.jpg\",\"alt\":\"Agile: The new active ingredient in pharma development\"},\"heroImage\":null,\"thumbnailImage\":null},{\"sourcePublication\":{\"targetItem\":null},\"publicationSource\":null,\"externalPublication\":{\"value\":\"\"},\"title\":{\"value\":\"What\\u0026rsquo;s next for biosimilars in emerging markets?\"},\"url\":{\"path\":\"/industries/life-sciences/our-insights/whats-next-for-biosimilars-in-emerging-markets\"},\"eyebrow\":{\"targetItem\":{\"name\":\"Article\"}},\"articleType\":{\"targetItem\":{\"name\":\"Article\"}},\"contentType\":{\"targetItem\":{\"name\":\"Article\"}},\"description\":{\"value\":\"Affordable biologic therapies could help expand patients\\u0026rsquo; access to treatment in the developing world. Here\\u0026rsquo;s what pharma companies must know to unlock the potential.\"},\"standardImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/whats next for biosimilars in emerging market/whats next biosimilars_1536x1536_220.jpg\",\"alt\":\"What’s next for biosimilars in emerging markets?\"},\"heroImage\":null,\"thumbnailImage\":null},{\"sourcePublication\":{\"targetItem\":null},\"publicationSource\":null,\"externalPublication\":{\"value\":\"\"},\"title\":{\"value\":\"Helping to accelerate cures: Regulating the rapidly evolving field of cell and gene therapies\"},\"url\":{\"path\":\"/industries/life-sciences/our-insights/helping-to-accelerate-cures-regulating-the-rapidly-evolving-field-of-cell-and-gene-therapies\"},\"eyebrow\":{\"targetItem\":{\"name\":\"Interview\"}},\"articleType\":{\"targetItem\":{\"name\":\"Interview\"}},\"contentType\":{\"targetItem\":{\"name\":\"Article\"}},\"description\":{\"value\":\"In this interview, Peter Marks of the US Food and Drug Administration discusses how the organization has contributed to the broader ecosystem of innovation.\"},\"standardImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/helping to accelerate cures regulating the rapidly evolving field of cell and gene therapies/helping-to-accelerate-cures-1536x1536-600.jpg\",\"alt\":\"Helping to accelerate cures: Regulating the rapidly evolving field of cell and gene therapies\"},\"heroImage\":null,\"thumbnailImage\":null}]},\"useEnhancedAuthors\":{\"boolValue\":false},\"acknowledgements\":{\"value\":\"\"},\"showSocialShareFooter\":{\"boolValue\":false},\"template\":{\"id\":\"683910db-02ba-40ba-92e7-726c880160a9\"},\"hideFromSearchEngines\":{\"boolValue\":false},\"heroFiftyFiftyBackground\":{\"targetItem\":{\"displayName\":\"Deep Blue\"}},\"backgroundColor\":{\"targetItem\":{\"key\":{\"value\":\"Deep Blue\"},\"value\":{\"value\":\"deep-blue\"}}},\"gradientDirection\":{\"targetItem\":{\"key\":{\"value\":\"Bottom Right\"},\"value\":{\"value\":\"bottom-right\"}}},\"hideStickySubscriptionBar\":{\"value\":false},\"enableRegWall\":{\"boolValue\":false},\"timer\":{\"value\":\"8\"},\"regWallHeading\":{\"value\":\"\"},\"showGoToHomeLink\":{\"boolValue\":true},\"regWallDescription\":{\"value\":\"\"},\"isInsightsStorePage\":{\"boolValue\":false},\"selectedModalSubscriptions\":{\"targetItems\":[]},\"link1\":{\"queryString\":\"\",\"className\":\"\",\"anchor\":\"\",\"linkType\":\"internal\",\"url\":\"\",\"text\":\"\",\"targetItem\":null},\"link2\":{\"queryString\":\"\",\"className\":\"\",\"anchor\":\"\",\"linkType\":\"internal\",\"url\":\"\",\"text\":\"\",\"targetItem\":null},\"link3\":{\"queryString\":\"\",\"className\":\"\",\"anchor\":\"\",\"linkType\":\"internal\",\"url\":\"\",\"text\":\"\",\"targetItem\":null},\"link4\":{\"queryString\":\"\",\"className\":\"\",\"anchor\":\"\",\"linkType\":\"internal\",\"url\":\"\",\"text\":\"\",\"targetItem\":null},\"link5\":{\"queryString\":\"\",\"className\":\"\",\"anchor\":\"\",\"linkType\":\"internal\",\"url\":\"\",\"text\":\"\",\"targetItem\":null},\"fullReportPDF\":{\"name\":\"Full Report PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"fullReportPDFDisplayName\":{\"value\":\"\"},\"appendixPDF\":{\"name\":\"Appendix PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"appendixPDFDisplayName\":{\"value\":\"\"},\"articlePDF\":{\"name\":\"Article PDF\",\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/unlocking-market-access-for-gene-therapies-in-the-united-states.pdf\",\"displayName\":\"Unlocking-market-access-for-gene-therapies-in-the-United-States\",\"title\":\"Unlocking market access for gene therapies in the United States\",\"keywords\":\"\",\"description\":\"\",\"extension\":\"pdf\",\"mimeType\":\"application/pdf\",\"size\":417486,\"pageCount\":\"\",\"thumbnailImageSrc\":\"\"},\"briefingNotePDF\":{\"name\":\"Briefing Note PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"discussionPapersPDF\":{\"name\":\"Discussion Papers PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"executiveSummaryPDF\":{\"name\":\"Executive Summary PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"executiveSummaryPDFDisplayName\":{\"value\":\"\"},\"researchPreviewPDF\":{\"name\":\"Research Preview PDF\",\"src\":null,\"displayName\":null,\"title\":null,\"keywords\":null,\"description\":null,\"extension\":null,\"mimeType\":null,\"size\":null,\"pageCount\":null,\"thumbnailImageSrc\":\"\"},\"heroImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/unlocking-market-access-5050-1536x1536.jpg\",\"alt\":\"Unlocking market access for gene therapies in the United States\"},\"standardImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/unlocking-market-access-5050-1536x1536.jpg\",\"alt\":\"Unlocking market access for gene therapies in the United States\"},\"heroImageTopOffset\":{\"value\":\"\"},\"headerOverlayOpacity\":{\"targetItem\":null},\"heroType\":{\"targetItem\":{\"displayName\":\"Fifty Fifty\"}},\"photoOverlayOpacity\":{\"targetItem\":null},\"hideHero\":{\"boolValue\":false},\"articleHeroVideoId\":{\"value\":\"\"},\"podcastHeroOmnyAudioID\":{\"value\":\"\"},\"heroBespokeInteractiveID\":{\"value\":\"\"},\"bespokeHeroRenderMode\":{\"targetItem\":null},\"audio\":{\"results\":[]},\"disruptor1up\":{\"results\":[{\"title\":{\"value\":\"Would you like to learn more about our \\u003ca href=\\\"/industries/life-sciences/how-we-help-clients\\\"\\u003eLife Sciences Practice\\u003c/a\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[]}},\"mediaID\":{\"value\":\"dis1\"},\"template\":{\"name\":\"Disruptor 1Up\"}},{\"title\":{\"value\":\"Developing tomorrow\\u0026rsquo;s leaders in life sciences\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/developing tomorrows leaders in life sciences/developing-tomorrows-leaders-1536x1536-0.jpg\",\"alt\":\"Developing tomorrow’s leaders in life sciences\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"LinkType\":\"internal\",\"Title\":\"\",\"Text\":\"Read the article\",\"Url\":\"/industries/life-sciences/our-insights/developing-tomorrows-leaders-in-life-sciences\",\"Target\":\"\",\"CssClass\":\"\",\"QueryString\":\"\",\"Anchor\":\"\",\"LinkTitle\":\"Developing tomorrow\\u0026rsquo;s leaders in life sciences\"}]}},\"mediaID\":{\"value\":\"dis2\"},\"template\":{\"name\":\"Disruptor 1Up\"}},{\"mediaID\":{\"value\":\"cop28\"},\"title\":{\"value\":\"Explore COP28 with McKinsey\"},\"description\":{\"value\":\"Join us for a series of dynamic virtual events during COP28. Discover new research, practical strategies, and collaborations across sectors that propel climate action and growth towards net-zero.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/sustainability/how we help clients/cop/cop28/cop28-page-thumb_1536x1536.jpg\",\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/capabilities/sustainability/how-we-help-clients/cop/overview\"}]}}},{\"mediaID\":{\"value\":\"attheedge\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eAt the Edge\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/at-the-edge/id1612870236\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3SnUcezwM20nKnzqvUl6iF\"}]}}},{\"mediaID\":{\"value\":\"authortalks\"},\"title\":{\"value\":\"Visit \\u003cem\\u003e\\u003ca href=\\\"/featured-insights/mckinsey-on-books/author-talks\\\"\\u003eAuthor Talks\\u003c/a\\u003e\\u003c/em\\u003e to see the full series.\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/author talks/authortalks_1536x1536_v1.png\",\"alt\":\"Author Talks\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/author-talks\"}]}}},{\"mediaID\":{\"value\":\"COVID\"},\"title\":{\"value\":\"Explore McKinsey’s ongoing coverage of the pandemic\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/risk/our insights/covid 19 implications for business/implications-briefing-note-4-standard-1536x1536.jpg\",\"alt\":\"COVID-19: Implications for business\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Read more about the business impact of coronavirus and how organizations can respond\",\"Title\":\"\",\"Url\":\"/featured-insights/coronavirus-leading-through-the-crisis\"}]}}},{\"mediaID\":{\"value\":\"CE\"},\"title\":{\"value\":\"Customer experience\"},\"description\":{\"value\":\"More insight into creating competitive advantage by putting customers first and managing their journeys.\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/public and social sector/our insights/customer experience/customer-experience_22934010_1536x864.jpg\",\"alt\":\"Customer experience\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"\"}]}}},{\"mediaID\":{\"value\":\"driversofdisruption\"},\"title\":{\"value\":\"Want to subscribe to \\u003ca href=\\\"/features/mckinsey-center-for-future-mobility/our-insights/drivers-of-disruption\\\"\\u003e\\u003cem\\u003eDrivers of Disruption\\u003c/em\\u003e\\u003c/a\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/drivers-of-disruption/id1687257324\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5fWXzWmVKacc5I7u9CQsah?si=KQ-wUOSyQlqcnfexExiH9Q\\u0026nd=1\"}]}}},{\"mediaID\":{\"value\":\"JOL\"},\"title\":{\"value\":\"The Journey of Leadership\"},\"description\":{\"value\":\"\\u003cstrong\\u003eHow CEOs Learn to Lead from the Inside Out\\u003c/strong\\u003e\\u003cbr /\\u003e\\nBy \\u003ca href=\\\"/our-people/dana-maor\\\"\\u003eDana Maor\\u003c/a\\u003e, \\u003ca href=\\\"https://www.linkedin.com/in/hanswernerkaas\\\"\\u003eHans-Werner Kaas\\u003c/a\\u003e, \\u003ca href=\\\"/our-people/kurt-strovink\\\"\\u003eKurt Strovink\\u003c/a\\u003e, and \\u003ca href=\\\"/our-people/ramesh-srinivasan\\\"\\u003eRamesh Srinivasan\\u003c/a\\u003e\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/journey of leadership/journey-of-leadership-book-cover-1536x1536.jpg\",\"alt\":\"The Journey of Leadership book cover\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/journey-of-leadership\"}]}}},{\"mediaID\":{\"value\":\"surveys\"},\"title\":{\"value\":\"McKinsey\\u0026rsquo;s original survey research\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey global surveys/mck-global-survey-landing-1284442931-thumb-1536x1536.jpg\",\"alt\":\"McKinsey Global Surveys\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Read more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-global-surveys\"}]}}},{\"mediaID\":{\"value\":\"healthcarepodcast\"},\"title\":{\"value\":\"Want to subscribe to \\u003cem\\u003eMcKinsey on Healthcare\\u003c/em\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-healthcare/id1469979748\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3y1AgAilV4E5Jz0x4wD9O2?si=mLCTUQ2ORTS_LC5gW_htlA\\u0026dl_branch=1\"}]}}},{\"mediaID\":{\"value\":\"myleadershipjourney\"},\"title\":{\"value\":\"My Leadership Journey\"},\"description\":{\"value\":\"A series of conversations with leaders about the people and experiences that shaped them\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/our insights/my leadership journey/my leadership journey collection page_131575496_thumb_1536x1536.jpg\",\"alt\":\"My Leadership Journey\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/my-leadership-journey\"}]}}},{\"mediaID\":{\"value\":\"lessonsfromleaders\"},\"title\":{\"value\":\"State of Organizations: Lessons from leaders\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/our insights/state of org lessons from leaders/soo-chapter-2-872507320-standard-1536x1536.jpg\",\"alt\":\"\\\"\\\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore more interviews\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/lessons-from-leaders\"}]}}},{\"mediaID\":{\"value\":\"stateoforg\"},\"title\":{\"value\":\"The State of Organizations 2023\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Report overview\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/the-state-of-organizations-2023\"}]}}},{\"mediaID\":{\"value\":\"titaniumeconomy\"},\"title\":{\"value\":\"The Titanium Economy\"},\"description\":{\"value\":\"How Industrial Technology Can Create a Better, Faster, Stronger America\\u003cbr /\\u003e\\nBy \\u003ca href=\\\"/our-people/asutosh-padhi\\\"\\u003eAsutosh Padhi\\u003c/a\\u003e, Gaurav Batra, and \\u003ca href=\\\"https://fernweh.com/nick-santhanam/\\\"\\u003eNick Santhanam\\u003c/a\\u003e\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/the titanium economy/titanium_3d-1536x1536-hero-trans.png\",\"alt\":\"The Titanium Economy Book cover\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/the-titanium-economy\"}]}}},{\"mediaID\":{\"value\":\"GII\"},\"title\":{\"value\":\"Global Infrastructure Initiative\"},\"description\":{\"value\":\"Convening global leaders in infrastructure and capital projects in pursuit of new solutions\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/operations/our insights/the global infrastructure initiative/jpg-cpi-improving-construction-productivity-1536x864.jpg\",\"alt\":\"Improving construction productivity\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"http://www.globalinfrastructureinitiative.com/\"}]}}},{\"mediaID\":{\"value\":\"FOApodcast\"},\"title\":{\"value\":\"Subscribe to \\u003ca href=\\\"/featured-insights/future-of-asia/future-of-asia-podcasts\\\"\\u003e\\u003cem\\u003eFuture of Asia Podcasts\\u003c/em\\u003e\\u003c/a\\u003e\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/future-of-asia/id1480316959\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/2CZX4AR2DT4hQCFKJG0cCv?si=B20tkrOmQYymuCUhKCQOwA\"}]}}},{\"mediaID\":{\"value\":\"logisticsdisruptors\"},\"title\":{\"value\":\"Logistics Disruptors\"},\"description\":{\"value\":\"Meet the companies shaping how goods will move tomorrow.\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/travel logistics and infrastructure/our insights/logistics disruptors/tli-logistics-disruptors-1536x1536.jpeg\",\"alt\":\"illustration autonomous truck driving off into the future\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/travel-logistics-and-infrastructure/our-insights/logistics-disruptors\"}]}}},{\"mediaID\":{\"value\":\"mckinseyexplainers\"},\"title\":{\"value\":\"Looking for direct answers to other complex questions?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey explainers/mckinseyexplainers-flat-thumb-1536x1536.jpg\",\"alt\":\"Circular, white maze filled with white semicircles.\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore the full McKinsey Explainers series\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-explainers\"}]}}},{\"mediaID\":{\"value\":\"livesandlegacies\"},\"title\":{\"value\":\"\\u003cem\\u003e\\u003ca href=\\\"/featured-insights/mckinsey-on-lives-and-legacies\\\"\\u003eMcKinsey on Lives \\u0026amp; Legacies\\u003c/a\\u003e\\u003c/em\\u003e\"},\"description\":{\"value\":\"Highlighting the lasting impact of leaders and executives\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey on lives and legacies/lives-and-legacies-landing-page-thumb-1536x1536.jpg\",\"alt\":\"McKinsey on Lives \\u0026 Legacies\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore previous obituaries\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-lives-and-legacies\"}]}}},{\"mediaID\":{\"value\":\"Strategy\"},\"title\":{\"value\":\"Strategy in a digital age\"},\"description\":{\"value\":\"Our series on developing corporate and business-unit strategies in a digitally disrupted world.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/mckinsey digital/our insights/strategy in a digital age/digital-strategy_1536x864_flexpromoimage.jpg\",\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"View the collection\",\"Title\":\"\",\"Url\":\"/featured-insights/strategy-in-a-digital-age\"}]}}},{\"mediaID\":{\"value\":\"great\"},\"title\":{\"value\":\"The great re-make: Manufacturing for modern times\"},\"description\":{\"value\":\"This 21-article compendium gives practical insights for manufacturing leaders looking to keep a step ahead of today\\u0026rsquo;s disruptions.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/operations/our insights/the great remake manufacturing for modern times/jpg-ops-dm-compendium-cover-1536x864.jpg\",\"alt\":\"The great re-make: Manufacturing for modern times\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"View the collection\",\"Title\":\"\",\"Url\":\"/capabilities/operations/our-insights/the-great-re-make-manufacturing-for-modern-times-compendium\"}]}}},{\"mediaID\":{\"value\":\"futureofamerica\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eFuture of America\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/future-of-america/id1616517376\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/0FpeyjojJTKf2hVtQ3otah\"}]}}},{\"mediaID\":{\"value\":\"governmentpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Government\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-government/id1573645359\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/61XsO4B2ersroMft8t3KSq\"}]}}},{\"mediaID\":{\"value\":\"podcast\"},\"title\":{\"value\":\"Want to subscribe to the McKinsey Podcast?\\n\"},\"description\":{\"value\":\"\\u003cdiv class=\\\"cta-container -align-horizontal\\\"\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eGoogle Play\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eiTunes\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eStitcher\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn mck-rss-icon\\\"\\u003eRSS\\u003c/a\\u003e\\n\\u003c/div\\u003e\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[]}}},{\"mediaID\":{\"value\":\"operationspodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey Talks Operations\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-talks-operations/id1598128813\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/7LYQS2fxAoBmC3LgFNJbi8\"}]}}},{\"mediaID\":{\"value\":\"energyinsights\"},\"title\":{\"value\":\"Speak to an expert about our upstream capabilities\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/oil and gas/how we help clients/energy insights/newsletter-signup-promo-bar-1536x768.jpg\",\"alt\":\"EI newsletter sign up\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Contact us\",\"Title\":\"\",\"Url\":\"/industries/oil-and-gas/how-we-help-clients/energy-solutions/contact-us\"}]}}},{\"mediaID\":{\"value\":\"buildingproductspodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Building Products\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-building-product/id1735607317\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/79pncGJtBtzz7pFoR6OiH8\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/how-we-help-clients/mckinsey-academy/product-academy/mckinsey-on-building-product\"}]}}},{\"mediaID\":{\"value\":\"talentpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey Talks Talent\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-talks-talent/id1491112396\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5sW4eHEFMbOvAFJjMfN9a6\"}]}}},{\"mediaID\":{\"value\":\"outlook\"},\"title\":{\"value\":\"A longer, more comprehensive version of our Global Oil Supply \\u0026 Demand Outlook is available for purchase upon request.\\n\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Contact us\",\"Title\":\"\",\"Url\":\"/industries/oil-and-gas/how-we-help-clients/energy-solutions/contact-us\"}]}}},{\"mediaID\":{\"value\":\"talentpodcast2\"},\"title\":{\"value\":\"McKinsey Talks Talent Podcast\"},\"description\":{\"value\":\"Bryan Hancock, Brooke Weddle, and other talent experts help you navigate a fast-changing landscape and prepare for the future of work by making talent a competitive advantage.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/mckinsey talks talent/mck-mtt-disruptor-full-1536x864-smoke-may-2021.jpg\",\"alt\":\"McKinsey Talks Talent\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"See more episodes\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/mckinsey-talks-talent-podcast\"}]}}},{\"mediaID\":{\"value\":\"investing\"},\"title\":{\"value\":\"Subscribe to McKinsey on Investing\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/private-capital/our-insights/mckinsey-on-investing-issue-1/contact\"}]}}},{\"mediaID\":{\"value\":\"women matter\"},\"title\":{\"value\":\"Subscribe to McKinsey \\u003cem\\u003eWomen Matter Canada\\u003c/em\\u003e\"},\"description\":{\"value\":\"Please subscribe if your organization is interested in learning about participating in future research.\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"\"}]}}},{\"mediaID\":{\"value\":\"customs\"},\"title\":{\"value\":\"This article was written as part of a larger research effort to identify opportunities for improvement and innovation at customs agencies globally.\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/public-sector/our-insights/contact\"}]}}},{\"mediaID\":{\"value\":\"tech\"},\"title\":{\"value\":\"\\u003cspan class=\\\"disrupt-ab\\\"\\u003eCreating value beyond the hype\\u003c/span\\u003e\"},\"description\":{\"value\":\"Let\\u0026rsquo;s deliver on the promise of technology from strategy to scale.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/mckinsey digital/how we help clients/2024/never-just-tech_thumb_1536x1536.jpg\",\"alt\":\"Never just tech\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Get started\",\"Title\":\"\",\"Url\":\"https://www.mckinsey.com/capabilities/mckinsey-digital/how-we-help-clients?cid=njt-ste-crk-mbm-mbm--2403-promo01-njt-bam-web\"}]}}},{\"mediaID\":{\"value\":\"sust\"},\"title\":{\"value\":\"\\u003cspan class=\\\"disrupt-ab\\\"\\u003eMove from plans to progress.\\u003c/span\\u003e\"},\"description\":{\"value\":\"Sustainability matters. Together we’ll make it real.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/sustainability/how we help clients/sustainability-campaign_promo-thumb_1536x1536.jpg\",\"alt\":\"Move from plans to progress.\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Get started\",\"Title\":\"\",\"Url\":\"https://www.mckinsey.com/capabilities/sustainability/how-we-help-clients/?cid=susti24-ste-crk-mbm-m01-other-glb-web\"}]}}},{\"mediaID\":{\"value\":\"nwowpodcast\"},\"title\":{\"value\":\"Subscribe to the New World of Work podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/the-new-world-of-work/id1319502839?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3S6fHLW6mcbDJDp1wkArKI\"}]}}},{\"mediaID\":{\"value\":\"globalpodcast\"},\"title\":{\"value\":\"Want to subscribe to \\u003cem\\u003eThe McKinsey Podcast\\u003c/em\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/the-mckinsey-podcast/id285260960?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/4dyjRTP9xzEUPgleo6XjXI\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"YouTube\",\"Title\":\"\",\"Url\":\"https://www.youtube.com/@McKinsey/podcasts\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-podcast\"}]}}},{\"mediaID\":{\"value\":\"Qaudio\"},\"title\":{\"value\":\"Discover and subscribe to McKinsey Quarterly Audio\"},\"description\":{\"value\":\"\\u003cstrong\\u003eFive ways to subscribe:\\u003c/strong\\u003e\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/mckinsey-quarterly-audio/id1437925222?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5mb2zYJnrPcRrML8gx5doD\"}]}}},{\"mediaID\":{\"value\":\"shortlist\"},\"title\":{\"value\":\"Subscribe to the Shortlist\"},\"description\":{\"value\":\"McKinsey\\u0026rsquo;s new weekly newsletter, featuring must-read content on a range of topics, every Friday\"},\"image\":{\"src\":\"/~/media/mckinsey/email/shortlist/template/shortlist_promo-interrupter-849120982_1536x1536.jpg\",\"alt\":\"the Shortlist\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Get the Shortlist in your inbox\",\"Title\":\"\",\"Url\":\"/user-registration/manage-account/edit-subscriptions\"}]}}},{\"mediaID\":{\"value\":\"retailpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Consumer and Retail\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-consumer-and-retail/id1526250428\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/41D4bro8PPDOGhEgOEJyHB?si=7l3SeYCZQD-7v3toqd9fHQ\"}]}}},{\"mediaID\":{\"value\":\"insurancepodcast\"},\"title\":{\"value\":\"Want to subscribe to the \\u003cem\\u003eMcKinsey on Insurance\\u003c/em\\u003e podcast?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-insurance/id1533196359\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5gZ6YKF7n7C9zWaER4mFZ5\"}]}}},{\"mediaID\":{\"value\":\"strategypodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eInside the Strategy Room\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/inside-the-strategy-room/id1422814215?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/4TcFfiQ0e6OYuc5kRDLxqj\"}]}}},{\"mediaID\":{\"value\":\"mgipodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eForward Thinking\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/forward-thinking/id1319502839\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3S6fHLW6mcbDJDp1wkArKI?si=0zvPmiCsQ7SBAPanfpY4aA\\u0026nd=1\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/mgi/forward-thinking\"}]}}}]},\"globalDisruptors\":{\"disruptor1up\":{\"results\":[{\"mediaID\":{\"value\":\"cop28\"},\"title\":{\"value\":\"Explore COP28 with McKinsey\"},\"description\":{\"value\":\"Join us for a series of dynamic virtual events during COP28. Discover new research, practical strategies, and collaborations across sectors that propel climate action and growth towards net-zero.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/sustainability/how we help clients/cop/cop28/cop28-page-thumb_1536x1536.jpg\",\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/capabilities/sustainability/how-we-help-clients/cop/overview\"}]}}},{\"mediaID\":{\"value\":\"attheedge\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eAt the Edge\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/at-the-edge/id1612870236\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3SnUcezwM20nKnzqvUl6iF\"}]}}},{\"mediaID\":{\"value\":\"authortalks\"},\"title\":{\"value\":\"Visit \\u003cem\\u003e\\u003ca href=\\\"/featured-insights/mckinsey-on-books/author-talks\\\"\\u003eAuthor Talks\\u003c/a\\u003e\\u003c/em\\u003e to see the full series.\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/author talks/authortalks_1536x1536_v1.png\",\"alt\":\"Author Talks\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/author-talks\"}]}}},{\"mediaID\":{\"value\":\"COVID\"},\"title\":{\"value\":\"Explore McKinsey’s ongoing coverage of the pandemic\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/risk/our insights/covid 19 implications for business/implications-briefing-note-4-standard-1536x1536.jpg\",\"alt\":\"COVID-19: Implications for business\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Read more about the business impact of coronavirus and how organizations can respond\",\"Title\":\"\",\"Url\":\"/featured-insights/coronavirus-leading-through-the-crisis\"}]}}},{\"mediaID\":{\"value\":\"CE\"},\"title\":{\"value\":\"Customer experience\"},\"description\":{\"value\":\"More insight into creating competitive advantage by putting customers first and managing their journeys.\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/public and social sector/our insights/customer experience/customer-experience_22934010_1536x864.jpg\",\"alt\":\"Customer experience\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"\"}]}}},{\"mediaID\":{\"value\":\"driversofdisruption\"},\"title\":{\"value\":\"Want to subscribe to \\u003ca href=\\\"/features/mckinsey-center-for-future-mobility/our-insights/drivers-of-disruption\\\"\\u003e\\u003cem\\u003eDrivers of Disruption\\u003c/em\\u003e\\u003c/a\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/drivers-of-disruption/id1687257324\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5fWXzWmVKacc5I7u9CQsah?si=KQ-wUOSyQlqcnfexExiH9Q\\u0026nd=1\"}]}}},{\"mediaID\":{\"value\":\"JOL\"},\"title\":{\"value\":\"The Journey of Leadership\"},\"description\":{\"value\":\"\\u003cstrong\\u003eHow CEOs Learn to Lead from the Inside Out\\u003c/strong\\u003e\\u003cbr /\\u003e\\nBy \\u003ca href=\\\"/our-people/dana-maor\\\"\\u003eDana Maor\\u003c/a\\u003e, \\u003ca href=\\\"https://www.linkedin.com/in/hanswernerkaas\\\"\\u003eHans-Werner Kaas\\u003c/a\\u003e, \\u003ca href=\\\"/our-people/kurt-strovink\\\"\\u003eKurt Strovink\\u003c/a\\u003e, and \\u003ca href=\\\"/our-people/ramesh-srinivasan\\\"\\u003eRamesh Srinivasan\\u003c/a\\u003e\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/journey of leadership/journey-of-leadership-book-cover-1536x1536.jpg\",\"alt\":\"The Journey of Leadership book cover\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/journey-of-leadership\"}]}}},{\"mediaID\":{\"value\":\"surveys\"},\"title\":{\"value\":\"McKinsey\\u0026rsquo;s original survey research\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey global surveys/mck-global-survey-landing-1284442931-thumb-1536x1536.jpg\",\"alt\":\"McKinsey Global Surveys\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Read more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-global-surveys\"}]}}},{\"mediaID\":{\"value\":\"healthcarepodcast\"},\"title\":{\"value\":\"Want to subscribe to \\u003cem\\u003eMcKinsey on Healthcare\\u003c/em\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-healthcare/id1469979748\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3y1AgAilV4E5Jz0x4wD9O2?si=mLCTUQ2ORTS_LC5gW_htlA\\u0026dl_branch=1\"}]}}},{\"mediaID\":{\"value\":\"myleadershipjourney\"},\"title\":{\"value\":\"My Leadership Journey\"},\"description\":{\"value\":\"A series of conversations with leaders about the people and experiences that shaped them\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/our insights/my leadership journey/my leadership journey collection page_131575496_thumb_1536x1536.jpg\",\"alt\":\"My Leadership Journey\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/my-leadership-journey\"}]}}},{\"mediaID\":{\"value\":\"lessonsfromleaders\"},\"title\":{\"value\":\"State of Organizations: Lessons from leaders\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/our insights/state of org lessons from leaders/soo-chapter-2-872507320-standard-1536x1536.jpg\",\"alt\":\"\\\"\\\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore more interviews\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/lessons-from-leaders\"}]}}},{\"mediaID\":{\"value\":\"stateoforg\"},\"title\":{\"value\":\"The State of Organizations 2023\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Report overview\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/our-insights/the-state-of-organizations-2023\"}]}}},{\"mediaID\":{\"value\":\"titaniumeconomy\"},\"title\":{\"value\":\"The Titanium Economy\"},\"description\":{\"value\":\"How Industrial Technology Can Create a Better, Faster, Stronger America\\u003cbr /\\u003e\\nBy \\u003ca href=\\\"/our-people/asutosh-padhi\\\"\\u003eAsutosh Padhi\\u003c/a\\u003e, Gaurav Batra, and \\u003ca href=\\\"https://fernweh.com/nick-santhanam/\\\"\\u003eNick Santhanam\\u003c/a\\u003e\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey books/the titanium economy/titanium_3d-1536x1536-hero-trans.png\",\"alt\":\"The Titanium Economy Book cover\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-books/the-titanium-economy\"}]}}},{\"mediaID\":{\"value\":\"GII\"},\"title\":{\"value\":\"Global Infrastructure Initiative\"},\"description\":{\"value\":\"Convening global leaders in infrastructure and capital projects in pursuit of new solutions\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/operations/our insights/the global infrastructure initiative/jpg-cpi-improving-construction-productivity-1536x864.jpg\",\"alt\":\"Improving construction productivity\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"http://www.globalinfrastructureinitiative.com/\"}]}}},{\"mediaID\":{\"value\":\"FOApodcast\"},\"title\":{\"value\":\"Subscribe to \\u003ca href=\\\"/featured-insights/future-of-asia/future-of-asia-podcasts\\\"\\u003e\\u003cem\\u003eFuture of Asia Podcasts\\u003c/em\\u003e\\u003c/a\\u003e\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/future-of-asia/id1480316959\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/2CZX4AR2DT4hQCFKJG0cCv?si=B20tkrOmQYymuCUhKCQOwA\"}]}}},{\"mediaID\":{\"value\":\"logisticsdisruptors\"},\"title\":{\"value\":\"Logistics Disruptors\"},\"description\":{\"value\":\"Meet the companies shaping how goods will move tomorrow.\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/travel logistics and infrastructure/our insights/logistics disruptors/tli-logistics-disruptors-1536x1536.jpeg\",\"alt\":\"illustration autonomous truck driving off into the future\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/travel-logistics-and-infrastructure/our-insights/logistics-disruptors\"}]}}},{\"mediaID\":{\"value\":\"mckinseyexplainers\"},\"title\":{\"value\":\"Looking for direct answers to other complex questions?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey explainers/mckinseyexplainers-flat-thumb-1536x1536.jpg\",\"alt\":\"Circular, white maze filled with white semicircles.\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore the full McKinsey Explainers series\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-explainers\"}]}}},{\"mediaID\":{\"value\":\"livesandlegacies\"},\"title\":{\"value\":\"\\u003cem\\u003e\\u003ca href=\\\"/featured-insights/mckinsey-on-lives-and-legacies\\\"\\u003eMcKinsey on Lives \\u0026amp; Legacies\\u003c/a\\u003e\\u003c/em\\u003e\"},\"description\":{\"value\":\"Highlighting the lasting impact of leaders and executives\"},\"image\":{\"src\":\"/~/media/mckinsey/featured insights/mckinsey on lives and legacies/lives-and-legacies-landing-page-thumb-1536x1536.jpg\",\"alt\":\"McKinsey on Lives \\u0026 Legacies\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Explore previous obituaries\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-on-lives-and-legacies\"}]}}},{\"mediaID\":{\"value\":\"Strategy\"},\"title\":{\"value\":\"Strategy in a digital age\"},\"description\":{\"value\":\"Our series on developing corporate and business-unit strategies in a digitally disrupted world.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/mckinsey digital/our insights/strategy in a digital age/digital-strategy_1536x864_flexpromoimage.jpg\",\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"View the collection\",\"Title\":\"\",\"Url\":\"/featured-insights/strategy-in-a-digital-age\"}]}}},{\"mediaID\":{\"value\":\"great\"},\"title\":{\"value\":\"The great re-make: Manufacturing for modern times\"},\"description\":{\"value\":\"This 21-article compendium gives practical insights for manufacturing leaders looking to keep a step ahead of today\\u0026rsquo;s disruptions.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/operations/our insights/the great remake manufacturing for modern times/jpg-ops-dm-compendium-cover-1536x864.jpg\",\"alt\":\"The great re-make: Manufacturing for modern times\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"View the collection\",\"Title\":\"\",\"Url\":\"/capabilities/operations/our-insights/the-great-re-make-manufacturing-for-modern-times-compendium\"}]}}},{\"mediaID\":{\"value\":\"futureofamerica\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eFuture of America\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/future-of-america/id1616517376\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/0FpeyjojJTKf2hVtQ3otah\"}]}}},{\"mediaID\":{\"value\":\"governmentpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Government\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-government/id1573645359\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/61XsO4B2ersroMft8t3KSq\"}]}}},{\"mediaID\":{\"value\":\"podcast\"},\"title\":{\"value\":\"Want to subscribe to the McKinsey Podcast?\\n\"},\"description\":{\"value\":\"\\u003cdiv class=\\\"cta-container -align-horizontal\\\"\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eGoogle Play\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eiTunes\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn btn-fill\\\"\\u003eStitcher\\u003c/a\\u003e\\n    \\u003ca href=\\\"#\\\" class=\\\"btn mck-rss-icon\\\"\\u003eRSS\\u003c/a\\u003e\\n\\u003c/div\\u003e\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[]}}},{\"mediaID\":{\"value\":\"operationspodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey Talks Operations\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-talks-operations/id1598128813\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/7LYQS2fxAoBmC3LgFNJbi8\"}]}}},{\"mediaID\":{\"value\":\"energyinsights\"},\"title\":{\"value\":\"Speak to an expert about our upstream capabilities\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":\"/~/media/mckinsey/industries/oil and gas/how we help clients/energy insights/newsletter-signup-promo-bar-1536x768.jpg\",\"alt\":\"EI newsletter sign up\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Contact us\",\"Title\":\"\",\"Url\":\"/industries/oil-and-gas/how-we-help-clients/energy-solutions/contact-us\"}]}}},{\"mediaID\":{\"value\":\"buildingproductspodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Building Products\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-building-product/id1735607317\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/79pncGJtBtzz7pFoR6OiH8\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/how-we-help-clients/mckinsey-academy/product-academy/mckinsey-on-building-product\"}]}}},{\"mediaID\":{\"value\":\"talentpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey Talks Talent\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-talks-talent/id1491112396\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5sW4eHEFMbOvAFJjMfN9a6\"}]}}},{\"mediaID\":{\"value\":\"outlook\"},\"title\":{\"value\":\"A longer, more comprehensive version of our Global Oil Supply \\u0026 Demand Outlook is available for purchase upon request.\\n\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Contact us\",\"Title\":\"\",\"Url\":\"/industries/oil-and-gas/how-we-help-clients/energy-solutions/contact-us\"}]}}},{\"mediaID\":{\"value\":\"talentpodcast2\"},\"title\":{\"value\":\"McKinsey Talks Talent Podcast\"},\"description\":{\"value\":\"Bryan Hancock, Brooke Weddle, and other talent experts help you navigate a fast-changing landscape and prepare for the future of work by making talent a competitive advantage.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/people and organizational performance/mckinsey talks talent/mck-mtt-disruptor-full-1536x864-smoke-may-2021.jpg\",\"alt\":\"McKinsey Talks Talent\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"See more episodes\",\"Title\":\"\",\"Url\":\"/capabilities/people-and-organizational-performance/mckinsey-talks-talent-podcast\"}]}}},{\"mediaID\":{\"value\":\"investing\"},\"title\":{\"value\":\"Subscribe to McKinsey on Investing\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/private-capital/our-insights/mckinsey-on-investing-issue-1/contact\"}]}}},{\"mediaID\":{\"value\":\"women matter\"},\"title\":{\"value\":\"Subscribe to McKinsey \\u003cem\\u003eWomen Matter Canada\\u003c/em\\u003e\"},\"description\":{\"value\":\"Please subscribe if your organization is interested in learning about participating in future research.\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"\"}]}}},{\"mediaID\":{\"value\":\"customs\"},\"title\":{\"value\":\"This article was written as part of a larger research effort to identify opportunities for improvement and innovation at customs agencies globally.\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Learn more\",\"Title\":\"\",\"Url\":\"/industries/public-sector/our-insights/contact\"}]}}},{\"mediaID\":{\"value\":\"tech\"},\"title\":{\"value\":\"\\u003cspan class=\\\"disrupt-ab\\\"\\u003eCreating value beyond the hype\\u003c/span\\u003e\"},\"description\":{\"value\":\"Let\\u0026rsquo;s deliver on the promise of technology from strategy to scale.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/mckinsey digital/how we help clients/2024/never-just-tech_thumb_1536x1536.jpg\",\"alt\":\"Never just tech\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Get started\",\"Title\":\"\",\"Url\":\"https://www.mckinsey.com/capabilities/mckinsey-digital/how-we-help-clients?cid=njt-ste-crk-mbm-mbm--2403-promo01-njt-bam-web\"}]}}},{\"mediaID\":{\"value\":\"sust\"},\"title\":{\"value\":\"\\u003cspan class=\\\"disrupt-ab\\\"\\u003eMove from plans to progress.\\u003c/span\\u003e\"},\"description\":{\"value\":\"Sustainability matters. Together we’ll make it real.\"},\"image\":{\"src\":\"/~/media/mckinsey/business functions/sustainability/how we help clients/sustainability-campaign_promo-thumb_1536x1536.jpg\",\"alt\":\"Move from plans to progress.\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Get started\",\"Title\":\"\",\"Url\":\"https://www.mckinsey.com/capabilities/sustainability/how-we-help-clients/?cid=susti24-ste-crk-mbm-m01-other-glb-web\"}]}}},{\"mediaID\":{\"value\":\"nwowpodcast\"},\"title\":{\"value\":\"Subscribe to the New World of Work podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/the-new-world-of-work/id1319502839?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3S6fHLW6mcbDJDp1wkArKI\"}]}}},{\"mediaID\":{\"value\":\"globalpodcast\"},\"title\":{\"value\":\"Want to subscribe to \\u003cem\\u003eThe McKinsey Podcast\\u003c/em\\u003e?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/the-mckinsey-podcast/id285260960?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/4dyjRTP9xzEUPgleo6XjXI\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"YouTube\",\"Title\":\"\",\"Url\":\"https://www.youtube.com/@McKinsey/podcasts\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/featured-insights/mckinsey-podcast\"}]}}},{\"mediaID\":{\"value\":\"Qaudio\"},\"title\":{\"value\":\"Discover and subscribe to McKinsey Quarterly Audio\"},\"description\":{\"value\":\"\\u003cstrong\\u003eFive ways to subscribe:\\u003c/strong\\u003e\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/mckinsey-quarterly-audio/id1437925222?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5mb2zYJnrPcRrML8gx5doD\"}]}}},{\"mediaID\":{\"value\":\"shortlist\"},\"title\":{\"value\":\"Subscribe to the Shortlist\"},\"description\":{\"value\":\"McKinsey\\u0026rsquo;s new weekly newsletter, featuring must-read content on a range of topics, every Friday\"},\"image\":{\"src\":\"/~/media/mckinsey/email/shortlist/template/shortlist_promo-interrupter-849120982_1536x1536.jpg\",\"alt\":\"the Shortlist\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Get the Shortlist in your inbox\",\"Title\":\"\",\"Url\":\"/user-registration/manage-account/edit-subscriptions\"}]}}},{\"mediaID\":{\"value\":\"retailpodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eMcKinsey on Consumer and Retail\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-consumer-and-retail/id1526250428\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/41D4bro8PPDOGhEgOEJyHB?si=7l3SeYCZQD-7v3toqd9fHQ\"}]}}},{\"mediaID\":{\"value\":\"insurancepodcast\"},\"title\":{\"value\":\"Want to subscribe to the \\u003cem\\u003eMcKinsey on Insurance\\u003c/em\\u003e podcast?\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/mckinsey-on-insurance/id1533196359\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/5gZ6YKF7n7C9zWaER4mFZ5\"}]}}},{\"mediaID\":{\"value\":\"strategypodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eInside the Strategy Room\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://itunes.apple.com/us/podcast/inside-the-strategy-room/id1422814215?mt=2\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/4TcFfiQ0e6OYuc5kRDLxqj\"}]}}},{\"mediaID\":{\"value\":\"mgipodcast\"},\"title\":{\"value\":\"Subscribe to the \\u003cem\\u003eForward Thinking\\u003c/em\\u003e podcast\"},\"description\":{\"value\":\"\"},\"image\":{\"src\":null,\"alt\":\"\"},\"moreLinks\":{\"jsonValue\":{\"value\":[{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Apple Podcasts\",\"Title\":\"\",\"Url\":\"https://podcasts.apple.com/us/podcast/forward-thinking/id1319502839\"},{\"CssClass\":\"btn btn-fill\",\"LinkType\":\"external\",\"Target\":\"_blank\",\"Text\":\"Spotify\",\"Title\":\"\",\"Url\":\"https://open.spotify.com/show/3S6fHLW6mcbDJDp1wkArKI?si=0zvPmiCsQ7SBAPanfpY4aA\\u0026nd=1\"},{\"CssClass\":\"\",\"LinkType\":\"internal\",\"Target\":\"\",\"Text\":\"Listen to previous episodes\",\"Title\":\"\",\"Url\":\"/mgi/forward-thinking\"}]}}}]},\"disruptorsignup\":{\"results\":[{\"mediaID\":{\"value\":\"full-width\"},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"fullwidth\"},\"value\":{\"value\":\"Full Width\"}}},\"callToAction\":{\"url\":\"/user-registration/register-mvc\",\"text\":\"Subscribe\"},\"title\":{\"jsonValue\":{\"value\":\"Stay current on your favorite topics\"}}},{\"mediaID\":{\"value\":\"left\"},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"left\"},\"value\":{\"value\":\"Left\"}}},\"callToAction\":{\"url\":\"/user-registration/register-mvc\",\"text\":\"Subscribe\"},\"title\":{\"jsonValue\":{\"value\":\"Stay current on your favorite topics\"}}}]}},\"ceros\":{\"results\":[]},\"exhibit\":{\"results\":[{\"id\":\"C8835D6719484A1F860E989598D5C7E1\",\"displayName\":\"Exhibit 1\",\"mediaID\":{\"value\":\"1\"},\"includeTheAccessibilityDisclaimerText\":{\"boolValue\":true},\"headline\":{\"jsonValue\":{\"value\":\"\"}},\"hideBottomBorder\":{\"boolValue\":false},\"hideEyebrow\":{\"boolValue\":false},\"eyebrow\":{\"jsonValue\":{\"value\":\"\"}},\"displayNumber\":{\"value\":\"1\"},\"description\":{\"jsonValue\":{\"value\":\"\"}},\"desktopImage\":{\"alt\":\"The challenges with alternative-payment models are significant.\",\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/svgz-unlocking-market-access-ex1.svgz\",\"description\":\"\"},\"mobileImage\":{\"alt\":\"\",\"src\":null},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"Medium content column width\"},\"value\":{\"value\":\"medium\"}}},\"flourishDataVisualizationID\":{\"value\":\"\"},\"pNGImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/png-unlocking-market-access-ex1.png\",\"alt\":\"The challenges with alternative-payment models are significant.\"},\"height\":{\"value\":\"1251\"},\"width\":{\"value\":\"1536\"},\"mobileSVGImage\":{\"src\":null,\"alt\":\"\"},\"mobilePNGImage\":{\"src\":null,\"alt\":\"\"}},{\"id\":\"395FE681F08F4FAC9D8B41E891E86FC8\",\"displayName\":\"Exhibit 2\",\"mediaID\":{\"value\":\"2\"},\"includeTheAccessibilityDisclaimerText\":{\"boolValue\":true},\"headline\":{\"jsonValue\":{\"value\":\"\"}},\"hideBottomBorder\":{\"boolValue\":false},\"hideEyebrow\":{\"boolValue\":false},\"eyebrow\":{\"jsonValue\":{\"value\":\"\"}},\"displayNumber\":{\"value\":\"2\"},\"description\":{\"jsonValue\":{\"value\":\"\"}},\"desktopImage\":{\"alt\":\"Manufacturers have options when considering how to change payment for gene therapy.\",\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/svgz-unlocking-market-access-ex2.svgz\",\"description\":\"\"},\"mobileImage\":{\"alt\":\"\",\"src\":null},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"Medium content column width\"},\"value\":{\"value\":\"medium\"}}},\"flourishDataVisualizationID\":{\"value\":\"\"},\"pNGImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/png-unlocking-market-access-ex2.png\",\"alt\":\"Manufacturers have options when considering how to change payment for gene therapy.\"},\"height\":{\"value\":\"930\"},\"width\":{\"value\":\"1536\"},\"mobileSVGImage\":{\"src\":null,\"alt\":\"\"},\"mobilePNGImage\":{\"src\":null,\"alt\":\"\"}},{\"id\":\"725D5A74BC304BD4B4B8BD93F7DEF386\",\"displayName\":\"Exhibit 3\",\"mediaID\":{\"value\":\"3\"},\"includeTheAccessibilityDisclaimerText\":{\"boolValue\":true},\"headline\":{\"jsonValue\":{\"value\":\"\"}},\"hideBottomBorder\":{\"boolValue\":false},\"hideEyebrow\":{\"boolValue\":false},\"eyebrow\":{\"jsonValue\":{\"value\":\"\"}},\"displayNumber\":{\"value\":\"3\"},\"description\":{\"jsonValue\":{\"value\":\"\"}},\"desktopImage\":{\"alt\":\"Spark Therapeutics has innovative payment programs for its Luxturna retinal-disease gene therapy.\",\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/svgz-unlocking-market-access-ex3.svgz\",\"description\":\"\"},\"mobileImage\":{\"alt\":\"\",\"src\":null},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"Medium content column width\"},\"value\":{\"value\":\"medium\"}}},\"flourishDataVisualizationID\":{\"value\":\"\"},\"pNGImage\":{\"src\":\"/~/media/mckinsey/industries/life sciences/our insights/unlocking market access for gene therapies in the united states/png-unlocking-market-access-ex3.png\",\"alt\":\"Spark Therapeutics has innovative payment programs for its Luxturna retinal-disease gene therapy.\"},\"height\":{\"value\":\"793\"},\"width\":{\"value\":\"1536\"},\"mobileSVGImage\":{\"src\":null,\"alt\":\"\"},\"mobilePNGImage\":{\"src\":null,\"alt\":\"\"}}]},\"image\":{\"results\":[]},\"exhibitcarousel\":{\"results\":[]},\"pullquote\":{\"results\":[]},\"disruptorsignup\":{\"results\":[{\"mediaID\":{\"value\":\"full-width\"},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"fullwidth\"},\"value\":{\"value\":\"Full Width\"}}},\"callToAction\":{\"url\":\"/user-registration/register-mvc\",\"text\":\"Subscribe\"},\"title\":{\"jsonValue\":{\"value\":\"Stay current on your favorite topics\"}}},{\"mediaID\":{\"value\":\"left\"},\"renderMode\":{\"targetItem\":{\"key\":{\"value\":\"left\"},\"value\":{\"value\":\"Left\"}}},\"callToAction\":{\"url\":\"/user-registration/register-mvc\",\"text\":\"Subscribe\"},\"title\":{\"jsonValue\":{\"value\":\"Stay current on your favorite topics\"}}}]},\"articlesidebar\":{\"results\":[]},\"globalsidebar\":{\"results\":[]},\"video\":{\"results\":[]},\"scrollycontainer\":{\"results\":[]},\"bespokeinteractive\":{\"results\":[]},\"storycontainer\":{\"results\":[]},\"interactive\":{\"results\":[]},\"sectionheader\":{\"results\":[]},\"statementdisruptor\":{\"results\":[]},\"fullbleedphoto\":{\"results\":[]},\"tocitem\":{\"results\":[]},\"quizcontainer\":{\"results\":[]},\"generalup\":{\"results\":[]},\"twoupmedium\":{\"results\":[]},\"accordion\":{\"results\":[]},\"factoid\":{\"results\":[]},\"promobarwithquote\":{\"results\":[]},\"oneupmedium\":{\"results\":[]},\"oneupmediumquote\":{\"results\":[]},\"gridwall\":{\"results\":[]},\"twoupsmall\":{\"results\":[]},\"oneclicksubscribe\":{\"results\":[]},\"promobar\":{\"results\":[]},\"promobanner\":{\"results\":[]},\"sectionhero\":{\"results\":[]},\"threeuplinklist\":{\"results\":[]},\"table\":{\"results\":[]},\"isFiveFiftyHorizontalArticle\":{\"boolValue\":false},\"fiveFifty\":{\"results\":[]}},\"contextItem\":{\"ancestors\":[{\"breadCrumbUrl\":{\"path\":\"/industries/life-sciences/our-insights\"},\"breadCrumbTitle\":{\"value\":\"Our Insights\"},\"isMiniSite\":{\"boolValue\":false},\"displayName\":\"Insights on Life Sciences\",\"template\":{\"id\":\"85FF05307883480F9A4C82123F72FFD8\"}},{\"breadCrumbUrl\":{\"path\":\"/industries/life-sciences/how-we-help-clients\"},\"breadCrumbTitle\":null,\"isMiniSite\":{\"boolValue\":true},\"displayName\":\"Life Sciences\",\"template\":{\"id\":\"414C6C64AD35440E9668CF39D8A18CCF\"}},{\"breadCrumbUrl\":{\"path\":\"/industries\"},\"breadCrumbTitle\":{\"value\":\"Industries\"},\"isMiniSite\":{\"boolValue\":false},\"displayName\":\"Industries\",\"template\":{\"id\":\"85FF05307883480F9A4C82123F72FFD8\"}},{\"breadCrumbUrl\":{\"path\":\"/\"},\"breadCrumbTitle\":{\"value\":\"\"},\"isMiniSite\":{\"boolValue\":false},\"displayName\":\"Home\",\"template\":{\"id\":\"85FF05307883480F9A4C82123F72FFD8\"}}]}}},\"placeholders\":{\"main-area\":[],\"sidebar-area\":[]}}]}},\"itemId\":\"81394b9f-5451-4aa5-bad7-e4dccfc807b3\",\"pageEditing\":false,\"site\":{\"name\":\"website\"},\"pageState\":\"normal\",\"language\":\"en\",\"pageMetaData\":{\"alternateLanguages\":[{\"languageCode\":\"en\",\"displayName\":\"English\",\"url\":\"/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\"}],\"currentLanguage\":\"en\",\"navigationLink\":\"industries\",\"activeItemId\":\"{BB8498AC-8CC4-4BFB-8832-53C76F3E61CF}\",\"miniSiteId\":\"{CDBF3A89-AE60-459E-ACF8-786E31307534}\",\"officeCode\":\"\",\"officeDisplayName\":\"\",\"subscriptionPracticeData\":null,\"isAlaisedPage\":false,\"originalHostName\":\"www.mckinsey.com\",\"updatedDate\":\"2023-03-04T09:46:52Z\",\"createdDate\":\"2019-08-20T07:22:45Z\",\"practice\":{\"isDefaultPractice\":false,\"name\":\"Life Sciences\",\"code\":\"N20\",\"stickyTitle\":\"Sign up for emails on new Life Sciences articles\",\"stickySubtitle\":\"Never miss an insight. We'll email you when new articles are published on this topic.\",\"previewLink\":\"\",\"previewLinkLabel\":\"Preview\",\"description\":null,\"descriptionText\":\"Get the latest articles on this topic delivered to your inbox\",\"frequency\":\"Alert\",\"regFormTitle\":null},\"url\":\"/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states\",\"isCareersPage\":false,\"officePath\":\"\",\"hideAppPromo\":false,\"itemInfo\":{\"id\":\"81394b9f-5451-4aa5-bad7-e4dccfc807b3\",\"fullPath\":\"/sitecore/content/McKinsey/Home/Industries/Life Sciences/Our Insights/Unlocking market access for gene therapies in the United States\",\"templateName\":\"ArticleJSS\",\"templateID\":\"683910db-02ba-40ba-92e7-726c880160a9\"}},\"defaultSettings\":{\"McKinsey Quarterly\":\"\\u003cem\\u003eMcKinsey Quarterly\\u003c/em\\u003e\",\"FacebookCID\":\"soc-web\",\"LinkedInCID\":\"soc-web\",\"TwitterCID\":\"soc-web\",\"Home Page SEO Details\":{\"Description\":\"McKinsey \\u0026 Company is the trusted advisor and counselor to many of the world's most influential businesses and institutions.\",\"Image_Url\":\"/~/media/images/global/seoimageplaceholder.jpg\",\"Image_Alt\":\"\"}},\"alumniDatalayerChunk\":\"static/chunks/alumnidatalayer.2eb8cbe055d39895.js\"},\"componentProps\":{},\"notFound\":false,\"noAccess\":false},\"__N_PREVIEW\":true,\"__N_SSP\":true},\"page\":\"/[[...path]]\",\"query\":{\"timestamp\":\"1729760555550\",\"path\":[\"industries\",\"life-sciences\",\"our-insights\",\"unlocking-market-access-for-gene-therapies-in-the-united-states\"]},\"buildId\":\"AymXir4ImcRSnB3UIpSL6\",\"runtimeConfig\":{\"CONFIG_ENV\":\"production\",\"CURRENT_ENV\":\"production\",\"PUBLIC_URL\":\"https://www.mckinsey.com\",\"PUBLIC_CMS_URL\":\"https://cms-prod.mckinsey.com\",\"RECAPTCHA_V3_KEY\":\"6LdC5twSAAAAAF0dePIbY_ckeF05mKdYYJXn7uTg\",\"INVISIBLE_RECAPTCHA_KEY\":\"6LcWCs0UAAAAAEik2NaGkfGH8mGHo1ThxIt-qUoE\",\"USER_SERVICE_API_HOST\":\"https://prd-api.mckinsey.com\",\"MOBILE_SERVICES_HOST\":\"https://mobileservices.mckinsey.com\",\"SEARCH_SERVICE_API_HOST\":\"https://mckapi.mckinsey.com\",\"OT_DATA_DOMAIN_SCRIPT_COM\":\"915b5091-0d7e-44d2-a8c4-cf08267e52fe\",\"OT_DATA_DOMAIN_SCRIPT_DE\":\"13f50396-9d33-4d95-ba3e-1f108fa91009\",\"OT_DATA_DOMAIN_SCRIPT_BR\":\"679eae24-1d5c-4f33-8aae-b35aa8269966\",\"ADOBE_LAUNCH\":\"a400cfbb2fd3\",\"BCOV_POLICY\":\"BCpkADawqM3Xn1B8iTmHawNytUSk0kXaQKMSM51CBVsYKHfwlRhZimTJqbOOq0NuyxTKQnvb4V9myMVRjwGkyGtJQO2HrUPOJHcsgkpbB-jyHwswonskf6XnZaF0TyyKkAQgbymSMtudeD9CLk-xCpqAzTaNUm7a3M3QKLN4pdLRNJ9_HbVMWzNpiUr5ezAVdMciDMwsD-gxNl43d7bfVP3wRhTNWbWUYn3WK7-Oz2gbxV6mMTm0jJU3SjK_x0meTprYUgdUWA-iDgwVglsnfJ_SVtVDPZypUokKv85GzFLM-ywjWlPM2Hg1ucemwwOpa-qvYBGfeMV7zP3n6s22hFCBveiWtHEBpV9N8f4rjmunMlxBx7kSlxIRjWquZm70hLRXMoxAgQ22BC86tBhgR_d1l9_-FzZuZIlZhzJwJi3ug1HszooHM8uEMOkHmB5nYj5XEgVk5JFYGcSwFSnMnNzE1ej2J3jcEiE3eSWHcremWjCZ0s9bs_8R08WpGWkBp8WMXUFfmhPBMk-MGixR_yIu7nJ6B_hYBnVhqKnnoW-xxEmRxgwG0Ev0S96cAcBG8qdlChGN7o1qN0heGTUIYnDk703q3lt9j7X4FgaITrlcPZOWZ96EHytVKUAtmtVp5BVGpiLn4viuUpEdAM_CLSBIaPVunk-39L8tm6m8iUYmbMX_KXPyaL900bQtVQgK39FCa0pUEZ_jSBOGNj1FH8NUPN2TS8_csNWfpN7gsaD9FBN3wUtawAD_RPdJ952odfwJqyvrkN89AyKnFdFMvUh6_4LCIQVYd4M5KC_k1WNLYb11KZhq6O4UaoyD4X1pV4-x0jBzEnc4VQTkL_04dw2xdPJ1uqUrmHuUcIBO0SKaEk6_5HYc3GKfYwmPz1oxMpOi-Rzw1QPyWIdbrcZdFbIHoVZ8FKfyslEv392pJMiKzUnVWL_3mZ0UqnGtddwlXYVdSs57AUdlrfOe7TVaaIMZ_kL7FSrbWrsaSufitSYr62xD1K1-qeb4wkx8QQEorxGJ3RG1Vpn97Pn5JEC_jvj0s7uzFgidYR9bp80EMmPCHUmRg-Hm1Aq1B4YMNc1ARnFz6UvT_8_pMhJEwKuypA-nPoJu4JZJNLVUdw\",\"sitecoreApiKey\":\"{AD59BE63-BA20-47D4-A1B0-ECF30588E2E2}\",\"sitecoreApiHost\":\"https://prod.mckinsey.com\",\"FB_APP_ID\":\"1382278882079245\",\"ARTICLE_API_HOST\":\"https://prd-api.mckinsey.com\",\"SITECORE_FORMS_SERVICES_API_HOST\":\"https://prd-api.mckinsey.com\",\"FEATURE_TOGGLES\":\"{\\\"stack_adapt_pixel\\\": true, \\\"article_seo_schema\\\":true, \\\"remember_me\\\": true, \\\"gql_promo_banner\\\": true, \\\"gql_highlight_bar\\\": true, \\\"gql_ceros_placeholder\\\": true, \\\"gql_two_up_medium\\\": true, \\\"gql_hero_with_partnership_mark\\\": true, \\\"gql_brightcove_gallery\\\": true, \\\"gql_one_up_medium\\\": true, \\\"gql_promo_bar_with_quote\\\": true, \\\"gql_fifty_fifty_hero\\\": true, \\\"gql_enhanched_hero\\\": true, \\\"gql_two_up_small\\\": true, \\\"gql_general_up\\\": true, \\\"gql_full_bleed_hero\\\": true, \\\"passwordless_login_enabled\\\": true, \\\"sso_enabled\\\": true, \\\"article_id\\\": \\\"\\\", \\\"personalisation_enabled\\\":true, \\\"hide_student_sticky_footer\\\":true, \\\"email_domain_validation_enabled\\\":true}\",\"HEADER_SCRIPT_HASH\":\"abcd1234\",\"OKTA_AUTH_CLIENT_ID\":\"0oa8ppb3ypQ8uOI8y697\",\"OKTA_AUTH_ISSUER\":\"https://dotcomidp.mckinsey.com/oauth2/aus2byav0jTElyFDD697/\",\"AUTO_REDIRECTION_DURATION\":\"5\",\"LINKEDIN_IDP\":\"0oaecyj1byxnfrfFk697\",\"APPLE_IDP\":\"0oaeg2lxy6mq4PX5F697\",\"GOOGLE_IDP\":\"0oaeczfkb03XL3E4O697\",\"ALUMNI_BASE_API_URL\":\"https://dev-gateway.intranet.mckinsey.com/:apiKey/v1\",\"ALUMNI_AUTHENTICATE_API_URL\":\"https://dev-ac3-okta-auth.intranet.mckinsey.com/authenticate\",\"ALUMNI_OKTA_URL\":\"\",\"ALUMNI_OKTA_ENABLED\":\"true\",\"GOOGLE_MAP_API_KEY\":\"AIzaSyDqrGDNMDjy9pXHkMf-_Ut33LoC725GSe4\",\"AWS_GATEWAY\":\"https://dev-gateway.mckinsey.com\",\"AWS_API_GATEWAY_ID\":\"o63viscaj4\",\"AWS_PERSONALIZATION_TRACKING_ID\":\"f3f97bc3-4ca7-4960-9e49-0bcff6294ab4\",\"AWS_PERSONALIZATION_CID\":\"recommendations-onw-onw-mck-mck-art-2410-v1-user-ext-web\",\"EVENTS_MODULE_CARDS_COUNT\":\"8\",\"RECOMMENDATIONS_OFFER_ACTIVITY\":\"Article Recommendations\"},\"isFallback\":false,\"dynamicIds\":[70281,79556,76731,68578,32991,98391,30067],\"gssp\":true,\"locale\":\"en\",\"locales\":[\"en\",\"da-DK\"],\"defaultLocale\":\"en\",\"isPreview\":true,\"scriptLoader\":[]}</script><script type=\"text/javascript\" src=\"/1sISTh/L/u/nAoEgpNcfg7J/GaO3tL2mVXLX7b/BVlZblY_cBA/SXAe/KgkXcSUB\"></script><div id=\"floating-ui-root\"></div><script src=\"https://assets.adobedtm.com/b0dfb38aec8a/63974894e9a9/launch-a400cfbb2fd3.min.js?l=1\" data-nscript=\"afterInteractive\"></script><script id=\"data-layer\" data-nscript=\"afterInteractive\">eventDataLayer.pageLoadCompleted()</script><next-route-announcer><p aria-live=\"assertive\" id=\"__next-route-announcer__\" role=\"alert\" style=\"border: 0px; clip: rect(0px, 0px, 0px, 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap; overflow-wrap: normal;\"></p></next-route-announcer></body></html>"
}